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ABSTRACT 
 
 
Purpose: Advanced radiotherapy treatments for Non-Small-Cell Lung Cancer 
(NSCLC) rely on conforming the radiation dose to the tumour geometry as tightly as 
possible; this increases the probability of killing the tumour cells while simultaneously 
reducing the radiation dose to nearby tissues and to organs at risk, subsequently 
reducing normal tissue reactions. Unfortunately, patient breathing is likely to 
compromise the method during implementation, as the breathing motion causes the 
tumour to move periodically out of the path of the radiation beam, while normal, 
healthy tissue periodically moves into the line of the beam. 
The aim of this project is to establish a simple breath-monitoring system which is 
inexpensive, easy to use and patient friendly; this could be achieved by developing a 
device that is considered to be non-invasive, and which also does not rely on 
connections to the treatment machine; it is based on a simple instrumented belt using 
strain-gauges which monitor the chest-to-wall motion during the breathing cycle.  
 
Methods and Materials: A total of fifty volunteers participated in this study. Three 
methods of breathing were used: free-breathing, audio-prompted breathing and 
visual feedback breathing, with synthesised breathing as the ‘ideal’ pattern. The 
breathing monitor was used in order to investigate the difference between various 
training regimes for helping subjects to modify their breathing patterns into a 
desirable pattern. 
 
Results: The results show that audio prompting — the method most commonly used 
in the clinic to date — was the least effective of the methods tested, resulting in large 
amplitude and phase variations compared to the other methods. Visual feedback (not 
currently used) is demonstrated as being far superior in regulating a subject’s 
breathing: this method produces far tighter control over both the amplitude and phase 
of the breathing pattern in comparison to any other method investigated. 
 
Conclusions: It is concluded that the current methods of regulating breathing in 
patients undergoing radiotherapy for lung tumours are inappropriate, and that a far 
better approach would be to use visual feedback. 
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NOTATIONS AND ABBREVIATIONS 
 
• ABC: Active Breathing Control (Device) 
• ADC: Analogue-to-Digital Conversion  
• BEV: Beam Eye View  
• CC : Cubic Centimetres 
• CT: Computed Tomography 
• CTV: Clinical Target Volume 
• 3-DCRT: Three-Dimensional Conformal Radiotherapy 
• DEBH: Deep Expiration Breath-Hold 
• DIBH: Deep Inspiration Breath-Hold 
• DMLC: Dynamic Multi-Leaf Collimator 
• DRR: Digital Reconstructed Radiograph 
• DVH: Dose Volume Histogram 
• EPI: Electronic Portal Imaging  
• FB: Free-Breathing 
• FoM: Figure of Merit 
• GTV: Gross Tumour Volume 
• Gy: Gray (SI Unit of Absorbed Dose) 
• HBSG: Held-Breath Self-Gating Technique 
• ICRU: International Commission on Radiation Units and Measurement 
• IM: Internal Margin 
• IMN: Internal Mammary Nodes 
• IMRT: Intensity-Modulated Radiation Therapy 
• mDIBH: Moderate Deep Inspiration Breath-Hold 
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• MLC: Multi-Leaf Collimator 
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• PET: Positron Emission Tomography 
• POPS: Proof of Principle System 
• PTV: Planning Target Volume 
• RoM: Range of Motion 
• RPM: Real Time Position Management System, Varian Medical 
Systems, Palo Alto, CA 994304 
• SBF: Stereotactic Body Frame 
• SCLC: Small-Cell Lung Cancer 
• SD: Standard Deviation 
• SM: Setup Margin  
• SPO2 : Oxygen Saturation 
• SRT: Stereotactic Radiotherapy 
• TCP: Tumour Control Probability 
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CHAPTER 1: INTRODUCTION 
 
External beam radiotherapy (or radiation therapy) is an important modality in treating 
malignant tumours. Progress over the last two decades in the area of radiation 
therapy technology has been exemplified by the development of state-of-the-art 
radiation treatments, such as 3-Dimensional Conformal Radiotherapy (3-DCRT) and 
Intensity-Modulated Radiation Therapy (IMRT), which have ultimately increased the 
chances of recovery for cancer patients, improved the Tumour Control Probability 
(TCP), and reduced the Normal Tissue Complication Probability (NTCP). The aim of 
3-DCRT is to conform the dose around the tumour, plus some extended volume, and 
then progress to escalate the dose to the tumour in order to improve the TCP and 
finally reduce the NTCP (Webb, 2001). IMRT is an advanced technique of 3-DCRT, 
whereupon the beam intensity is modulated by the planning computer system in 
order to deliver a higher dose to the tumour with a reduced margin. The application of 
the IMRT technique is unique for each patient since it can be modified according to 
each tumour shape with the use of a Multi-Leaf Collimator (MLC), which creates an 
irregular field, providing the best coverage of the tumour (Bortfeld et al., 2002). 
The use of 3-DCRT is critical in the treatment of unstable tumours, such as those 
in the thoracic area, where respiratory motion takes place and where most of the 
critical organs — such as the lung, heart, spinal cord and liver — are located. Since 
the field is modified and shaped around the tumour, any inter-fraction error (due to 
day-to-day setup) or intra-fraction error (due to organ movement) can cause 
geometric uncertainties and failure to deliver the right dose to the right target 
(Ramsey et al., 1999); if these errors are not corrected and subsequently persist 
throughout the treatment, a geographical miss will take place, whereby the dose 
prescribed for the tumour (Armstrong et al., 1998) will differ from that actually 
delivered to the tumour, which will result in a poor treatment outcome, a reduced 
TCP and a higher NTCP. 
Inter-fraction motion occurs because the patient is typically treated using multiple 
treatment fractions; for each fraction, the patient has to be positioned on the 
treatment couch in a manner which reproduces the planned alignment with the 
radiation beam. Despite efforts to deliver the treatment as accurately as possible, the 
position will nevertheless differ from day to day. To date, in most radiation therapy 
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departments, problems associated with inter-fraction movement have been controlled 
as much as possible, through the use either of patient immobilisation devices — such 
as the alpha-cradle (Bentel et al., 1997), the body foam-bag and the T-bar (Halperin 
et al., 1999) — or of portal films or electronic portal imaging devices and image-
guided radiotherapy, which are designed to reduce setup errors and to increase the 
accuracy of everyday treatments (Stroom et al., 1999). 
A number of devices and techniques are also used in order to limit intra-fraction 
or internal organ motion as much as possible, in addition to any changes in internal 
organs due to the treatment; this may be achieved by using respiratory gating 
radiotherapy, adaptive radiotherapy, an Active Breathing Control (ABC) device, or 
different patterns of breath control which the patient has been/could be trained in, 
such as Deep-Inspiration Breath Hold (DIBH) and moderate Deep Inspiration Breath 
Hold (mDIBH) (Halperin et al., 1999). While the control of intra-fraction motion 
nevertheless remains a challenge, the introduction of respiratory manoeuvres and 
gating radiotherapy with the objective of controlling intra-fraction motion has shown a 
significant outcome in reducing the Planning Target Volume (PTV) margin for 
respiration and for limiting the exposure of normal tissue to radiation (Keall et al., 
2001).  
Treatment of Non-Small Cell Lung Cancer (NSCLC) with radiation therapy is 
always a challenge for two key reasons: Firstly, the presence in the thoracic area of 
critical organs — such as the spinal cord posteriorly, the heart inferiorly, and the 
lungs located left and right of the oesophagus — are considered as limiting factors 
for escalating the dose; and, secondly, the effect on the tumour of respiratory motion 
may cause an inadequate dose to be delivered to the PTV (Mechalakos et al., 2004).  
The movement of a tumour due to respiratory motion will range from 0-22 mm in 
the superior-inferior direction and from 0-10 mm in the anterior-posterior direction 
(Mechalakos et al., 2004). In studies carried out by Mechalakos et al. (2004), the 
effects of respiratory motion on the dose coverage for Gross Tumour Volume (GTV) 
and the effect of TCP were investigated and monitored; the researchers analysed 
twelve different treatment plans for patients who had each been previously treated for 
NSCLC, either by IMRT or by static beam. The GTV ranged from 1.2 cc to 97.3 cc. 
PTVs were generated by adding 1 cm margin around the GTV. A further 0.6 cm was 
added in the transverse direction and 1 cm in the superior–inferior direction in order 
to allow for beam penumbra. The total dose was assumed to be 70 Gy. The 
 16
breathing motions were measured using fluoroscopic images; this was done during 
the free-breathing period. Systematic errors due to respiration motion were 
investigated. The study concluded that by using the recommendations, the margin for 
PTV would be sufficient to cover for respiratory motion; however, this needed to be 
carefully evaluated if the patient was seen to be breathing heavily or if the tumour 
otherwise had an irregular shape; in some cases, it might be up to 3.8 cm (Ahn et al., 
2004). It is important to recognise that these ranges differ from one patient to another 
and will also depend significantly on the location of the tumour and the patient’s 
breathing pattern (Kong et al., 2005). Figure 1 shows the movement of the PTV 
outside the treatment field due to respiratory movement. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1: The effects of respiratory motion 
The effective increase in volume and blurring of the shape of the tumour due to its 
periodic motion is shown in red; the PTV (volume to be irradiated) is shown by the grey 
coil. Notice how the tumour moves beyond the grey lines, which would constitute an 
underdose to the tumour with the potential of leaving cancerous cells untreated. 
(Image with kind permission of Mechalakos, J. Radiotherapy and Oncology 71:191-
200, 2004) 
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1.1  RESPIRATORY MANOEUVRES AND GATING RADIOTHERAPY 
Respiratory manoeuvres — which has the goal of immobilising the organs and 
tumours during treatment — requires specific patient participation for it to be 
effective. There are several such manoeuvres, including ABC, DIBH, mDIBH and 
respiratory gated radiotherapy, as well as tumour-tracking techniques. The ABC, 
DIBH and mDIBH techniques will all produce significant effects in reducing the 
volume of normal tissue in the treatment field, but they also have the disadvantage of 
limitations: For example, they require patient participation; patients must have 
adequate pulmonary function; and they must have the ability to hold their breath to 
the full capacity of their lungs (Hanley et al., 1999). DIBH requires patients to hold 
their breath for 10-20 seconds at the end of inspiration under spirometer-based 
monitoring techniques, which measures lung volume through the measurement of the 
inhaled and exhaled air, and records it as a function of time. When DIBH is to be 
used, the patient usually attends a pre-simulation training session, during which he or 
she is coached by a radiation therapist in the reproduction of the same deep 
inspiration level during the simulation and treatment. 
Techniques, such as DIBH and the use of chest restrictors (devices which apply 
external pressure to the chest with the aim of limiting its motion and hence the 
patient’s ability to breathe), are poorly tolerated by lung cancer patients, who often 
have some form of lung dysfunction. In order to overcome these difficulties, 
techniques that try to capitalise on the patient’s Free-Breathing have been 
investigated; such methods rely on providing patients with some form of feedback 
signal (audio, visual or audio-visual) which enables them to match their breathing 
patterns to a predefined pattern. However, the development of these methods has 
occurred without detailed analysis of the best methods of presenting the feedback 
signal or of the best breathing pattern to be followed by the patient. 
This project is primarily aimed at improving our knowledge base concerning a 
patient’s response to and tolerance of different breath-training regimes which are 
designed in order to promote a regular and controlled breathing pattern over a time 
interval commensurate with conventional radiotherapy treatment. In general, this 
means developing methods of monitoring the chest motion as well as developing a 
robust method of analysing the data. As a subsidiary aim, it is hoped that the project 
will lead to the development of a simple and cost-effective device which can, in 
principle, be used either to control or to support the way in which the patient 
 18
maintains a stable breathing pattern without the need for extra equipment, such as 
Computed Tomography (CT), fluoroscopy imaging machines and treatment units.  
 
 
1.2  AIMS 
The aims of this project are fourfold: 
1. To develop a simple breath-monitoring system which is inexpensive, easy to 
use and patient friendly; 
2. to develop an appropriate method/methods for displaying the bio-feedback 
signal to the patient; 
3. to develop a robust method of determining a figure of merit for each method 
tested; and 
4. to use a random sample of healthy individuals in order to establish the best 
training signal to use (i.e. a simple sine wave based on treatment parameters, 
a square wave or a signal based on the patient’s normal Free-Breathing 
pattern). 
 
1.3  LAYOUT OF THE THESIS 
This thesis is divided into seven chapters. The present chapter has outlined the 
background of the investigation and the overall objectives of the project. This is 
followed by Chapter 2 which provides a short introduction concerning the ideas and 
goals of radical (curative) external beam radiotherapy, together with an overview of 
the background information available on the various types of lung cancer and its 
biology. Chapter 2 also discusses the concepts of the various volumes used in 
defining a treatment, as well as the ideas behind the all-important normal tissue 
complication probability and tumour control probability.  
Chapter 3 reviews in detail the methods and approaches adopted to control 
respiratory motion in patients with cancer. It considers most of the current 
techniques, including respiratory gating, breath-hold techniques and respiration 
synchronized radiotherapy; it also discuses the benefits of each of these techniques 
in relation to reducing the effects of motion on radiotherapy treatment and setup. 
Furthermore, the chapter reviews studies of respiratory gating previously used in 
response to different cancer diagnoses, the control of breathing and the variability of 
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respiratory motion, the effects of motion on the treatment of lung cancer and, finally, 
investigations of the benefits of biofeedback in radiotherapy.  
Chapters 4 and 5 compose the core of this thesis. Chapter 4 begins by describing 
the design and construction of a respiratory breathing device, which was built in-
house with the view of training patients to control their breathing during radiotherapy 
treatment. The chapter then progress to providing reports on investigations by way of 
examining the device and its ability to record breathing patterns.  
Chapter 5 describes the methods and the breathing data which were collected 
during the project. Several models are proposed: free-breathing, audio instruction 
breathing, and video feedback breathing; their purpose was to produce more 
consistent and stable breathing patterns during treatment. This chapter sets details 
data collected on the breathing patterns for each of the subjects, such as audio 
instruction breathing patterns and video feedback patterns. It also discusses the 
eligibility of each subject and the challenges associated with the use of the device by 
the subjects. Chapter 5 also presents a model for calculating the breathing phase 
and amplitude for each subject, calculated according to individual breathing patterns.  
Chapter 6 summarises the findings of the study based on data collected from the 
breathing patterns of subjects using the respiratory device. It then moves on to 
consider the potential for the clinical implementation of the device. It concludes with 
suggestions for future investigations and recommendations for further work.  
Chapter 7 provides the key conclusion points of this work and details the benefits 
of using breathing modalities manoeuvres, such as audio prompting and video 
feedback, as a means to providing steady breathing patterns; in addition, it gave the 
limitation of the device and methods and the further work and recommendations. 
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CHAPTER 2: GENERAL BACKGROUND 
 
2.1  NON-SMALL CELL LUNG CANCER 
Lung cancer is the leading cause of cancerous deaths in both men and women 
worldwide, accounting for approximately 18% of all types of cancer in men and 
women and causing over 900,000 deaths each year worldwide (Weitberg and 
Klastersky, 2002). For example, 7.9 million deaths caused by lung cancer occurred in 
2007, which amounts to around 13% of all deaths (Howington, 2008). In the UK, lung 
cancer is the second most common cancer, with 38,313 newly diagnosed cases 
being reported in 2004 (Hunt, 2008). The lifetime risk of developing lung cancer is 
7.63% in men and 5.71% in women; this risk is increased in smokers (Chua et al., 
2004). The overall five-year survival rate with all kinds of treatment modalities, such 
as surgery, chemotherapy and radiation therapy, is still very low at only 
approximately 10%-15%, and mostly depends on the stage of the disease and the 
stage of detection of the tumour (Kong et al., 2005). Unfortunately, approximately 
70% of all cases show signs of metastasis upon detection.  
The UK five-year survival rate for men and women with all types of lung cancer is 
7% (Hunt, 2008). The progression and management of lung cancer depends on two 
major factors: Firstly, the involvement of any adjacent structures, regional metastasis, 
or any regional lymph nodes, such as the hilar, mediastinal and supraclavicular 
nodes; and secondly, the distant metastasis to other organs, which are the lungs, 
adrenal glands, liver, bone, and brain (Choi et al., 2001).  
 
2.2  AETIOLOGY OF LUNG CANCER 
The aetiological factors affecting lung cancer include smoking, which is the leading 
risk factor and accounts for approximately 85% of all cases. Tobacco smoke contains 
many carcinogens, which are linked to biological effects including mutations and 
adduct formation (Chung et al., 1995). A lifetime smoker is at 20 to 30 times greater 
risk of developing lung cancer during his or her lifetime than a non-smoker (Parkin et 
al., 2001). Other factors also play a key role, such as age, genetics and gender; for 
example, the majority of patients develop lung cancer beyond the age of 50, with the 
average age being 65 years (Weitberg, 2002) and, in relation to genetics, people who 
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have a family history of lung cancer will also have a slightly greater risk than those 
with no such history (Weitberg, 2002). A study of the population of Liverpool, UK, 
carried out by Cassidy et al. (2006)  found a five-fold increase in risk for those people 
who had had a first-degree relative who had experienced the disease. Another risk 
factor in relation to lung cancer is gender, the disease being more common in men 
than women, although the incidence in women continues to increase due to smoking 
(Parkin et al., 2001). Timofeeva et al. (2009) studied gender risk differences and 
found an increased risk of developing lung cancer in women compared to men due to 
oestrogen metabolism and the involvement of a certain enzyme called cytochrome 
P450 (CYP), especially in the early onset of lung cancer. The specific mechanism by 
which this enzyme affects women’s risk of experiencing lung cancer is beyond the 
scope of this thesis. 
Exposure to environmental factors, such as radon — particularly amongst miners 
(Parkin et al., 2001) — and occupational exposure (such as to asbestos, arsenic or 
cadmium), are also other factors for consideration and are increasing the risk of lung 
cancer. For instances, asbestos has the ability to cause abnormal segregation of 
chromosomes and DNA damage; asbestos exposure alone has been associated with 
a six-fold relative risk of lung cancer. The presence of related disease in the lung and 
pre-existent non-malignant lung disease, such as chronic obstructive pulmonary 
disease, idiopathic pulmonary fibrosis, pneumoconiosis and tuberculosis, are also 
factors which are actively increasing the risk of lung sarcoma (Weitberg, 2002). 
Lung cancer risk has also been found to be associated with certain 
polymorphisms in certain DNA repair genes (Rosel et al., 2006). Mutations to the 
DNA repair genes may stop the process of DNA repair and may ultimately lead to cell 
death (apoptosis). This event will form proto-oncogenes, and inhibit the activity of 
tumour suppressor genes, subsequently allowing the conversion of normal cells to 
malignant ones (Anderson et al., 1992). 
 
2.3  CLINICAL PRESENTATION  
Lung cancer is usually diagnosed and detected in its later stages, with only 10% 
being diagnosed in the early stages (Table 1); this is mainly due to the nature of lung 
tumours, which do not produce any pain or discomfort until they have developed to a 
stage whereby they are large in size and have started to invade the adjacent 
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structures and blood vessels, at which time symptoms will then begin to appear. The 
most common symptom of lung cancer is a cough, shortness of breath or dyspnea, 
which develops early in approximately 60% of lung cancer patients, and is also a 
common symptom, but which is usually associated with cough and sputum (Beckles 
M., et al., 2003). Haemoptysis is another very common symptom of lung cancer, 
although it is also considered to be another reason for late diagnosis of lung cancer, 
since patients who have smoked often cough up blood and have streaking of the 
sputum, while in their chest X-rays there are rarely any remarkable findings (Beckles 
et al., 2003). Others symptoms of lung cancer are anorexia, hoarseness, chest or 
bone pain, fever and weight loss (Weitberg, 2002).  
 
STAGE FREQUENCY OF 
DIAGNOSIS 
FIVE-YEAR SURVIVAL % 
I 10% >60% 
II 20% 30%-50% 
IIIA 15% 15%-30% 
IIIB 15% 3%-6% 
IV 40% <1% 
Table 1: NSCLC stages with frequency of diagnosis and five-year survival rates (Ettinger, 
D. et al., Clinical Advances in Non-Small Cell Lung Cancer (NSCLC) and Mesothelioma. 
The PeerPoint Medical Education Institute, LLC, 2005) 
 
2.4  DIAGNOSIS 
Clinical evaluation will include a physical examination and chest X-ray. The primary 
diagnosis modality for lung lesions is the chest X-ray, which provides a means of 
detecting enlarged lymph nodes in the chest or abnormal masses in the lungs; 
however, it has inadequate sensitivity for detecting early or pre-malignant growths at 
a stage where intervention can affect mortality. The most commonly used modality 
after chest X-ray is computed tomography scans for chest and abdomen, which 
provide early findings of any abnormality in the lungs (Weitberg, 2002). Sputum 
cytology is also considered a key early detection for lung cancer (Kennedy, 2000). 
There are some other modalities of diagnosis which can also be helpful in detecting 
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the advanced stages of the disease and the tumour; these are CT with intravenous 
contrast, Magnetic Resonance Imaging (MRI) of the chest, Positron Emission 
Tomography (PET), fine needle aspiration, pulmonary function studies, surgical 
staging with mediastinoscopy/mediastinotomy or thoracoscopy (Weitberg, 2002). 
Blood tests may also be carried out with the aim of checking the patient's general 
health; indeed, those which measure the levels of some proteins which are 
considered as tumour markers could also indicate the presence of a lung tumour. 
Such tests include PTH (Parathyroid Hormone), CEA (Carcinogenic Antigen) and 
CYFRA21-1 (Cytokeratin Fragment 19) (Braun, 2006). 
 
2.5  HISTOLOGY OF LUNG CANCER 
Lung cancer is classified into two major groups based on their histology and 
pathology: NSCLC, which accounts for 80% of all lung cancer cases, and Small Cell 
Lung Cancer (SCLC), which affects approximately 20% of patients (Weitberg, 2002). 
NSCLC, which is usually located in the periphery of the lung, includes squamous cell 
carcinoma, adenocarcinoma and large cell carcinoma. SCLC is usually located in the 
central mass of the lung and is often widespread at the time of diagnosis; it tends to 
be more aggressive and spreads sooner to distant sites. It is predominantly caused 
by a significant smoking history (Weitberg, 2002).  
 
2.6  STAGING OF LUNG CANCER 
The staging of lung cancer plays an important role in prognosis, the choice of 
treatment modalities and survival rate; the higher the stage, the worse the prognosis. 
Staging was developed in order to drive a relation between anatomic extend of the 
disease and prognosis of patients with lung cancer. The international system for the 
staging of lung cancer categorises and combines the variation of staging definition, 
and has given a consistent meaning and interpolation among physicians and 
scientists worldwide (Mountain, 2000).  
 The TNM staging system stands for Tumour, Nodes and Metastasis. T1-2-3-4 
explains the increasing primary tumour size, where NX-0-1-2-3-describes the 
absence or presence of regional lymph node metastasis. M0-1 describes the 
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presence or absence of tumour spread to distant lymph nodes or organ sites 
(Mountain, 2000). TNM staging is summarised in Table 2, while the staging of 
NSCLC is summarised in Table 3. 
Table 2: The TNM staging of lung cancer 
(http://www.oncoline.nl/index.php?pagina=/richtlijn/item/pagina.php&id=22056&richtlij
n_id=396) 
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During the undetected stage, cancer cells are found in sputum (mucus coughed 
up from the lungs), but no tumour can be found in the lung by imaging or 
bronchoscopy, or the primary tumour is too small to be assessed.  
Stage 0 (carcinoma in situ) 
In stage 0, cancer is limited to the lung and found only in a few layers of cells. It 
has not grown through the top lining of the lung.  
Stage I 
In stage I, the cancer is in the lung only, with normal tissue around the tumour. 
Stage I is divided into stages IA and IB, based on tumour size. 
Stage II 
In stage II cancer has spread to nearby lymph nodes or to the chest wall (the ribs 
and muscles which make up the area of the body between the neck and the 
abdomen), the diaphragm (the thin muscle below the lungs and heart that 
separates the chest from the abdomen), the mediastinal pleura (the thin 
membrane that covers the outside of the lungs in the area near the heart), or the 
parietal pericardium (the outer layer of tissue that surrounds the heart). Stage II is 
divided into Stage IIA and Stage IIB, depending on the size of the tumour and 
whether it has spread to the lymph nodes.  
Stage III 
In stage III, the cancer has either: 
Spread to the lymph nodes in the mediastinum (the middle area between the 
lungs that contains the heart, major blood vessels, and other structures); or  
Spread to the lymph nodes on the opposite side of the chest or in the lower neck.  
Stage III is divided into stage IIIA (which is sometimes treated with surgery) and 
stage IIIB (which is rarely treated with surgery).  
Stage IV 
In stage IV, cancer has spread to other parts of the body or to another lobe of the 
lungs. 
Table 3: NSCLC Staging 
(http://www.cancer.gov/cancertopics/pdq/treatment/non-small-cell-lung) 
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2.7  TREATMENT OF LUNG CANCER 
Treatment modalities for lung cancer include surgery, chemotherapy and radiation 
therapy. The choice of modality is mostly dependent on the stage which the cancer 
has reached and whether or not the tumour is resectable. Treatment options for 
patients with NSCLC will also depend on a number of factors, including the stage of 
the disease, the individual’s overall functional and medical status, and patient 
preferences. Surgery is the primary treatment for patients with early-stage (Stages I 
and II) cancer who otherwise have a good general health. The goal of surgery is to 
remove the tumour cells completely and to provide a full cure. Chemotherapy in the 
late stages of NSCLC shows definite improvement in the median survival rate; 
however, the overall survival rate is still low (Miller et al., 2004). Survival rates and 
frequencies of diagnosis for the various stages are shown in Table 1. 
When chemotherapy is combined with another modality, such as surgery or 
radiotherapy, there is an improvement in the survival rate. A study by Arriagada et al. 
(1997) showed an improvement in the survival rate in patients with NSCLC if 
radiation therapy was combined with chemotherapy using an agent such as cisplatin. 
With this in mind, approximately 3/4 of the patients diagnosed with NSCLC will be at 
a relatively advanced stage by the time of diagnosis, and so will need another 
modality, such as radiation therapy (Weitberg, 2002). However, NSCLC is 
considered to be one of the most difficult malignant lesions to treat with radiation 
therapy. There are several reasons for this: Geometrical difficulties due to respiratory 
motion, the number of low-tolerance neighbouring organs, such as the spinal cord 
and the oesophagus (Dirkx et al., 1999), and dosimetric difficulties due to the 
presence of huge inhomogeneities (Dirkx et al., 1999). The role of radiation therapy 
for the treatment of NSCLC may be either curative or palliative; the treatment is 
usually delivered via an external photon beam. The field arrangements usually begin 
with 2 fields — anterior-posterior and posterior-anterior — to a total dose of 45-50 Gy 
(1.8-2.0 Gy per fraction); boost fields are then applied (usually oblique fields with 
shielding for the spinal cord) and the total dose is taken up to 60-70 Gy for curative 
and 30 Gy for palliative therapy (Khan and Potish, 1999).  
Some studies have suggested higher doses for NSCLC to increase the local 
control and survival rate: Martel et al. (1999) recommend a total dose of 84 Gy in 42 
fractions in order to achieve 50% Local Progression-Free Survival (LPFS) > 30 
months without any increasing toxicity for NTCP. The aim of the study was to 
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estimate the TCP model parameters, which are the doses required for producing 
50% probability of tumour control (D50) and the normalised slope (y). The study was 
based on the clinical experience of using 3-DCRT treatment plans for NSCLC (Martel 
et al., 1999).  
The study analysed treatment plans for 76 patients who had been treated for 
NSCLC between the years of 1986 and 1992. Their dosimetric data included the 
tumour volume, which ranged from 4.3 cc to 856 cc, the nodal involvement, the 
tumour stage, histology and other factors such as sex, age and weight. The 
treatment plans for 66 patients were composed using the conventional AP/PA 
treatment field for NSCLC, while the remaining 10 were treated using 3-DCRT fields. 
All patients were prescribed a total dose ranging from 64 Gy to 82 Gy. TCP was 
calculated using a mathematical model. LPFS was used as a measurement for the 
local TCP. Although the study suggested that using LPFS with NSCLC is difficult, 
since it is low in lung cancer patients and reduces with time, the results showed an 
increase in LPFS when the prescribed dose was higher than 70 Gy (Martel et al., 
1999). The study, which was comprehensive and ran for about 6 years, showed that 
in the treatment of NSCLC, increasing the dose would be beneficial, improving the 
survival rate without causing toxicity to any normal tissue. 
Another study, by Kong et al. (2005), suggested that the total dose should be up 
to 70-97 Gy if all the critical criteria of the surrounding normal tissue were taken into 
consideration; however, it is essential to note that the higher the prescribed dose, the 
higher the risk of both short- and long-term toxicity to healthy tissue. Overall, 
conventional external beam radiotherapy suggests a poor outcome, and the result is 
not completely satisfactory: the median survival rate is still quite low, at only around 
8-12%, and the five-year survival rate is 5-10% (Sixel et al., 2003). 
Treatment of NSCLC with radiation therapy is always a challenge for two main 
reasons: firstly, there is the presence in the thoracic area of critical organs — such as 
the spinal cord posteriorly, the heart inferiorly, and the lungs located left and right of 
the oesophagus — which are considered to be a limiting factor for escalating the 
dose; secondly, the effects on the tumour of respiratory motion may cause an 
inadequate dose to be delivered to the PTV (Mechalakos et al., 2004).  
However, in recent years, the introduction of 3-DCRT and IMRT have brought the 
hope of better local tumour control, higher survival rates and fewer normal tissue 
complications (Bradley et al., 2002). Dose escalation has improved local control, but 
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may nevertheless cause chronic pneumonitis, which can lead to death in some cases 
(Claude et al., 2004). There are some basic precautions to be taken when using 
3-DCRT in order to reach the goal of successful treatment with a higher tumour 
control outcome and less normal tissue toxicity: first, the margin around the PTV has 
to be as tight as possible; second, all inter-fraction and intra-fraction movement has 
to be controlled (see Chapter 1); and third, the dose has to conform with the lesion 
and be within tolerance levels for normal tissue. In recent years, 3-DCRT has proven 
its effectiveness in the treatment of locally-advanced unresectable NSCLC, as it 
provides excellent coverage for the GTV, allowing the dose to be raised without a 
concomitant increased risk of harm to normal tissue (Lagerwaarda et al., 2002).  
A study by Armstrong (2000) investigated the impact of 3-DCRT on the treatment 
of NSCLC and the potential of the conformal treatment to increase the survival rate. It 
reviewed every aspect of the 3-DCRT, such as the software and hardware 
technology, the delineation of target volume used with the 3-DCRT, the techniques 
available for escalating the dose and the effects of normal tissue toxicity 
(pneumonitis) when the dose was escalated. The main finding was that 3-DCRT was 
able to deliver high radiation doses (>70 Gy) with minimum toxicity to lung tissue 
compared with that of conventional treatment, thus increasing the survival rate for 
locally advanced NSCLC. However, the study suggested a long follow-up for patients 
after completing the treatment, for the purpose of detecting any long-term toxicity 
(Armstrong, 2000).  
 Xu (2002) conducted a study with the aim of improving the outcome of radiation 
therapy for NSCLC without increasing the risk of toxicity to normal tissues. The study 
was carried out on 135 patients with NSCLC, of whom 62 were treated with high-
dose 3-DCRT, while the remaining 73 were treated using conventional radiotherapy. 
Three months after treatment, the rate of remission of the lesions was found to be 
44.9% in the conventional therapy group and 77.8% in the 3-DCRT group; there was 
also a significant difference (p<0.01) between the two groups in the efficiency rate. 
The 1-2 year survival rate was determined to be better under 3-DCRT, at 77.8% in 
comparison to 42.5% for conventional radiotherapy. 
Another study, by Grills  (2003), evaluated the benefits of four different 
techniques for reducing normal tissue toxicity and increasing the tumour dose when 
treating NSCLC. The techniques evaluated were Intensity-Modulated Radiation 
Therapy (IMRT), 3-DCRT using multiple beam angles, limited 3-DCRT using only two 
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or three beams, and the standard technique of radiation therapy, which included 
Elective Nodal Irradiation (ENI) to treat the mediastinum. The study, which was 
carried out on 18 patients with stage I to IIIB inoperable NSCLC, concluded that the 
use of 3-DCRT, especially with only three or four beams, reduced the NTCP by 
reducing the mean dose and the volume of lung receiving at least 20 Gy
 
(lung V20) 
compared with the standard technique which includes ENI. It also increased the 
deliverable radiation dose >80% in comparison with ENI (Grills, 2003). 
In another investigation, Miller (2004) attempted to evaluate the GTV coverage 
and normal tissue complication probability using the conventional 2-dimensional 
radiation therapy and 3-DCRT. The subjects were 34 NSCLC patients and the results 
showed that 3-DCRT could provide better coverage for GTV in comparison with 2-D 
radiation therapy, thus permitting an increased total dose to the target volume without 
increasing the toxicity to the normal tissues (Miller, 2004). 
All of the above studies suggest that increasing the total prescribed dose would 
ultimately increase the survival rate and local tumour control in NSCLC without 
increasing the risk of normal tissue damage. However, consideration of toxicity 
remains under investigation and caution must be applied whenever higher doses are 
used.  
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2.8  THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY  
Current state-of-the-art radiation therapy makes use of highly advanced modalities in 
imaging and treatment, and has led to the treatment of cancer becoming more 
precise and highly conformed, ultimately increasing the accuracy of the treatment 
and minimising the toxicity to adjacent normal tissue. The most advanced technique 
in recent years has been 3-DCRT, which has been developed from 3-D imaging 
modalities, such as MRI, PET and CT, and relies on full anatomic information relating 
to the patient, which includes the lesion site but is also extended well beyond it to 
account for any effects of radiation scatter in the area outside the lesions (Purday, 
1999). In the patient model, this information will then feed into the radiation planning 
system. Thus, 3-DCRT is a treatment modality using 3-D anatomic information in 
order to establish the arrangement of the treatment fields so that the dose can be 
precisely conformed around the tumour volume in such a way that a higher dose will 
be delivered to the tumour, while a minimal dose will be delivered to adjacent normal 
tissue. 
The major factor upon which 3-DCRT depends is the delineation of the anatomic 
structure of surrounding normal tissue and the tumour itself. in order to achieve 
accurate dose distributions and to arrange the irradiated field in such a way that 
successfully avoids normal, healthy tissue, radiation oncologists must contour not 
only the bony landmarks, as in 2-D planning, but also all of the normal tissue in the 
area of the irradiated field and lesion, which some may consider time-consuming 
when compared with 2-D treatment planning. 
The 3-DCRT plan will be based on contouring the Gross Tumour Volume (GTV), 
the Clinical Target Volume (CTV) and the Planning Target Volume (PTV), plus the 
normal adjacent tissue and the Organs at Risk (OAR) in the irradiated area. One 
major tool of 3-DCRT is the Beam Eye View (BEV) (Figure 2); this is the basic 
visualising tool (Khan, 2003), providing a 3-dimensional view of the lesion and the 
adjacent normal tissue, which ultimately helps the planner of the radiotherapy 
treatment and the radiation oncologist to view the patient in the same orientation as a 
radiation beam pointing in that same direction, and thus helping them to arrange the 
treatment fields to target the PTV and avoid healthy normal tissue. Figure 2 shows a 
BEV of a 3-DCRT field with PTV (red) and the OAR in the area (kidneys, liver, and 
spinal cord). 
 31
 
 
 
 
 
 
 
 
 
 
 
Fig. 2: Beam Eye View of 3-DCRT planning 
(http://www.radonc.uchicago.edu/typea/scripts/content.cgi?template=defa) 
Another tool which is unique to 3-DCRT planning is the Digitally Reconstructed 
Radiograph (DRR) (Figure 3), produced from the patient’s CT images. DRR is mostly 
used with the aim of localising the volume of interest and the radiation field for 
delivering radiation treatment. It is produced by calculating the set of volume data 
which has been produced by the CT images; this produces images similar to the 
simulation portal image, but with noticeably better contrast and detail of soft tissues 
and bone structures than regular simulator films. Moreover, it provides greater 
freedom, enabling viewing of the structures of interest in relation to the central axis of 
the radiation beam from any viewing angle. It also provides beam geometries of the 
actual treatment field which the simulation cannot provide due to the geometric 
limitations of the simulator, such as the restricted physical movement of the 
apparatus (e.g. gantry and table) (Khan, 2003). The outcome of the treatment with 
3-DCRT will depend on how accurate and precise the delineation of GTV, PTV and 
OAR are; however, the use of PET or CT will no doubt improve the treatment plan.  
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Fig. 3: DRR of lung field 3-DCRT 
(http://www.webtie.org/sots/Meetings/Lung/June192001/ 
/Bogart/images/slide30_trans.jpg) 
 
Fitton et al. (2008) carried out a study with the objective of establishing a protocol 
to use PET in the delineation of the Primary Tumour (PT) in treating NSCLC, which 
would lead to a reduced inter-observer variation in gross tumour volume and improve 
the treatment plan for radiation therapy. The 22 patients in the study all had localised 
NSCLC. The CT and three-dimensional (3D) PET data images were collected 
separately before the initiation of the treatments. The patients were then divided into 
two groups according to the tumour-adjacent organs: the first group comprised 
patients with a primary lung tumour which was surrounded by the lung and visceral 
pleura, where there was no invasion or chest wall involvement, while those in the 
second group had a primary lung tumour with invasion to adjacent nodes, such as 
hilar nodes, or adjacent structures, such as the heart. The study had two phases with 
a year between them: the first phase was when the primary tumour was delineated 
by physicians using CT images, while the second phase was completed a year later 
when the primary tumour was delineated using fused images of CT and PET.  
The result for Group One did not show a reduction in inter-observer variation (p = 
0.1628) for all regions using CT, while for Group Two there was a strong reduction in 
inter-observer variation when compared with Group One. A significant difference was 
detected between the two groups (the difference between the two phases was 
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significant, i.e. p = 0.0003, paired Student’s t-test). In conclusion, it was suggested 
that using PET imaging improves the segmentation of the primary tumour (Fitton et 
al., 2008). PET images and fused images of CT and PET are considered valuable 
tools in the treatment of thoracic tumour where the PT is surrounded by healthy 
normal tissue and tissue which limits the radiation dose, such as heart and hilar 
nodes, as the study suggested. 
 
Fig. 4: Dose volume histogram, showing dose against percentage of irradiated 
volume of PTV, Lung and spinal cord 
(http://www.tomotherapy.com/images/cases/stAgnes_ctrue_8.jpg) 
Figure 4 shows a third important tool in 3-DCRT planning: the Dose Volume 
Histogram (DVH), which is a graphical display of three-dimensional dose distribution 
data which presents the dose distributions to the volume of normal tissue and to the 
lesion; the dose versus volume of the area of interest is displayed, which includes the 
tumour and the contours of all critical structures. The DVH of a good plan will 
produce a higher dose to the target volume and a minimum dose to the normal 
surrounding tissues. DVH is considered to be a major and important tool for analysis 
of the outcome of the plan, and is ultimately a useful way of making comparisons 
plans. Using 3-DCRT tools, such as DVH, in the evaluation of individual treatment 
plans and the development of biological models, such as TCP/NTCP, has also 
greatly assisted clinicians in designing treatment plans and in prescribing a 
tumouricidal radiation dose without causing any toxicity to adjacent organs. Tumour 
Control Probability (TCP) and Normal Tissue Complication Probability (NTCP) are 
values which are used to quantify the damage to the tumour and to the surrounding 
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normal tissues respectively. Ideally, treatment with ionising radiation aims to achieve 
100% TCP and 0% NTCP; in practice, the estimated value of each depends on 
clinical experience. 
 
2.9  GTV, CTV AND PTV  
It is important to clearly define the three main terms designating tumour volume. The 
International Commission on Radiation Units and Measurement (ICRU, 1993; 1999) 
has released two reports offering recommendations, definitions, and suggestions for 
radiation therapy treatment margins and volumes, the volumes being based on three 
definitions of GTV, CTV and PTV (Figure 5).  
The gross tumour volume is defined by the gross palpable tumour extent. It 
includes the tumour, the tumour bed, and any microscopic disease, and is defined as 
‘the confirmed tumour that is palpable or visible by physical or radiological 
examination’ (ICRU, 1993) (Figure 5). The GTV can be defined by physical 
examination or by any radiological diagnostic method, such as CT, MRI or PET. In 
NSCLC, the GTV includes the tumour or residual tumour, as well as any lymph 
nodes involved.  
 
 
 
 
 
 
 
 
 
 
Fig. 5: Gross Tumour Volume (GTV), Clinical Target Volume (CTV) and Planning 
Target Volume (PTV1 and PTV2) (Graham et al., 1999). 
The clinical target volume comprises the GTV and any subclinical or microscopic 
disease, including potential sites which are at high risk of disease, disease extension 
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or nodal disease. The definition of the CTV is usually based on general oncology 
principles, and the experience and knowledge of the radiation oncologist. Its 
determination normally requires the radiation oncologist to consider the local invasive 
capacity of the lesion, and its ability to metastasise to other areas during the period 
from diagnosis to treatment. Once the CTV has been defined, the dose and dose 
distribution will be calculated in mind of achieving the desired treatment goal, which 
may be curative, palliative or local tumour control treatment. In the case of NSCLC, 
the CTV is usually defined with a margin around the GTV to cover lymph node 
regions, such as the ipsilateral hilum and the mediastinum, divided into two values: 
The ipsilateral hilum and the ipsilateral mediastinum, and the subclavicular fossa 
(Figure 6) (Graham et al., 1999). When a dose is prescribed to the CTV, the radiation 
oncologist must balance the treated volume in order to produce a Tumour Control 
Probability with the normal tissue toxicity of the adjacent healthy tissues and Organs 
at Risk (OAR). 
     
Fig. 6: The thoracic lymph nodes 
(http://lelaneemeollamokowich.files.wordpress.com/2008/03/lymph-nodes-of-
pulmonary-system.gif) 
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Finally, the planning target volume is calculated by ensuring that all the tissues 
included in the CTV will receive the prescribed dose, which means that a larger 
geometrical area will be irradiated (Graham et al., 1999; ICRU, 1999). The PTV 
accounts for variations in patient setup as well as any possible uncertainties or 
errors, such as inter-fraction setup errors and tumour mobility; it includes a setup 
margin (SM) (Figure 7, Pg 38), which takes into account all uncertainties in patient-
beam positioning in relation to the treatment machine coordinate system. Moreover, 
included in the PTV is the Internal Margin (IM), which allows for any internal organ 
motion such as respiratory motion. A study by Graham et al. (1999) suggests that the 
PTV will have two values: The first, PTV1, includes the GTV and CTV, and has a 
margin for any uncertainties; the second, PTV2, is contoured around the GTV with a 
margin ranging from 7 to 10 mm (Figure 5). The dose prescriptions are specified to 
the central points of PTV1 and PTV2 (isocentre). PTV1 will take the initial dose for 
treatment — which in the study was 50 Gy — while PTV2 will take the boost dose, 
which was 70 Gy (Graham et al., 1999; ICRU, 1999). 
Thus, the PTV is larger than the CTV, mostly for the purpose of covering for any 
geometric uncertainties due to intra-fraction motion or inter-fraction uncertainties and 
patient setup errors. In the treatment plan, the PTV has to be covered by ≥95% of the 
isodose line (ICRU, 1993; 1999). The usual margin from CTV to PTV is between one 
and two cm (Mechalakos et al., 2004).  
 
 
 
 
 
 
 
 37
Fig. 7: Target definition (ICRU, 1999) 
The GTV is defined as the volume which can be demonstrated to contain tumour cells 
and can be observed on CT images. CTV is the volume which is created by adding a 
margin to GTV, to account for subclinical spread of the tumour. PTV is the volume 
created by adding a margin to the CTV; it accounts for changes in position which include 
the Setup Margin (SM) and for the intra-fraction motion, which includes the Internal 
Margin (IM). OAR is an Organ at Risk in the treatment field. 
PTV margins should be individually determined and set for each patient, since 
tumour motion varies from patient to patient depending on tumour location. A study 
by Sixel et al. (2003) investigated the use of a digital fluoroscopy imager attached to 
CT simulation in order to measure the tumour motion in three dimensions for patients 
with NSCLC; the overall objective was to reduce the planning target volume for each 
patient, which would reduce the exposure of normal tissue within the radiation field. 
The 10 patients in the study, of average age 67.5 years, had unresectable NSCLC 
with nodal involvement. Their tumours were located in the upper lobe, right middle 
lobe, right lower lobe, left upper lobe and left lower lobe. The tumour volumes ranged 
from 13 cc to 276.40 cc. Tumour motion was measured during the simulation using 
CT and fluoroscopy over periods of several breathing cycles. The radiation oncologist 
then contoured GTV and CTV, and PTV with a 15 mm margin. The results of the 
study showed that the tumour could vary in motion from patient to patient, depending 
on the location of the tumour, with greatest variation (more than 10 mm) in the 
PTV 
GTV 
 
CTV 
 
OAR 
IM 
SM 
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superior-inferior direction. This suggested that the margin added to PTV for intra-
fraction motion should be calculated individually for each patient and that using a 
standard PTV margin would be improper (Sixel et al., 2003). Although the study used 
only ten patients, which was considered to be a limiting factor, it shows that each 
patient’s anatomy and tumour is unique, so that PTV margins should be customised 
and individualised accordingly. 
While increasing the radiation dose to 70-80 Gy could give better local control, as 
reported in other studies referred to above, it could also increase the normal tissue 
toxicity, particularly if the tumour moves during treatment (Lisbshitz, 1984). Caraig 
(2001) investigated whether the superior-inferior motion of the tumour was 
predictable from location or pulmonary functions. Their study, of 22 patients with 
unresectable NSCLC stage I, IIIA, IIIB and IV, estimated the tumour motion using 
double exposed orthogonal simulator films which had been taken during the 
breathing cycles: one exposure was taken at the maximum expiration and the other 
at the maximum inhalation. The differences in the tumour position between the two 
films were used to calculate the maximum movement of the tumour. The study found 
that superior-inferior tumour movement could not be predicted from the tumour 
position and pulmonary functions; in addition, it suggested that the PTV margin 
should be individualised for each patient — a recommendation confirmed by Sixel et 
al. (2003) — and that using respiratory gating or breathing control techniques could 
ultimately improve the outcome of the treatment by reducing normal tissue toxicity 
(Caraig, 2001). Taken together, the work of Caraig (2001) and Sixel et al. (2003) 
shows that the treatment of NSCLC is always difficult, especially if the movement of 
the tumour cannot be predicted; hence the importance of limiting respiratory motion, 
by using respiratory gating or breathing manoeuvres, or by increasing the PTV 
margin to cover the tumour motion. 
The PTV essentially incorporates the safety margin required to allow for the 
external setup uncertainties in beam alignment and daily patient setup for any 
internal organ motion and for any organ deformation, such as changes in size or 
shape due to the treatment (Antolak and Rosen, 1999). Thus, the PTV is the volume 
that receives the radiation during the treatment, encompassing the tumour and its 
margins to cover for all geometric uncertainties. 
Uncertainties include both systematic and random errors, which have different 
inputs to the treatment. Systematic errors occur in the treatment in the same direction 
and with the same timing in each session, and may be attributed to differences in 
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table sag, laser calibration or mechanical calibration between different rooms (CT, 
simulator and accelerator) (Craig et al., 2001); they may be corrected in the first few 
fractions by repeating the portal films or using Electronic Portal Imaging (EPI). By 
contrast, random errors occur in different areas and at different magnitudes in every 
treatment; they are mostly due to differences in the patient setup error and organ 
motion, and thus cannot be predicted or corrected. Systemic and random errors will 
have different radiobiological effects on the treated tumour and the surrounding 
normal tissues, which can be seen in the TCP or NTCP results of the treatment 
(Craig et al., 2001). Smaller systemic errors will also have a smaller effect on the 
tumour control probability, whereas larger systemic errors will have a larger effect 
(Lagerwaarda et al., 2002).  
Herk (2003) investigated the biological and physical effects of random, systematic 
geometric errors and respiratory motion in delivering a fractional radiation dose to 
CTV by using a Gaussian blurring model. A software model was developed in order 
to calculate the effects and in order to compare the resulting dose plan distribution 
with the Gaussian model of the planned dose. For physical effects, the model used 
hypothetical dose distribution with Gaussian distribution and random errors estimated 
from the normal distribution, with the respiratory motion error added in the 
craniocaudal direction. For biological effects of the treatment, the study used a linear 
quadratic model by which the physical dose was converted to the biological effective 
dose and the number of fractions calculated. The study found that respiratory motion 
could cause large systematic errors, but did not mention how large these errors were, 
since this was considered to be beyond its scope. It did, however, suggest that if 
respiratory motion has a small amplitude it should be treated as Gaussian, while 
motion of larger amplitude would cause asymmetry and would lead to irregular total 
dose distributions; this would then help in deciding the margin for random errors, 
which should be based on the direction of respiratory motion. Regarding the effects 
of random errors, the results indicated that a shift of 1 cm in CTV away from the 
radiation source would cause a decrease in the total dose of 6%; however, the 
direction of the tumour had no effect on random errors (Herk, 2003). 
Establishing the PTV is a major factor in achieving successful treatment, because 
the correct PTV margin will ultimately produce the best coverage of the target volume 
with the maximum dose delivered to the tumour site, whereas expanding it beyond 
this limit would expose normal adjacent tissue to excessive radiation, which could 
cause complications; in the case of NSCLC, these may include pneumonitis or other 
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major respiratory problems, which can, in some cases, lead to death (Sunyach et al., 
2000). 
The outcome of the treatment and the prognosis of the disease will thus depend 
on the accuracy of the clinical delineation of the GTV, CTV and PTV, allowing a high 
homogenous dose to be delivered to the target while also limiting the dose to the 
adjacent normal tissue. Developing the PTV from the CTV involves many 
procedures, including the acquisition of data, its transfer to the planning system, and 
contouring all the critical structures in the area by using all the features available in 
the planning system, such as BEV and DRR. Meanwhile, patient setup, patient 
movement, internal organ movement and tumour movement must all be taken into 
consideration (Armstrong, 1998) as all stages of the delineation of the GTV are 
usually contoured manually by the radiation oncologist.  
GTV delineation for 3-DCRT is done by using the images from a number of 
planning modalities, such as CT and MRI, which usually covers the thoracic area 
from the bottom of the larynx to the bottom of the second lumbar vertebra 
(Armstrong, 1998). The images are then transferred to the planning system, where 
computer software tools are able to automatically create the CTV and the PTV 
according to margins which have been determined for each organ. Creating the PTV 
from the CTV is limited by the surrounding normal structures; the BEV is a useful tool 
here, providing the planner with all the details of the location of the CTV and the 
surrounding normal structures. Antolak and his group at the University of Texas MD 
Anderson Cancer Centre (Antolak et al., 1999) recommend that the CTV to PTV 
margin should have a radius expansion of 1.65 times the Standard Deviation (SD) of 
geometric uncertainty in all directions (X, Y, Z), which means that each point of the 
CTV has to be covered by at least 95% of the PTV. The goal of this recommendation 
is to keep the CTV covered at all times with the prescribed dose, so if the PTV 
receives 95% of the prescribed dose, the CTV will have a minimum of 90% coverage.  
Craig et al. (2001) examined CTV-PTV margins and the uncertainties involved, 
concluding that the judgment of the margin is critical: If it is too tight, there is a 
probability that the CTV will not receive the full recommended dose, reducing the 
TCP; if it is too large, the toxicity to adjacent normal tissue will increase, which 
means an increase in NTCP. Their study presented a model for creating a PTV while 
evaluating the range of associated uncertainties and their effect on the TCP. The 
recommendation was a uniformed margin of 0.7 mm which, in the case of a spherical 
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CTV, would give 95% coverage of the PTV. However, an irregular shape would 
receive a different coverage. 
 
2.10  ISSUES IN APPLYING IMRT TO MOVING ORGANS 
The more advanced the techniques used to treat cancer, the higher the level of 
complexity, and so the risk of errors will ultimately increase. The major problem with 
using IMRT to treat lung and abdominal tumours is that the movement of the tumour 
due to respiration, could cause a geometric miss and increase the dose to the critical 
organs in the area, such as the heart, coronary artery or lungs. Intra-fraction motion 
may also cause around 20% error in the dose when using the IMRT technique 
(George et al., 2003). Intra-fraction motion defeats the purpose of using IMRT, since 
the dose will not be delivered to the PTV as planned. Conformal radiotherapy, which 
aims to conform the dose around the target volume while sparing the adjacent 
normal tissue and the OAR (Ramsey et al., 2001), includes 3-DCRT, stereotactic 
radiotherapy (SRT) and IMRT.  
In this project, we consider only 3-DCRT and IMRT which, by conforming the 
dose, allows increased local control and survival rates. From the radiobiological view, 
3-DCRT aims to maximise the TCP and minimise the NTCP. IMRT based on 
modulating the beam intensity across the treatment field, allowing the delivery of a 
uniformed dose to an irregular target through non-coplanar or coplanar fields, while 
sparing as much of the adjacent normal tissue as possible. The accuracy of use of 
both 3-DCRT and IMRT depends on the precise definition of the tumour volume 
(GTV, PTV and CTV), as any misdelineation could consequently result in a poor 
treatment outcome and local-distance metastasis. 
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CHAPTER 3: LITERATURE REVIEW 
 
3.1  INTRODUCTION TO RESPIRATION MANAGEMENT 
The main two goals of radiation therapy are to destroy the cancerous cells and to 
increase the survival rate of patients with cancer (Haas, 2008). These two goals are 
best achieved when the radiation therapy dose prescribed to the Planning Target 
Volume (PTV) is delivered to a tumour, which is A static relative to the radiation 
beam. This provides the opportunity to maximise control over the dose delivered to 
the tumour as well as that delivered to normal healthy tissues and organs at risk. 
However, as discussed in Chapter 1 and shown in Figure 1, tumours of the lung, liver 
and kidney are not stationary but move with the patient’s breathing cycle: Ohara et al. 
(1989) and Ross et al. (1990) have shown that such tumours may move 1-3 cm 
during quiet breathing. Thus, as already mentioned, the goals of radiation therapy are 
affected not only by the random and systematic daily setup errors but also by tumour 
motion, which is directly associated with normal respiratory activity. Respiratory 
motion not only affects the tumour and PTV, but also plays a role in increasing the 
toxicity to the healthy adjacent tissues, such as the spinal cord and oesophagus 
(Weissa et al., 2008), which can move into the radiation field during treatment. In 
order to minimise respiration-induced motion and to limit the effects of intra-fraction 
motion on tumours, the direct effects of respiratory motion on NTCP and TCP have 
been investigated by several groups of researchers. Most of the studies previously 
carried out have assessed the effectiveness of using breath-hold manoeuvres and 
breath-control devices with the objective of eliminating or reducing intra-fraction 
motion, thus allowing a reduction of the respiratory margin around the PTV, sparing 
the normal tissue, and escalating the tumour dose (Weissa et al., 2008). Generally, 
such investigations have involved the study of breath-hold at inspiration or expiration 
during CT-scanning and treatment.  
There are three main types of patient-controlled breathing manoeuvres, which 
can be used in order to control the respiratory motion during radiotherapy on lung 
tumours: Deep Inspiration Breath Hold (DIBH), Deep Expiration Breath Hold (DEBH) 
and self-breath holding during the inspiration or expiration phases. There is also 
another type of breath hold which is used for breast cancer treatment, called 
moderate Deep Inspiration Breath Hold (mDIBH). 
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The above methods of motion control are all under the direct control of the 
patient, and therefore do not involve the use of any external devices in order to 
modify the breathing pattern or motion of the chest wall. There are, however, other 
techniques which rely solely on the use of external control devices to actively modify 
the patient’s breathing or chest wall movement, or which otherwise attempt to use the 
patient’s breathing or chest wall movement to control the beam-on and beam-off 
characteristics of the radiotherapy treatment machine; these methods include the use 
of a spirometer, the Active Breathing Control (ABC) system, Free-Breathing gating, 
respiratory gating radiotherapy (coupled with either breath hold, active breathing 
control devices or IMRT), real-time tumour tracking (robotic radiotherapy) and 
synchronised respiration techniques. Each method is discussed in the following 
sections. 
 
3.2  BREATH HOLD  
The concept of the breath hold (BH) technique is to immobilise the tumour by holding 
the breath, which, in theory, improves the outcome of radiation therapy, allows for 
dose escalation and reduces the toxicity to the surrounding normal tissue 
(Rosenzweig et al., 2000). This technique is mostly used for patients with lung 
cancer, sometimes in association with external devices such as ABC or a respiratory 
gating system; alternatively, it may be used alone with or without respiratory 
mentoring (patient training). Rosenzweig et al. (2000) have suggested that the use of 
the DIBH technique could allow a 10% increase in the prescribed tumour dose with a 
concomitant reduction in the normal tissue dose, which would therefore improve 
patient outcomes. 
Barnes et al. (2001) investigated the benefits of using DIBH in patients with 
NSCLC to immobilise the tumour, then compared these with free breathing (FB). The 
study was performed on 10 selected patients with stage I-IIIB NSCLC, Karnofsky 
performance status ≥ 60% and a tumour mass visible under anterior-posterior (AP) 
fluoroscopy (Karnofsky performance status is a scale index which is used to classify 
patients with cancer in order to determine the treatment modality of each patient and 
the prognosis: the lower the scale, the worse the prognosis and outcome of the 
treatment (Abernethy et al., 2005)). In this study, the selection criterion was the ability 
of the patients to hold their breath for 15 seconds, with tumour location in different 
areas of the lungs, such as right lower lobe, right upper lobe, left lower lobe and right 
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middle lobe. The measurements were taken in two sessions: in the first, fluoroscopy 
images were taken when the patient was in the treatment position, breathing freely 
with no instruction, and five breathing cycles were recorded; in the second, the BH 
manoeuvre was employed, where the patient was asked to hold his/her breath for as 
long a period as possible, without any other device or manipulation supporting the 
BH. This session was repeated three times in order to estimate the mean time of 
DIBH. The tumour position at the superior edge of the FB fluoroscopy was marked 
and used as a guide for the tumour position during BH.  
The maximum superior and maximum inferior tumour positions were recorded for 
five seconds during DIBH. The average superior-inferior displacement of the tumour 
was estimated from the three BH recording sessions. For each patient, three 3-DCRT 
plans were generated with the aim of establishing the margin needed to generate the 
PTV from GTV: the first PTV was produced from FB scans, the second from DIBH 
scans and the last from the DIBH scan, but using the FB margin. Each of the plans 
had the same treatment parameters, with treatment energy of 6 MV and total 
prescribed dose of 70.9 Gy. The results showed a reduction of 32.5% in lung volume 
receiving ≥ 20 Gy when the DIBH manoeuvre was applied, for two reasons: the 
increasing lung volume when the patient performed deep inspiration and the 
reduction in PTV margin due to tumour immobilisation. Although the results indicate 
that the technique is a promising one which could reduce the dosimetric effect of 
tumour motion and reduce the PTV margin, allowing dose escalation, it could 
nevertheless not be applied to most or all patients with NSCLC, for many reasons. 
First, the number of patients was limited, with the study being carried out on only 10 
patients, yet two of these could not cope with the manoeuvre. Second, the authors of 
the study warn that before patients could use such manoeuvres, they would have to  
meet a number of eligibility criteria, such as the ability to hold and control breathing 
for a certain amount of time (BH ≥15 s). Finally, this manoeuvre involves the use of 
fluoroscopy imaging, which adds to the exposure dose to patients. This indicates the 
need to develop a technique to produce stable breathing patterns that would be 
suitable for all patients with NSCLC and would not rely on the use of a fluoroscope.  
In another study, Hanley et al. (1999) used the DIBH technique to decrease lung 
density (when patients performed DIBH, it increased the air volume in the lungs while 
simultaneously reducing lung density, which therefore reduced the volume of 
irradiated normal tissues) and to immobilise the tumour during treatment, again 
reducing the respiratory margin and allowing an increase in the prescribed dose to 
lung tumours. The study examined five NSCLC patients at stages IIA to IIIB, 
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Karnofsky performance status 70-90, with tumours located in the right middle lobe, 
right middle/lower lobe and left lower lobe. The patients, who were required to hold 
their breath for 12 and 16 seconds, had training sessions before the treatment and 
simulation, and so were coached in how to perform a reproducible DIBH. The 
coaching session began with quiet tidal breathing, followed by slow deep inspiration, 
a maximum inspiration, then a breath hold. A spirometer was used to help the 
patients hold their breath and to measure the inhaled and exhaled air volume.  
Each patient underwent four CT scans in different respiratory conditions: FB, 
DIBH, shallow inspiration BH and shallow expiration BH. The PTV for the DIBH scan 
included a margin for setup uncertainty of 0.75 cm; however, the margin for 
respiratory motion was reduced from 1-2 cm to 0.2-0.5 cm. 3-DCRT planning was 
used in order to delineate the GTVs in all the different CT scans, which were taken 
during the different breathing manoeuvres, and three different treatment plans were 
produced with the same treatment parameters. The first plan was produced from the 
FB scan with normal lung density, the second from FB with normal lung density, 
although the margin for PTV was reduced to estimate the benefit of gated 
radiotherapy, and the final plan was produced by using DIBH CT scans to establish 
the effects of immobilising the tumour and the reduction of lung density. The results 
showed that using DIBH would reduce the normal tissue complications of the lungs 
and would then facilitate dose escalation. Lung density was significantly reduced by 
28% and 37% in two patients respectively, and one patient with a very small tumour 
motion had his lung density decreased by 43%, while the other two patients’ lung 
density decreased by 16% and 4% respectively. The mean reduction in lung density 
for all five patients was 0.26 g/cc. 
These results indicate that there are three advantages to using DIBH over the 
other breath-holding techniques: first, this method provided a powerful tool for 
immobilising the tumour if the patient could hold his/her breath for 12 to 16 seconds; 
second, since the intra-fraction motion was controlled, it reduced the normal lung 
volume in the area of high dose by 18%, which subsequently reduced the NTCP and 
could aid in escalating the dose; finally, it reduced the lung density and decreased 
the mass of irradiated lung, which also allowed the escalation of the dose (Hanley et 
al., 1999). However, the study is considered to be limited, since it was carried out on 
only five patients, as there were only five who were able to control their breathing and 
hold their breath for the required amount of time. In addition, the patients had been 
verbally coached and forced to hold their breath by using a spirometer, which added 
stress and increased the likelihood that patients would be distressed by the 
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combination of radiation treatment, DIBH and the spirometer. All of these factors 
could ultimately increase the treatment time and the workload of staff. 
Rosenzweig et al. (2000) investigated the benefits of using 3-DCRT with DIBH in 
order to treat NSCLC, aiming to immobilise the tumour and then decrease the PTV 
margin, which would lead to less normal tissues toxicity. Their study involved seven 
patients with NSCLC, all of whom had been trained to perform DIBH before the 
simulation session. The training session started with quiet tidal breathing, then verbal 
coaching to perform deep inspiration, followed by deep expiration, then deep 
inspiration and finally breath-hold. The patients followed this sequence of breathing 
with the aim of producing approximately 100% vital capacity during breath hold. A 
differential pressure pneumotachograph spirometer (a device placed directly in the 
airway to measure the air-flow velocity during inspiration and expiration (Bronzino, 
2000)) was also used to monitor patients’ lung inflation levels and to control the 
reproducibility of deep inspiration.  
After the training session, the patients underwent a simulation where sets of CT 
scans were taken at different levels of breathing (FB, deep inspiration, shallow 
inspiration and shallow expiration). All of the treatment plans were carried out using a 
3-DCRT planning system and PT volumes were generated by adding margins of 
10-15 mm to CTV. There were four treatment fields using a 10 MV photon beam and 
a total dose of 81 Gy. During treatment, the patients were monitored by the radiation 
therapist and had verbal coaching over an intercom system; breathing traces were 
followed by the therapist. The result was similar to those of other studies: DIBH was 
able to limit the intra-fraction motion so that the PTV could be reduced and the dose 
to the tumour could be increased from 69.4 Gy to 87.9 Gy. The study also showed 
that despite the increased dose, the NTCP decreased and did not exceed 25% when 
DIBH was used. Furthermore, the study recommended that the DIBH techniques 
should be used with all thoracic patients with the benefit of dose escalation in the 
treatment of lung tumours (≥ 81 Gy), aiding improvement of the local control of 
NSCLC primary lesions (Rosenzweig et al., 2000). 
However, there are some limitations concerning patients’ tolerance of the 
technique, which means that this method can be applied only to cooperative patients 
who are able to perform it reproducibly for the duration of their treatment. Another 
problem is that DIBH will increase the treatment time compared to free breathing; in 
the study, the FB simulation time was 110 minutes, compared with 211 minutes for 
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DIBH, with an average treatment time for DIBH of 27 minutes (Rosenzweig et al., 
2000). Since radiation therapy departments are very busy, using such a technique 
would therefore increase the pressure on the staff and reduce the number of patients 
being treated each day.  
Mah et al. (2000) studied the implementation of the DIBH technique in relation to 
the treatment of seven NSCLC patients, selected to join the study because they were 
able to perform certain breathing manoeuvres sufficiently well. During the coaching 
session, the patients’ breathing was monitored with the use of a spirometer, its output 
being displayed and recorded as a function of time. In addition, a fluoroscopy unit 
was used in order to ensure inter- and intra-breath-hold reproducibility for each 
patient. The system required the use of a mouthpiece with a pressure sensor, with 
the objective of converting air pressure into digital signals, which were representative 
of the lung air volume. By adopting this method, the researchers were able to monitor 
the patients’ breathing patterns and their regularity. The DIBH technique involves 
verbal coaching of patients to perform vital slow capacity and then to reproduce deep 
inhalation breath-hold during simulation (fluoroscopy, CT) and treatment sessions. 
The goals of DIBH in this study were first to immobilise the tumour and secondly to 
expand the lung tissues; therefore, it would be away from the area of high dose 
within the treatment field. During DIBH and FB, sets of CT scans were taken in order 
to estimate the tumour position during the quiet breathing cycle. PTV was created 
from GTV by adding a 1 cm margin, the 3-DCRT system was used for planning and 
the treatment was limited to 3-4 treatment fields.  
The study concluded that using DIBH reduced tumour motion when compared to 
free breathing, thus allowing dose escalation. However, the PTV margin reduction 
was not mentioned, since it was considered to be beyond the scope of the study. In 
addition, the study warned that using DIBH would increase the treatment time and 
staff numbers, but with limited costs and increased patient compliance (Mah et al., 
2000). Although the study suggested the use of DIBH with the intention of reducing 
respiratory motion in comparison with free breathing, it was limited by studying only 
seven patients. Another limitation was that these seven were not randomly chosen 
but were instead selected as being able to perform DIBH for the time required. 
Finally, the patients were required to use a spirometer, which added to the stress of 
routine treatment. Again, the results of this study cannot be generalised to every 
patient, since not all NSCLC patients are able to perform the technique or to hold 
their breath for the time required. It has the same drawback as the studies discussed 
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above, in that both treatment time and simulation time are increased, since the DIBH 
technique requires a training session plus the use of a spirometer. 
 
3.3  BREATH HOLD AND BREAST CANCER TREATMENT 
Other studies concerned with the effectiveness of breath-hold techniques have been 
performed in the closely-associated area of the treatment of breast cancer, where 
tangential radiation fields are often used. During the normal breathing cycle, the PTV 
— which may or may not be the whole breast and include the skin surface — moves, 
so the delivered dose is not as prescribed. Another major concern is the possible 
encroachment of the lungs and the heart (organs at risk) into the field during normal 
breathing; with this in mind, the deep inspiration breath hold technique is a valuable 
method of reducing tumour motion during radiation therapy in such cases, as it can 
reduce the cardiac and lung volume in the treatment field (Lu et al., 2000). For 
completeness, some of the relevant evidence is discussed below.  
Lu et al. (2000) evaluated the potential benefits of DIBH in reducing cardiac 
volume during the typical tangent fields and the benefit of this breathing manoeuvre 
for breast cancer patients undergoing CT simulation for the left breast. This study 
used DIBH as a breathing pattern in 15 patients (46-72 years) with 0-3 positive 
nodes; all 15 patients had wide local excisions for their lesions. At CT simulation, 
patients had two sets of CTs: one was done during quiet normal breathing for the 
planning of the tangential field treatment of their left breast, while the second set was 
completed during the DIBH (20 s). The two sets of CT scans were used to compare 
the volume of cardiac tissue in the treatment field during normal breathing and DIBH. 
During DIBH, patients were instructed to hold their breath for 20 seconds, and their 
breathing cycles were monitored by a window and video system. At the moment 
when the chest reached maximum inhalation and stabilised, the scans would be 
initiated. In addition, during the different breathing patterns a set of scout scans (I-IV) 
were taken for the total target area and could then be used to define the tangential 
fields for actual treatment and for the breath-holding manoeuvres, and to calculate 
the cardiac volume and the difference in depth during DIBH (Lu et al., 2000). The 
planning of tangential fields was done using the two sets of CT scans. During CT 
simulation, radiopaque markers were placed on the patient’s chest to mark the 
medial and lateral border of palpable breast tissue, scar area and the border of the 
right breast. A straight midline wire was placed longitudinally on the patient’s skin and 
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used as a reference point for reproducibility during different breathing cycles, 
providing data concerning the correct volume of cardiac tissue in the treatment field.  
The results showed that the majority of patients could tolerate DIBH for 20 
seconds without complaint. In addition, for seven of the patients (47%) the use of 
DIBH during their CT scans allowed the cardiac volume to be totally eliminated from 
the treatment field. For another seven patients there was a reduction in cardiac tissue 
of 81% and the last patient had no cardiac tissue in the field, even during normal 
breathing. For all patients, the average reduction of cardiac tissue in the field was 
84±24% (9.2 cc). The Maximum Heart Distance (MHD) was also reduced in 13 
patients, due to the expansion of the lung during deep inspiration, which pushed the 
heart tissue away from the treatment field. The MHD was thus reduced from an 
average of 1 cm in normal breathing to 0.1 cm under DIBH. There was also an 
increase in lung volume during deep inspiration; this was still within the tolerance limit 
and did not produce any later lung complications (Lu et al., 2000).  
These results show the benefit of using the DIBH technique. However, the study 
was done in breast cancer patients who had proper lung function and were able to 
hold their breath for the time required. Its results cannot therefore be applied to lung 
cancer patients suffering from reduced pulmonary function and breathing difficulty. In 
addition, the studies used CT scans to calculate the cardiac volume, which will have 
increased the radiation dose to the patient. 
A study carried out by Remouchamps et al. (2003) evaluated ways of reducing 
the dose to breast cancer patients’ OAR, such as lungs, heart, contralateral breast 
and coronary artery. This was done in order to ensure adequate dose coverage for 
the internal mammary lymph nodes. The study evaluated the use of moderate Deep 
Inspiration Breath Hold (mDIBH) with an ABC device and compared it with the free-
breathing patterns during the radiation therapy session.  
The study also used deep tangential fields with FB compared with IMRT and 
mDIBH; the results showed reductions in the heart and lung volume and in lung and 
heart mean dose, while also maintaining coverage of the CTV and PTV when using 
mDIBH with ABC and IMRT for breast treatment. The study limitation was limiting to 
breast cancer patients whom able to hold their breath and did not suffer from any 
lung problem. The study technique could not be used with every NSCLC patient 
whom suffers with breathing and pulmonary problems. In addition to that the study 
used ABC device to control the breathing of patient and to help them produce a 
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stable breathing patterns, which then added more panicking and stressing to the 
patients and overall increasing the treatment time. 
Korreman et al. (2005) investigated the dosimetric benefits of Free-Breathing and 
compared them with the voluntary breath-hold technique by conducting a study of 
seventeen patients, each with breast cancer and who underwent CT scans during 
various breathing manoeuvres: Non-coached breathing (which included Free-
Breathing), end-of-inspiration gating and deep inspiration/end-expiration breath hold. 
The study concluded that the use of the end-inspiration breath hold technique 
combined with DIBH reduced the cardiac dose and spared the normal lung tissue. 
The study was limited in the way that it been done in breast cancer patients, thus 
whatever result would be can not apply to NSCLC patients since patients with 
NSCLC would have a problem with breathing and could produce unstable breathing 
patterns. Another limitation for the study that each patient went through different type 
of breathing manoeuvres which is harshly difficult to be perform by patients with lung 
cancer. 
 
3.4  ACTIVE BREATHING CONTROL  
Active breathing control is another method which is able to limit respiratory motion 
when the patient holds his/her breath at a predefined air volume for temporary 
immobilisation of respiratory motion by valve occlusion (Wong et al., 1999). The ABC 
method is interventional in that the patient’s airflow is temporarily blocked by a valve 
to achieve immobilisation. The system consists of an airflow meter and a valve which 
is able to stop the breathing cycle at a certain lung volume; by means of implication, 
the results should be consistent with those of the patient-controlled breath-hold 
techniques.  
Wong et al. (1999) studied the use of ABC in the thoracic and abdominal areas 
with the aim of reducing the respiratory margin in the PTV. The investigation covered 
12 patients: Four with Hodgkin’s disease, four with lung cancer, and four with liver 
cancer. The results showed that the use of the ABC device was well accepted by all 
patients, including those with lung cancer; they were able to hold their breath for 
about 15-20 seconds, and there was subsequently a noticeable reduction in the 
breathing motion of about 3 mm. This study showed that ABC could be used by 
means of limiting intra-fraction motion for patients with thoracic and abdominal 
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tumours; however, for lung patients it was unclear as to what effect the histology and 
the stage of the lung cancer would have, since each stage of lung cancer will 
differentially affect the patient’s breathing and the length of time he can hold his 
breath. Although the result sounded promising for reducing the PTV margins, 
however, the lung cancer patients number was limited it was only four patients with 
lung cancer. In addition using ABC with breath hold added another stressing to 
patients. 
 
3.5  SELF-BREATH-HOLD 
During this technique the patient voluntarily holds his/her breath for a certain time 
and to a certain point of his/her breathing cycle. During treatment, the patient partially 
controls the radiation beam with the use of a hand-held switch, having the ability to 
switch the beam off, while only the therapist can switch it on. Barnes et al. (2001) 
investigated the dosimetric benefit of the voluntary Breath Hold at Deep Inspiration 
(DIBH) for ten patients with Stage I–IIIB NSCLC without using any extra external 
monitor. CT scans were also used for Free-Breathing sessions and DIBH where 
fluoroscopy was used for reproducing the tumour position and to set the upper and 
lower limits of tumour movement. Eight of the ten patients completed the study, while 
the other two could not cope with the DIBH technique. The authors subsequently 
concluded that voluntary breath hold for NSCLC patients could reduce the lung 
volume receiving ≥ 20 Gy from 12.8% during Free-Breathing to 11.0% with voluntary 
DIBH. The reduction of lung volume is due to the stabilising of the tumour during the 
treatment by the breath hold. 
Kimura et al. (2004) investigated the use of a voluntary breath-hold technique 
accompanied by spirometer-based monitoring in order to control organ motion and 
increase the level of reproducibility — especially with elderly patients and those with 
lung dysfunction — and then to implement this technique for extracranial stereotactic 
radiotherapy for lung or liver. Five healthy volunteers were trained to hold their breath 
before each CT session, learning to perform a deep inspiration and a deep expiration 
under a spirometer-monitor which could display a real-time breathing curve showing 
the state of inspiration, expiration and breath-hold. The training sessions were 
repeated three to four times until the patients became familiar with the method and 
were able to stabilise their breathing. CT-simulation scans were completed with the 
use of fluoroscopy and a spirometer-monitor, and were taken at the end of the 
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inspiration phase and of the expiration phase in order to estimate diaphragm 
movement. 3-DCRT planning and DRR were used for verification purposes and for 
evaluation of intra-fraction and inter-fraction reproducibility. In addition, the study 
evaluated systematic errors in the 3-DCRT treatment plan system and in CT.  
The authors concluded that a voluntary breath-hold technique was better than 
various others, such as ABC or DIBH, since patients adopting these were forced to 
hold their breath and there was a need for extra apparatus, such as EPID (Kimura et 
al., 2004); furthermore, the costs of these other techniques fell within the upper 
range. They claimed that their approach had relatively good reproducibility, with a 
mean setup error of 3 mm in all directions, while diaphragm movement was 
significantly reduced to a range of 7.1-19 mm (with a mean of 13.4 mm), especially at 
end-expiration; thus they recommended its use with extra-cranial stereotactic 
radiotherapy (Kimura et al., 2004). 
The study by Kimura et al. (2004) was limited in generalisability, particularly as it 
was carried out only on five healthy volunteers. Its aim was to help elderly patients 
and those with pulmonary problems to produce stable breathing in order to control 
organ motion; however, the results cannot be generalised for use with all patients 
with lung cancer, as its subjects were healthy and able to perform stable breathing 
patterns without the use of ABS or DIBH. Another issue is that four training sessions 
were needed to produce stable breathing patterns, which would increase treatment 
time, reduce patient throughput and adversely affect the functioning of the 
radiotherapy department if there were not enough staff to cope with the extra time 
needed. On the other hand, the study succeeded in limiting treatment costs by 
minimising the use of extra devices, such as ABC and EPID, since some radiation 
therapy departments would not be able to meet extra costs. 
In another investigation, Kim et al. (2001) examined the benefits of the Held-
Breath Self-Gating (HBSG) technique in the treatment of lung cancer. The study was 
carried out on 16 different patients, each of whom had been undergoing radiation 
therapy for NSCLC and was able to hold his or her breath for 10 or more seconds. 
They were aged between 48 and 71 years, and had NSCLC stage I, IIIA, IIIB and IV. 
The histology of the disease included adenosquamous cell carcinoma, squamous cell 
carcinoma, adenocarcinoma, large cell carcinoma and bronchio-alveolar carcinoma. 
The tumour locations were in the right upper lobe, the right middle lobe, the right 
lower lobe, the left upper lobe and the left lower lobe. All patients were coached in 
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how to control their breathing and perform the breath-hold technique at four different 
points — maximal and end tidal, inspiration and expiration — and were asked to hold 
it for as long as they could and repeat this six times for each phase. The breathing 
cycles were monitored with the use of a video fluoroscopy unit for visualisation at the 
simulator. Diaphragm movement reproducibility was measured at each phase. The 
study concluded that the method was tolerated well by all patients and that maximum 
inspiration and expiration produced the best positional consistency. In addition, the 
HBSG technique showed a reduction of diaphragmatic motion, with an average of 
11.9 mm and a range of 4.4 to 21.5 mm compared with tidal breathing (Kim et al., 
2001). The study recommended the use of HBSG in the treatment of lung cancer 
with the intention of immobilising the tumour and thus ultimately reducing the PTV 
margin, sparing the normal tissue and allowing for dose escalation (Kim et al., 2001). 
The study of Kim et al. (2001) approached the stability of breathing by the HBSG 
technique to eliminate intra-fraction motion and reduce the PTV margin. However, 
the patients were selected according to their ability to hold their breath, which thus 
eliminated all patients who had experienced difficulties in breathing control and who 
were considered unable to hold their breath for a certain length of time. The 
procedure of the study was complicated in that the patients first had to go through a 
training session and then had to control their breathing at different points in their 
breathing cycles. Finally, they were exposed to more radiation, since the technique 
required the use of video fluoroscopy. 
 
3.6  FORCED SHALLOW BREATHING WITH ABDOMINAL COMPRESSION 
The forced shallow breathing technique with abdominal compression was originally 
used for the stereotactic treatment of small lesions in the lung and liver (Wulf et al., 
2000). It consists of a Stereotactic Body Frame (SBF) and an attached plate which 
presses on the abdominal area. The goal is to reduce diaphragm movement while 
permitting the patient to breathe normally (Wulf et al., 2000; Keall et al., 2006). 
Simulator fluoroscopy is used during some days of the treatment in order to verify the 
reproducibility of diaphragm motion (Keall et al., 2006). 
Negoro et al. (2001) evaluated the reproducibility of the daily setup and the 
reduction of respiratory tumour movement using a body frame in 3-DCRT for lung 
cancer. The SBF, which was shaped according to the patient’s body contours, had 
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three parts: the body shell, the laser markers and a small abdominal pressing plate. 
Laser marks and skin marks were used in order to align the patient during treatment 
and simulation. The study was carried out on 18 lung cancer patients, 16 of whom 
had unresectable peripheral lung tumours and poor pulmonary function, while the 
other two had refused surgery for their tumour. The mean age was 65.2 years and 
tumour size ranged from 0.5 to 33 cc. SBF was used to immobilise patients from the 
thorax area to the pelvis area. Fluoroscopy of the X-ray simulator was used in order 
to estimate the tumour movement due to respiration, while daily orthogonal-view 
portal imaging was used for daily setup errors and alignment. Using the body frame 
and abdominal compression reduced the range of movement from 8-20 mm with a 
mean of 12.3 mm to 2-11 mm with a mean of 7.0 mm (p = 0.0002). The absolute 
setup errors were 8 mm in all directions (anterior-posterior, craniocaudal and left-
right) and less than 5 mm in all verifications of all directions: 90% (L-R), 100% (A-P) 
and 93% (C-C) (Negoro et al., 2001). 
The study concluded that implementing this technique reduced respiratory tumour 
movement; however, daily setup verification was required for hypo-fractionated 
conformal therapy. Furthermore, the use of SBF was not suited to every patient; the 
study found difficulty in aligning a patient’s rotation with the body axis, as this would 
increase the variation in daily setup errors. Another consideration is the body weight 
of the patient, with particular reference to obese patients; this can be seen as a 
limiting factor in reducing daily setup errors. The study emphasised that verification 
for daily treatment had to be done on a daily basis in order to avoid any significant 
decrease of target volume, especially when applying hypo-fractionated treatment. In 
addition, the PTV margin could not be reduced unless the daily setup verification was 
carried out in the same position and in the same treatment room for each patient; 
they recommended a PTV margin of 5 mm in the A-P and L-R directions and 
8-10 mm in the C-C direction (Negoro et al., 2001). 
A very recent study of this method was carried out by Heinzerling et al. (2008), 
which investigated the different levels of abdominal compression force — Medium 
Compression (MC) and High Compression (HC) — and organ motion during 
stereotactic body radiotherapy for lung tumours using four-dimensional (4D)-CT scan 
analysis. Three 4D-CT scans were taken for each of ten patients diagnosed with lung 
cancer in the lower lobe of the lung, and different levels of abdominal compression 
were then applied. The maximum position of the tumour was limited to the peak of 
inspiration and expiration phases. The study found that using 4D-CT scans with 
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abdominal compression — especially with HC force — reduced the motion of lung 
tumours, especially in the superior-inferior direction. The mean (±SD) MC force was 
47.6±16.0 N, while HC was 90.7±27.1 N; the mean overall reduction in tumour 
motion was 13.6 mm for MC and 8.3 mm for HC. However, regarding the direction of 
tumour movement. 
Although the study examined ten lung cancer patients with tumours at varying 
sites and locations, using different levels of abdominal compression would ultimately 
not be a successful technique to adopt with all lung cancer patients, for various 
reasons. At any level, abdominal compression could cause breathing problems in 
some patients, considering the fact that they have lung problems and will be lying on 
the treatment coach while trying to hold their position for the treatment time. 
Furthermore, the study used stereotactic body radiotherapy with 4-DCT scans, which 
are very costly; such expensive treatment would not be available in every radiation 
therapy department. In addition, stereotactic body radiotherapy cannot be applied to 
all lung cancer patients, since it does not incorporate the normal number of treatment 
sessions and the standard dose; a total dose of 48-50 Gy is usually delivered in five 
or fewer fractions to small lung lesions of early stage NSCLC (Vassiliev et al., 2009). 
Finally, this technique would require more time than the usual treatments, as well as 
staff training, which would add to the cost of the treatment itself. 
 
3.7  REAL-TIME TUMOUR TRACKING SYSTEMS  
Another technique for tracking intra-fraction motion and for accommodating 
respiratory motion is the real-time tumour-tracking system, which is based on 
repositioning the radiation beam dynamically so as to follow the tumour’s changing 
position (Keall et al., 2006). The main goal of such a system is to reduce the 
respiratory margin around the PTV. This is more complicated and more invasive for 
patients than other methods, since a radio-opaque marker and fiducial seeds — 
usually gold particles of specific size — have to be implanted in or near the tumour 
(Figure 8) (Shirato et al., 2000). The positions of the fiducial seeds are tracked using 
a pair of stereotactic kilovoltage X-ray imaging devices, and radiation is delivered 
only when the fiducial seeds are in their proper place (Shirato et al., 2000; 
Seppenwoolde, 2002). 
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Shirato et al. (2000) developed a linear accelerator synchronised with a 
fluoroscopic real-time tumour tracking system, which increased the accuracy of 3D 
conformal radiotherapy for mobile tumours in the lung (3 patients), rectum, prostate, 
and bladder. A 2 mm gold marker (99.9% Au) was inserted into the tumours of 14 
patients with different types of mobile tumour, so that the motion could be detected 
by a CT scan. CT scans were taken at three different respiratory phases — 
inhalation, exhalation, and average respiratory — in a way which allowed an estimate 
of the relationship between the tumour and the surrounding normal tissues during 
each phase. During the scan, patients were asked to hold their breath during either 
the inhalation or exhalation phase. The PTV was formed by taking the average GTV 
in the different CT scans; in addition, a 10 mm margin was added to PTV. PTV 
reduction was carried out using four-dimensional treatment planning and by taking 
the average of the tumour motions in all directions. It was found that the tracking 
system could reduce unwanted radiation to the patient, thus reducing the margin 
around the PTV to less than 10 mm. Furthermore, it increased the accuracy of the 
treatment by ± 1 mm every 0.033 seconds during radiotherapy (Shirato et al., 2000). 
However, the authors suggest that more studies need to be carried out in order to 
avoid the invasive procedure of inserting the marker, and the treatment time would 
be three to five times longer than for conventional treatment. 
 
 
 
 
 
 
 
Fig. 8: Radio-opaque fiducial seeds (the white worm-like structures) in a lung. 
With kind permission of Keall et al. (2006) 
Similarly, Shimizu et al. (2001) used a real-time tumour tracking system to 
investigate the 3D movement of lung tumours in four patients. Again, a 2 mm gold 
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marker was inserted into the tumour. The study found that the range of motion while 
the beam was on was reduced to 5.3 mm in all directions for all four patients. The 
study concluded that the real tumour tracking system is useful for radiotherapy.  
There are, however, some major issues in relation to real-time tumour tracking, 
such as that it is costly and involves many techniques which require high staffing 
levels. Although using real-time tracking with a seed implant will ultimately enhance 
the radiation treatment by reducing the effects of tumour motion, it also potentially 
causes more complications for the patient; the seed implant could cause 
pneumothorax or interstitial emphysema, which is the accumulation of air around the 
lung. Pneumothorax occurs in 3.3% to 15% of all patients, and may cause long-term 
pulmonary complications, such as asthma and, in severe cases, can ultimately lead 
to death, especially in patients with compromised lung function (Laurent et al., 2000). 
 
3.8  FLUOROSCOPY IMAGING  
Fluoroscopy imaging can be used to track the radio-opaque markers for the 
measuring of tumour motion during the respiratory cycle, and can also serve as a tool 
for directly tracking tumour motion during treatment. The problem with X-ray 
fluoroscopy, however, is that the patient is subjected to more radiation (Keall, 2006). 
A study by Chen et al. (2001) found that the extra skin dose due to fluoroscopic 
tracking of diaphragm motion varied from 1.25 cGy to 9.82 cGy for a one-minute 
fluoroscopic examination; bearing in mind that the system is used daily, the total 
exposure would be considerable (Tasunashima et al., 2004). This is considered as a 
major problem to the patients since an extra radiation dose will be delivered in daily 
bases which then could increase chance of developing extra complication.  
 
3.9  RESPIRATORY GATING RADIOTHERAPY 
Most of the above-mentioned studies into breath control were carried out using 
patients with suitable lung function; in other words, they were selected as they were 
considered able to control their breathing for a certain amount of time, whereas 
breath-hold techniques are often poorly tolerated by patients with lung cancer 
(Underberg et al., 2005). In addition, most of the above-mentioned methods and 
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techniques increased the treatment times, as reported in studies by Hanley et al. 
(1999), Mah et al. (2000), Rosenzweig et al. (2000) and Remouchamps et al. (2003). 
NSCLC patients tend to suffer from shortness of breath and irregular breathing 
patterns, which consequently makes it difficult and uncomfortable for them to control 
their breathing during their treatment to limit intra-fraction motion, whether by DIBH or 
by any other breathing manoeuvre. Furthermore, using respiratory manoeuvre 
techniques requires time for the patients to become trained for simulation and 
treatment and, therefore, it is ultimately considered more beneficial to allow such 
patients to breathe normally while their breathing is monitored by a respiratory gating 
system.  
Respiratory gating has been used for some time in medical imaging, such as with 
the use of CT and MRI, and with the objective of reducing artefacts and blurring (Lui 
et al., 1993; Mori, 1994). This is a method of treating a tumour whereby the radiation 
beam is turned on only when the tumour is within a narrow range of positions, which 
is referred to as the gating window. The radiation beam is active only when the 
tumour is in a certain position, and when the respiratory cycle is at a reproducible 
point which is defined before the treatment session. If irregular breathing patterns or 
cycles appear, the beam will then be immediately switched off. However, in order to 
keep this point reproducible, the patient has to make an effort to actively hold his 
breath or control his breathing cycle (Kubo et al., 2000). 
The most popular commercially available respiratory gating system is the Real-
Time Position Management (RPM) (Varian Medical Systems), which uses markers 
on the body’s surface (usually the abdomen or chest wall) in order to monitor external 
body motion, which is assumed to correlate with the tumour motion. As mentioned 
above, the beam is switched on only when the markers are within a certain well-
defined position window, with the assumption being made that the tumour is also 
within a defined position window. 
Various authors have investigated the benefits of using respiratory gating 
radiotherapy in lung tumour treatment. A study carried out in Japan by Ohara et al. 
(1989) investigated the benefit of using respiratory gating in the treatment of lung 
cancer. Ohara and his group used a phantom integrated into the linac control 
systems; the phantom simulated the lung motion due to breathing, and directly 
switched the microwave oscillator of the linac on and off according to preset positions 
of the phantom tumour. Seven patients were studied; their breathing cycles (chest 
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wall movement) were programmed into the phantom, and the position of the phantom 
tumour was monitored. A series of control positions were defined for each simulated 
tumour, and the process was then applied to the treatment with the radiation beam 
being turned on and off according to pre-set points in the simulated respiratory cycle. 
The study concluded that using such a gating method could be beneficial in the 
treatment of lung cancer, especially if the tumour is located close to the diaphragm. 
However, the study was vague in the diagnoses of the patients plans that been 
simulated . Even though the study suggested the use of respiratory gating with lung 
patients but this assumption was only based on the phantom study not in actual 
patients. 
Ford et al. (2002) investigated and evaluated the use of a commercial gating 
system (RPM) in radiotherapy treatment delivery with the objective of minimising and 
reducing intra-fraction motion due to breathing. The study was carried out on a total 
of 8 patients, 4 of whom were diagnosed with liver cancer and 4 with lung cancer. 
Patients were selected according to the size and location of the tumour. The criteria 
were that the tumours had to be mobile, small and located near structures or organs 
at risk.  
The patients performed breathing control at the end of expiration and at the end 
of inspiration. CT scan and fluoroscopy images were used during the treatment and 
simulations in order to verify the position of the diaphragm and variation in soft 
tissues. During the treatment with gating, the patients had audio coaching sessions in 
order to increase reproducibility. The study found that the mean variability of soft 
tissue movement which was observed in portal films during gated treatments was 
between 2.6 and 5.7 mm, while it reduced the intra-fraction motion due to respiration 
between 0.6 mm and 1.4 mm. It was concluded that most of the treatment variability 
was due to patient setup errors rather than respiratory motion. The suggested use of 
EPI and gated localised film during the treatment twice a week would increase the 
patient total dose in the early days of treatment (Ford et al., 2002); however, in later 
fractions a correction for this is usually made. 
The study did have some limitations: first, it investigated the use of a commercial 
gating system (RPM) with electronic portal imaging, which could bias results in favour 
of the system; second, its only aim was to investigate the use of a commercial 
system in reducing respiratory motion, although it was diverted into studying the 
patients’ coaching and inter-fraction motion, and comparing gating with other 
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methods for reducing this motion; third, the study used lung cancer and liver cancer 
patients without giving any details relating to the stage, histology or pathology of their 
cancer. Diaphragm movement was taken as a surrogate for tumour motion in both 
groups of patients, assuming that their breathing was of the same pattern; however, 
this was not true, as each patient’s breathing was different and they showed unique 
breathing patterns, with the variation changing and becoming irregular, depending on 
the tumour location and size. Another limitation was the number of patients, which is 
considered too small for investigating the effectiveness of RPM in treating either lung 
or liver cancer. The selection of patients for this study was based on tumour size and 
location, so the results cannot be applied to patients with large tumours located in the 
centre of lung lobes. Finally, using EPI as the basis to check the patients’ position 
twice a week would increase the treatment time, as suggested in reference to other 
studies. 
 
3.9.1 BREATH-HOLD WITH RESPIRATORY GATING 
The use of respiratory-gated radiotherapy systems is considered to be more precise 
and the reproducibility of breathing cycle will increase if patient breathing 
manoeuvres are applied, providing that patients can tolerate it for the duration of the 
treatment, (Spoelstra et al., 2008). Nevertheless, the ability of patients to perform the 
Breath-Hold for certain time is considered as a limiting factor as mention in studies 
above, since not every patient would be able to hold his breath, could increase the 
patients complains and the treatment time, Hanley et al. (1999), Barnes et al. (2001). 
Kini et al. (2003) investigated the effects of intra-fraction motion on a daily basis 
and monitored patient respiratory patterns using the respiratory-gated radiotherapy 
(RPM) system. The goal was to discover whether the use of respiratory manoeuvres 
— such as free breathing and the monitoring of the breathing cycle audibly or visually 
by the patient — would increase the precision of respiratory-gating radiotherapy. The 
study was carried out on five patients with no reference to their stage of cancer, nor 
their cancer specification. During the study, the selected patients had training 
sessions in free breathing, audio prompting and video feedback. The study showed 
that free-breathing would be the worse option to use with gated radiotherapy in 
producing unstable breathing patterns, since patients had no control over their 
breathing. Audio prompting produced a more stable frequency of the breathing cycle; 
however, it provided unstable amplitude (which plays a major role in gated 
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radiotherapy, since the gated window is set according to the amplitude). Video 
feedback produced a more stable breathing cycle in regard to the amplitude.  
The study suggested that using audio prompting and video feedback would be 
beneficial during gated radiotherapy, and even suggested the use of breath-hold to 
increasing the precision of the treatment (Kini et al., 2003). It had some limitations 
and there was some lack of clarity as to what it was trying to establish; the entire 
study appears to have been completed in a short time just to give an idea concerning 
the use of the RPM system with different coaching methods. The first limitation was 
the selection of subjects; the study was carried out only on five patients with tumours 
in the chest and without any specification of what ‘chest malignancies’ referred to; the 
authors give more information about the RPM system than about the patients. The 
second limitation of the study is the fact that the duration of coaching for patients is 
not specified; no information is given concerning the length of each session, as all 
that is mentioned is that the patients were coached and a few breathing cycles were 
recorded. Finally, the study does not reveal when the training sessions took place — 
was it before simulation, during simulation or immediately before the treatment? 
The concept behind the Kini et al. (2003) study appears generally similar to that 
of the research reported in this thesis, but there are major differences between the 
two studies. First, Kini et al (2003) investigated the use of patient training in order to 
improve treatment with gated radiotherapy, whereas in the present study the main 
reason to coach patients was to eliminate the need for any high specification 
machines such as RPM. The second difference is that a number of breathing cycles 
were recorded by Kini et al. (2003), whereas in the present study only four minutes 
were recorded. Third, all of the equipment used by Kini et al. (2003) was related to 
the RPM system, so that they used audio prompts based on the system, the camera 
which came with the system and even an LCD screen which was part of the RPM 
facility, whereas the device and the system used in the new work reported here are 
totally independent of any other machine. The final difference between the two 
investigations is that Kini et al. (2003) made the assumption that abdominal marker 
motion was correlated to tumour motion, whereas we make no such assumption here 
but are focused only on studying the expansion of the chest, with the aim of helping 
patients to control their breathing during treatment and so to produce more stable 
breathing patterns. 
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Butler et al. (2004) studied the amount of lung tissue which could be saved when 
using respiratory gating radiotherapy by comparing the masses of lung tissue 
receiving at least 20 Gy, which is used as indicator of probable lung toxicity to the 
average of the gated GTV volumes at different locations, with all characteristics 
related to the disease, such as pulmonary function and lung density. Gating was 
done during different phases of the respiratory cycle, either by inspiration or 
expiration. Ten patients with primary lung cancer were the subjects of this study. CT 
scans were taken for each patient during different phases of the respiratory cycle: 
FB, inspiration and expiration using the assisted breath-hold technique based on a 
spirometer. The Varian RPM system was used for gating. CTV was created by 
adding 1.8 mm to GTV for FB and 0.8 mm for gated treatment. The PTV for the 
gating treatment was calculated without any respiratory motion margin; only a setup 
error margin was permitted. 
The results showed no difference between inspiration and expiration phases in 
sparing more lung tissue; however, respiratory gating was shown to save 43% more 
normal lung tissue if either phase was applied. Despite the fact that the study was 
sponsored by Varian Medical Systems, Inc., Palo Alto, CA, the result was considered 
impartial, since the study concluded that using respiratory gating as a treatment 
option would increase the treatment time, the total cost and the overall number of 
staff required. 
A study carried out by Berson et al. (2004) investigated the use of the Varian 
RPM gating system with the aim of reducing respiratory motion during treatment 
sessions, and also attempted to establish which types of patient would benefit the 
most from using this particular treatment system. The study was conducted on 108 
patients, each of whom had been diagnosed with different cancer at different sites, 
such as the lung, breast, and the upper abdominal and mediastinal areas. Different 
treatment techniques, such as 3-DCRT, IMRT and stereotactic radiotherapy, were 
used. During the simulation and the treatment, patients’ breathing patterns were 
either FB or DIBH with gating. The results showed that gating could be used by all 
patients during simulation and treatment. The study recommended the use of DIBH 
techniques with gating over Free-Breathing, since there was no tumour motion during 
DIBH, the treatment time was shorter and, finally, DIBH was totally reproducible. 
However, the study also found that using DIBH with gating depended on the patient’s 
ability to perform such a technique, Berson et al. (2004). The study was 
comprehensive one in including 108 patients for this investigation, in addition patients 
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diagnoses were different among patients, which make the study as full study 
.Another good point for the study was investigation the used of different treatment 
modalities such as 3-DCRT , IMRT and etc. However, this study was the same as the 
above mentions study by Kini et al. (2003) and Ford et al. (2002) in the way that it 
investigated the use of RPM system and how it could improve the accurate of 
respiratory gated treatment. 
As mentioned above, respiratory gating radiotherapy is one of the most effective 
techniques for treating mobile lesions, such as lung and abdominal tumours. It has 
been proven to be very well tolerated by most patients — regardless of their stage or 
their histology — since it does not require any respiratory manoeuvres and patients 
are able to breathe freely , Ohara et al. (1989) , Ford et al. (2002), Butler et al. (2004)  
While some authors, such as Berson et al. (2004), have suggested that the use of 
the DIBH with respiratory gating radiotherapy delivers a more precise dose to the 
PTV, the patients’ ability to perform DIBH and the time taken for training sessions 
nevertheless remain limiting factors. Respiratory gating radiotherapy also aids in 
limiting the margin of respiratory motion from the PTV; however, this effect is still 
under investigation, and there is so far no clear data on how much is safe for 
elimination or reduction of the margin without affecting the total dose coverage to the 
PTV.  
 
3.9.2  RESPIRATORY GATING RADIOTHERAPY AND IMRT 
Using respiratory gating radiotherapy and the modality of IMRT will provide two 
benefits to the patients during the treatment: First, respiratory gating will eliminate or 
at least limit respiratory motion and hence reduce normal toxicity; second, an 
increase in tumour dose homogeneity will be experienced. Therefore, respiratory 
gating with IMRT reduces the dose to normal tissue and Organs at Risk, such as 
lungs, oesophagus and heart (Keall et al., 2006), while still allowing for a more 
uniformed tumour dose and possible dose escalation. 
Keall et al. (2006) investigated the implementation of respiratory gated intensity-
modulated radiotherapy for the treatment of NSCLC, aiming to improve the coverage 
of the planning target, reduce normal tissue dose and improve the survival rate of 
lung cancer patients. The study used the commercial RPM system with external 
respiration signal markers; patients selected had to have suitable lung function so 
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that they were able to produce stable respiratory patterns. In addition, age, tumour 
position and overall health condition were well specified. 
During the study, the patients had respiratory coaching using audio prompts and 
visual biofeedback. The report covers each modality in full detail used in the study; 
for instance, the use of fluoroscopy, the respiratory-gated IMRT planning procedure, 
portal imaging, respiratory-gated CT imaging and dosimetric quality assurance. 
However, regarding the breathing coaching, it refers to the method used in an earlier 
study by Kini et al. (2003). The study concluded that using IMRT with gated 
radiotherapy was a very complicated technique and in addition it could increase the 
treatment time by 2 minutes. The study suggested the use of highly dosimetric quality 
assurance whenever this technique is used.  
The study was mainly intended to provide guidelines for the implementation of 
respiratory gated IMRT at Virginia Commonwealth University, USA, with no indication 
of the number of patients used and it based it training session in Kini et al. (2003). It 
concludes that if respiratory gated IMRT is implemented carefully, it will ultimately 
improve the outcome of radiation treatment. 
 
3.9.3 SYNCHRONISING RESPIRATORY GATING AND ADAPTIVE RADIOTHERAPY  
Kubo et al. (2000) studied the technical aspects of synchronising the radiotherapy 
beam with respiration using the gating system (BSRT). The study was an inclusive 
description and comprehensive in investigating different methods of breathing 
monitoring such as voluntary breath-hold, forced breath-hold, or breathing gating , 
the effects of gating on machine output, the extent of organ displacement due to 
respiration motion and, finally, the use of different types of sensors, such as 
thermistors, thermocouples, pneumotachography and strain gauges. It recommends 
fluoroscopic imaging as a successful tool for indicating the movement and the 
direction of the tumour, and the use of temperature sensors and strain gauges to 
produce the most desirable signal in addition to accuracy, reproducibility and the 
comfort of the patient. Finally, the authors suggest that using gating radiotherapy with 
breath hold will reduce the treatment volume. There was no change in machine 
output or beam characteristics when using the gating system (Kubo et al., 2000). The 
study covered every technical aspect of BSRT and it could be useful to be used as a 
guideline for such a modalities. 
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The core aim of adaptive radiation therapy is to acquire data on patient geometry 
and organ motion which was previously obtained from images during the treatment 
and adapted or aligned to the treatment parameters; such alignment is based on soft-
tissue and bony contrast. This is done on a day-to-day basis using EPID in order to 
measure setup errors (Perez and Brady, 2008). It leads to reduced treatment set-up 
uncertainty and provides information concerning daily organ motion and variations in 
anatomy (Wittmer et al., 2009). It also requires the use of a suitable treatment 
machine (LINAC equipped with MLC) and on-line imaging devices. Adaptive 
radiotherapy requires many steps: first, the acquisition of everyday images is 
necessary in order to ensure a complete record of patients’ changes and deformation 
during treatment; second, the dose needs to be recalculated for every image; finally, 
assembling all dosimetric information in common images is required with the use of a 
deformable image registration algorithm (Ramsay, 2006). The advantage of adaptive 
radiotherapy is in improving clinical outcomes and treatment efficiency for lung 
cancer patients, which leads to dose escalation. Seibert et al. (2007) found that using 
adaptive radiotherapy for NSCLC could reduce the V20 of the lung by 21% and that 
with online information obtained during treatment the radiation oncologist could 
develop a model to predict changes in the tumour and so optimize the treatment. 
However, this system is not available to every clinic, it increases the treatment time, 
exposes patients to extra radiation doses (which must be corrected for) and, most 
importantly, increases the workload of the staff, so that staffing levels need to be 
increased appropriately to cope with this complex treatment (Barrett et al., 2005). 
A drawback common to all of the above studies is that the methods used require 
control of the breathing cycle to limit tumour motionm, so patients have to perform 
manoeuvres such as DIBH in order to control their breathing. While this is mostly (but 
not always) well accepted by healthy volunteers or patients without significant 
respiratory dysfunction, it is apparently not so well tolerated by those with some form 
of respiratory impairment. Another disadvantage of these methods is that they 
require the use of highly sophisticated systems which are directly integrated with the 
treatment machine. This significantly increases the risk of machine-dependant failure, 
the requirements for sophisticated quality assurance and the overall treatment cost 
and time. Furthermore, techniques which require the implantation of fiducial markers 
together with extensive gated CT scans are invasive, place the patient under 
additional stress. The additional steps involved increase the treatment cost and 
overall treatment time as much as threefold (Kubo et al., 2000). 
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The above drawbacks have led to the assumption that allowing a patient to 
breathe freely or asking him/her to follow some pre-designed breathing pattern 
following coaching may provide a more comfortable and more widely accepted 
method of breath control than DIBH, chest restrictors, etc. The following section 
reviews the available literature on patient breath coaching methods and devices. 
 
3.10  PATIENT COACHING METHODS AND DEVICES 
The coaching method and device will depend mostly on the biofeedback of the 
patients’ breathing patterns. Biofeedback techniques have long been used in the 
treatment of bronchial asthma and pulmonary disease (Vachon, 1976; Ritz, 2004). A 
review by Ritz et al. (2004) of earlier studies investigating the efficacy of biofeedback 
in asthma management concluded that biofeedback using spirometric feedback, 
video display and coaching patients to follow certain patterns were beneficial for 
asthmatic patients; however, it also found that using these techniques would make 
no difference to lung function.  
Another study was carried out by Spoelstra et al. (2008) with the aim of 
investigating the use of a smaller treatment field in order to reduce toxicity when 
concurrent chemo-radiotherapy and respiration-gated radiotherapy with time-
integrated electronic portal images were used for the treatment of locally advanced 
NSCLC. Eleven patients with lung cancer and TNM-stage III, IIIA and IIIB were 
treated and audio-coached using respiration-gated radiotherapy at end-inspiration. 
PTV was generated by adding 5 mm in all directions in order to account for treatment 
setup errors, while another margin of 5 mm was added to the cranial-caudal direction 
for respiratory motion. The study concluded that using gating radiotherapy with 
patient audio-coaching would increase the reproducibility of internal organs and 
would subsequently improve the dosimetry of the treatment by increasing the total 
lung volume by 17% compared with the same method without coaching. During end-
inspiration, the lung is expanded with air, which increases lung volume and reduces 
the fractional amount of normal tissue being irradiated, thus potentially reducing 
NTCP, which could then lead to a decrease in the margin for PTV (Spoelstra et al., 
2008). 
The most frequently cited study which discusses the benefits of training patients 
to control their breathing is by Kini et al. (2003), who investigated the use of audio 
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prompting and visual feedback in mind of training patients during treatment. The 
study was carried out on patients with chest tumours, and their treatment included 
respiratory gated radiotherapy using RPM. Patient training tools included audio 
prompting and the use of a computer system with a recorded message instructing 
patients to breathe in and out at periodic intervals. Another tool was visual feedback, 
which depended on using a monitor in order to show the patients their breathing 
patterns and to further help them to maintain the same pattern by watching the image 
Kini et al. (2003) concluded that patient training and coaching during treatment would 
ultimately increase the reproducibility of the breathing pattern; specifically, they 
recommend the use of visual feedback over audio prompting.  
Neicu et al. (2006) investigated the effectiveness of combining breathing 
coaching with a dynamic radiotherapy method, called Synchronised Moving Aperture 
Radiation Therapy (SMART) in the treatment of lung cancer patients. The method 
used a radiation beam to track tumour motion using a dynamic multi-leaf collimator. 
The study, of five healthy volunteers and 33 lung patients, used respiratory coaching 
techniques in order to control their breathing and to improve reproducibility. The 
coaching was carried out using audio prompts and video biofeedback via the RPM 
respiratory gating system for less than four minutes (200 s); however, the total 
training session took an hour to complete. The training and coaching techniques 
were the same as those developed by Kini et al. (2003). The five healthy subjects 
had no problem with the breathing coaching, while six lung cancer patients produced 
stable breathing patterns and were excluded from the breathing coaching. Four other 
patients could not cope with the coaching due to their health and lung problems, and 
thirteen more could not attend the video session and could be coached only by audio 
instructions. This left only ten of the 33 patients who were able to complete the audio 
and video breathing coaching. The results showed an improvement in treatment with 
the SMART technique when using respiratory coaching, but coaching using the RPM 
respiratory gating system was limited and needed to be improved in order to be 
tolerated by all patients. The study started with 33 patients but was completed in only 
ten patients, which limits the generalisability of the results to lung cancer patients. 
Furthermore, the study did not mention the stage or the diagnosis of the patients 
beyond stating that all 33 had lung cancer. The study recommended that the use of 
the SMART technique with breathing training would be more efficient than using free 
breathing, but this was tested in only ten patients. Finally, the training session took 
an hour, which is another limiting factor for this technique, since time is considered 
critical in any radiation therapy department.  
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Coaching patients to breathe in certain patterns will improve the outcome of 
radiation therapy treatment, as mentioned in all of the above studies; however, not all 
patients could cope with it, and another way of coaching or training needs to be 
developed to help patients to produce stable breathing patterns without the need for 
complicated machines or techniques and without forcing patients to perform the 
desired patterns. 
In another study, George et al. (2006) investigated the causes of residual motion 
during respiratory gating. Residual motion is defined as an uncontrolled motion which 
cannot be completely eliminated due to the unpredictable movement of the tumour or 
an organ; it is now an important part of the advanced techniques of radiotherapy, 
such as IMRT, 3-DCRT and respiratory gating, and requires the allowance of a small 
margin (Saw et al., 2006). George and colleagues studied twenty-four SCLC and 
NSCLC patients aged from 36-82 years. The breathing techniques used were the 
same as those adopted by Kini et al. (2003). The coaching sessions were divided 
into three segments of 4 minutes each; there were five sessions for each patient with 
a week between sessions.  
The study used the RPM respiratory gating system. During the first (FB) session, 
the patient was asked to breathe normally with no instructions or protocol, and the 
session was recorded. Next, the audio instructions session was recorded for four 
minutes, followed by the Audio-Visual (AV) biofeedback session; four of the twenty-
four patients were unable to complete the study due to complications or death. The 
study concluded that there was no change in residual motion during the training 
sessions. Additionally, patients were able to produce stable breathing patterns in the 
first four minutes. Finally, respiratory training could produce more respiratory 
reproducibility, thus increasing the outcome of respiratory-gated radiotherapy 
(George et al., 2006). 
The study was based on using patient coaching methods in conjunction with the 
commercially available RPM gated system, as were most of the investigations 
reviewed above. Kini et al. (2003) used this technique to train subjects while using 
and investigating the RPM system. Although the results of the study were promising, 
showing that coaching could increase breathing reproducibility, which thus increased 
the accuracy of gated radiotherapy, it is nevertheless based on the use of a more 
sophisticated machine and system, such as RPM. The methods of patient training 
using audio prompting and video feedback have not so far been investigated without 
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the use of such systems, but the need for lower cost treatment and to reduce the 
likelihood of stress or the potential for panicking by patients during the treatment 
leads us to consider using Kini’s method of training subjects to stabilise their 
breathing without the need for machines such as RPM. 
Another study was recently conducted by Keall et al. (2006), who investigated the 
impact of audio-video feedback used with the commercial RPM gating system to 
increase the efficiency of gating and improve respiratory reproducibility by reducing 
residual motion. A total of 331 minutes of breathing traces were recorded over five 
sessions for each of twenty-four lung patients. Those selected for this study were 
over 18 years old, had no discomfort or pain in supine position, were not oxygen 
dependent and were receiving external radiotherapy. One patient withdrew from the 
study, three others could not complete the full five sessions, another died during the 
study, and two more finally withdrew due to back pain. The study used the same 
protocol as the study above, and the same (RPM) gating system.  
This time, there were four parts to each session, the first being FB, which was 
recorded for four minutes. The second was an audio prompting part which was based 
on the frequency and the amplitude produced during the Free-Breathing session. The 
patients were instructed to breathe in and out, and the data was again recorded for 
four minutes. The third part was for visual biofeedback, where the patients were 
shown their breathing trace on an LCD monitor, and subsequently asked to follow it. 
Finally, there was a combined AV biofeedback part, where the breathing cycles were 
again recorded for four minutes. 
The study concluded that the audio instructions tended to increase the amplitude 
when compared with the FB and visual sessions, thus reducing treatment precision. 
However, by using audio-visual biofeedback, there was a significant increase in the 
reproducibility of gating radiotherapy and reducing the residual motion than 
compared with Free-Breathing and audio instruction alone. In addition, the study 
concluded that the patients felt more comfortable with the visual biofeedback. 
As the study concluded that using audio prompting and video biofeedback could 
improve the outcome and precision of treatment with gating radiotherapy, but more 
investigation needed to be done to allow patients to breathe freely while performing 
stable breathing patterns. Further studies were also required to discover how patients 
could perform stable breathing patterns without the need for extra machines or 
complicated procedures.  
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3.11  SUMMARY 
The literature attests to the fact that techniques such as DIBH, DEBH and chest 
restrictors are not well tolerated by lung cancer patients, who often have some form 
of lung dysfunction. This obvious difficulty has led to the development of techniques 
which have attempted to capitalise on the patient’s free breathing. However, it seems 
that the search for a technological solution has, to some extent, outstripped the 
evidence as to the best way to train a patient to breathe in a regular and controlled 
fashion, thus missing the potential for a simple solution to the problem of monitoring 
chest wall motion. While this clearly ignores the potential weakness of the 
assumption that tumour motion and chest wall motion are indeed correlated, this is 
nevertheless considered to be beyond the scope of the current study. 
As suggested above, the research and literature on breathing manoeuvres are 
quite limited, and there has been no rigorous analysis of the best method(s) of 
patient coaching (i.e. pure free breathing, visual feedback, audio feedback or audio-
visual feedback) for use with the aim of promoting a stable and controlled breathing 
pattern. Furthermore, most of the above studies investigated the use of audio 
instruction and video biofeedback with a commercial gating system (RPM), and it 
was mostly based on the same technique and the same number of patients, such as 
the studies by George et al. (2006) and Keall et al. (2006), thus limiting the sources 
of information for the investigation and providing a limited analysis of performance. 
The choice of using the gating system is not open to every facility, since it is costly 
and requires complicated planning and the use of CT scans etc., thus increasing the 
total absorbed dose above that which is used in the diagnostic and curative phases 
of the treatment. Finally, the RPM system significantly increases the treatment and 
setup time — and thus the distress for the patient — and the treatment costs are also 
increased.  
Table 4 summarises all the literature review results, in addition to detailing the 
advantages and disadvantages of each breathing method. 
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Breathing 
Manoeuvres 
Authors and 
Dates 
Results 
Summarised 
Limitations 
Breath-hold Rosenzweig, 2000;  
Barnes, 2001; 
Hanley, 1999;  
Mah, 2000;  
Lu, 2000; 
Remouchamps, 
2003;  
Korreman, 2005. 
Immobilises the 
tumour, reduces 
NTCP, leads to 
dose escalation 
and improves 
patient treatment 
outcomes. 
Not all patients 
could perform BH. 
Increased the 
treatment time. 
Active Breathing 
Control 
 
Wong, 1999. Limits intra-fraction 
motion 
Based on use of 
extra device for 
controlling 
breathing. Not 
suitable for all 
patients 
Self-Breath Hold Barnes, 2001; 
Kimura, 2004;  
Kim, 2001. 
Immobilises the 
tumour, reduces 
the PTV margin, 
leads to dose 
escalation 
Requires the use 
of fluoroscopy, 
EPID, extra dose 
to patients and not 
all patients could 
perform it. 
Forced Shallow 
Breathing 
Wulf, 2000;  
Keall, 2006; 
Negoro, 2001;  
Heinzerling, 2008. 
Reduces 
respiratory motion, 
increases daily 
setup accuracy 
Needs daily 
verifications, 
inability to detect 
patient’s rotation 
along the body 
axis. Needs the 
use of CT and 
fluoroscopy for 
every treatment 
Real Time Tumour 
Tracking 
Shirato, 2000;  
Shimizu, 2001. 
Patient breathes 
freely, reduces 
PTV margin and 
increases the 
accuracy of the 
treatment, 
reducing the 
effects of tumour 
motion 
Invasive; increases 
treatment time 3-5 
times; costly; risk 
of pneumothorax, 
emphysema and 
long-term 
pulmonary 
complications 
Fluoroscopy 
Imaging 
Chen, 2001. Increases the 
accuracy of 
treatment 
Extra skin dose, 
requires radio-
opaque markers 
Respiratory Gating  
With BH, 
Synchronising and 
IMRT 
Ohara, 1989;  
Ford, 2002; 
Soelstra, 2008;  
Kini, 2003;  
Butler, 2004;  
Berson, 2004; 
Keall, 2006;  
Kubo, 2000. 
Patient breathes 
freely, decreases 
respiratory motion, 
decreases NTCP 
and increases TCP 
Increased 
treatment time and 
cost, and requires 
more staff. 
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Adaptive 
Radiotherapy 
Perez and Brady, 
2008; Seibert et al., 
2007 
Improves the 
clinical outcomes 
of lung cancer, 
could reduce V20  
and leads to dose 
escalation 
Not available to 
every clinic. Extra 
radiation dose. 
Costly and 
increases both 
treatment time and 
staff workload. 
Patient Coaching  Spoelstra, 2008;  
Kini, 2003;  
Neicu, 2006;  
George, 2006;  
Keall, 2006. 
Increases the 
reproducibility of 
internal organs, 
decreases NTCP, 
eliminates the 
unpredictable 
movement of the 
tumour or an 
organ. If used with 
gating it would 
increase the 
outcome of 
respiratory-gated 
radiotherapy 
Never used alone. 
Still needs more 
investigation in 
order to be used 
widely in treatment 
for every lung 
cancer patient. 
 
Table 4: Summary of the literature review results 
 
3.13  RESEARCH AIM 
The aim of this project is restated here for completeness: The work is primarily 
aimed at the improvement of our knowledge of a patient’s response to and 
tolerance of different breath-training regimes, each of which has been 
designed with the objective of promoting a regular and controlled breathing 
pattern over a time interval commensurate with conventional radiotherapy 
treatment times. In general, this also means developing methods of 
monitoring the chest wall motion as well as developing a robust method of 
analysing the data. As a subsidiary aim, it is hoped that the project will 
ultimately lead to the development of a simple and cost-effective device which 
can, in principle, be used to control breathing without the need for support 
from the treatment machines, or other sophisticated machines such as those 
which are used in other hospitals. 
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CHAPTER 4: DESIGN AND TESTING OF A  
RESPIRATORY MONITORING SYSTEM  
 
4.0  INTRODUCTION 
This chapter discusses the design and testing of a system focused with monitoring 
and controlling the breathing patterns of patients undergoing radiotherapy. The 
reasoning behind the chosen approach is discussed. A system (Figure 9) has been 
adopted in the design and prototyping phase; this means that system specifications 
were first devised and the hardware and software then designed by means of 
facilitating the requirements within the specification. Once the system had been built, 
a testing phase was undertaken and the results were then used to modify the design 
with the aim of improving overall functionality and usability. The hardware and 
software were then modified and the testing phase revisited. This iterative process 
was continued until the system could be produced in such a way that it satisfied the 
constraints and requirements of the specification, and was ultimately deemed to be 
usable and robust. 
 
Fig. 9: InRad device 
Put figure 
here 
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4.1  SYSTEM DESIGN 
The assumption that regulating the breathing pattern improves the ability to treat 
patients with NSCLC is well documented and has been discussed in the previous 
chapters. While the correlation between the chest wall and tumour motion has not 
been totally proved, the evidence demonstrates that controlling the breathing reduces 
the amount of tumour motion in and out of the beam.  
The objective of this thesis, as stated in Chapter 1, was to design and 
manufacture a system to monitor a patient’s breathing cycle in order to assess 
methods of assisting the patient in adopting a suitable breathing pattern, and to also 
identify the best of these methods. The reasons for modifying the breathing pattern of 
a patient undergoing thoracic radiotherapy have already been discussed in Chapters 
2 and 3. A further goal was to design a system which was considered to be 
inexpensive, easy to use and could also be adopted by any radiotherapy treatment 
centre without the need for interconnections to the radiotherapy treatment machine. 
The work was predicated on the ubiquitously held assumption that there is a 
correlation between chest-wall movement and tumour movement, which this project 
did not set out to investigate. Table 5 summarises the main investigator and the 
management of this project, in addition to the company building and providing 
support for the device and software. 
 
 
Project 
Management 
Device 
Concept / 
block 
design 
Device 
Build 
Device 
testing 
Software 
conceptual 
design 
Software 
build 
Software 
testing 
Al-
Mohammed / 
Supervisor 
Al-
Mohammed 
RM 
Cybernetics 
Al-
Mohammed 
Al-
Mohammed 
Al-
Mohammed 
Al-
Mohammed 
 
Table 5: Device Design and Build 
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4.2  SYSTEM REQUIREMENTS  
The following functional specifications and system requirements were based on the 
aims and objectives of the project, and the limitations perceived to be present in 
devices discussed in the literature:  
• It should be non-invasive and comfortable for the subject; 
• It should be passive and not use restrictive methods to modify the breathing 
(e.g. no chest-press or breathing restraints); 
• It should be USB or battery powered so as not to expose the subject or user 
to harmful voltages or currents; 
• It should be portable in size and weight; 
• It should work independently of any radiotherapy equipment, without the need 
of support from fluoroscopic equipment, linear accelerator or video camera 
systems that are integrated into a radiotherapy equipment room; 
• It should have the ability to record the subject’s respiratory cycle for up to 5 
minutes; 
• It must be computer-driven with a software package which can analyse the 
recorded data in real-time, and provide audio and visual feedback information 
that can be presented to the subject; 
• Its function controls must be PC-based and driven from a single screen 
software console (or at most two); 
• It should provide training patterns composed of pure waveforms and 
waveforms derived from the patient’s own free breathing pattern; 
• It should provide an overlay of the training waveform and the subject’s real-
time breathing pattern in different display formats for presentation to the 
subject during training and analysis phases (display formats should be 
continuous graphs, sliding bars, modulated tones, or composites of these); 
• It should provide an output which can be read directly into a spreadsheet for 
offline analysis; 
• Data should be recordable in anonymous subject-specific data files;  
• Construction cost must be less than £3,000. 
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4.3  POSSIBLE TECHNIQUES AND SENSORS 
The problem of designing the sensing system was broken down into two parts: 
Choosing the most appropriate method to monitor the breathing cycle, and deciding 
on the most appropriate sensor. Based on the criteria outlined above and the review 
of methods currently used (Chapter 3), the following possible combinations of 
methods and sensors were identified. 
 
4.3.1  Methods 
• (M1) Monitor the influx and efflux of air from the nose / mouth;  
• (M2) Monitor the rise and fall of the chest wall; 
• (M3) Monitor the expansion / contraction of the chest volume. 
 
 
4.3.2  Sensors 
M1: 
a) Mechanical flow sensors 
b) Hot-wire flow sensors 
c) Pressure-change sensors (piezoelectric, semiconductor, membrane) 
 
M2: 
a) Reflective laser systems (laser displacement) 
b) Capacitive systems and magneto-resistive 
c) Three-axis accelerometers 
d) Global positioning systems (GPS) 
 
M3: 
a) Strain-gauges 
b) Resistive elements – linear variable resistors, liquid metal. 
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4.3.3   M1 – Monitoring Air Flow from the Nose or Mouth 
Mechanical flow sensors are often used to monitor the flow of gas in machinery as 
well as in hospital (patient-based) systems. Unfortunately, an exhaustive search and 
testing of commercial sensors failed to identify a device which was small in size and 
weight, but which also provided an output signal allowing a differentiation between 
inhaling and exhaling, and which was easy to integrate into a device suitable for 
placing close to a subject’s nose/mouth without interfering with normal breathing. A 
further complication with these devices was that if the subject stops breathing — 
even momentarily — the signal will fall to zero, mimicking a change in direction of 
breathing and destroy any correlation between the signal and depth of inhalation or 
exhalation. 
Medical sensors in the M1 group were extremely expensive; as already noted, 
the cheaper commercial sensors provided a signal which was independent of the 
direction of air flow and ultimately not usable for this project. One commercial system 
used in the analysis of sleep disorders did seem to offer the possibility of an ‘off-the-
shelf’ solution; this was the Stardust device (Starduste-Respironics Inc, Murrayville, 
USA) (Figure 10 and Figure 11), which uses a 7-channel recording equipment in 
order to monitor breathing during sleep (Ferguson et al., 2002) in individuals suffering 
from obstructive sleep-disordered breathing or sleep apnoea.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10: Stardust kit 
 
 
 78
 
 
 
 
 
 
 
 
 
Fig. 11: Use of the Stardust device by a sleep-related breathing disorder patient 
(http://www.cpap-europe.com/stardust-home-screening-rental-o-50.html) 
 
The Stardust device is portable, weighing less than 250g, and can be used at 
home. It has three sensors and can record data for up to 8.5 hours using a 9V 
battery. It records nasal airflow, breathing effort, heart rate, oxygen saturation, and 
body position (supine or prone). It measures respiratory effort via a respiratory effort 
belt, heart rate via a finger pulse oximeter and airflow via a nasal cannula/pressure 
transducer system (Figure 11) (Deldin et al., 2006). The data is then recorded and 
stored in the system, and can be loaded onto a laptop computer via a serial 
connection. Figure 12 showing the out put of Stardust device. 
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Fig. 12: Output of the Stardust device 
 
4.3.4  M2 – Monitoring the Rise-Fall of the Chest Wall 
Laser-based position detection is currently the method most often used in 
radiotherapy treatment rooms, usually in the form of the RPM gating system, which 
uses laser position detection. The system was considered inappropriate for our use, 
as it requires a direct connection to a linear accelerator. In principle, a simpler system 
could be built but this would still nevertheless require the use of laser tracking 
devices and software, which would be ultimately too expensive and outside the 
scope of this research to design. 
Capacitive and electrostatic methods do, however, offer a possible way of 
monitoring chest movement, but these would require some form of reference 
framework to be placed over the subject; this would be impractically slow and 
cumbersome to use in any real setting — or even in a controlled environment. 
A three-axis accelerometer system would seem to be the most appropriate 
solution for M2-type measurements; such a system would consist of an 
accelerometer pack (typically a cube with a side length of about 3 cm) placed on the 
subject’s chest wall, which has an output which would provide a time-varying signal 
which could be integrated via hardware or software in order to produce the 
displacement. The disadvantage is the time taken to prototype the electronics and 
software needed to perform the mathematical integration operations and the time 
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needed to quality assure the output signals. Such a device would, however, certainly 
satisfy the above design criteria. 
Finally, GPS systems — which are currently not used in such applications as far 
as the author is aware — would be extremely expensive and outside the scope of 
this work to design.  
 
4.3.5  M3 – Monitoring the Expansion / Contraction of the Chest Volume 
Both strain gauges and resistive elements lend themselves to integration in a simple 
chest belt; they are cheap, easily maintained, and robust. The electronics and 
mechanics needed to monitor the output of such devices, and are relatively simple to 
realise. A chest belt method for monitoring chest expansion would consist of a simple 
non-compliant belt attached to either side of the sensor, which would then simply 
need to be buckled around the subject’s chest. The tension in the belt — which could 
initially be easily adjusted for the subject’s comfort — would vary in response to the 
subject’s breathing, increasing with inhalation, and decreasing with exhalation. Strain 
gauges and resistive elements (including liquid metal) would be sensitive to 
temperature, and so would consequently require temperature compensation. They 
are also passive devices, and so a system based on them might well be limited in 
terms of its sensitivity. However, their simplicity and low cost — in comparison to all 
the other methods reviewed — make them very appealing. 
 
4.4  SYSTEMS CHOSEN FOR FURTHER INVESTIGATION 
Due to the expense and complications associated with systems based on M2, these 
were rejected for further investigation. 
The commercial system (M1) used for analysis of sleep disorders looked very 
promising and it was decided that this would be investigated further. An ex-
demonstration system was purchased at a significantly reduced cost; however, an 
analysis of its functionality revealed that, while it apparently provided differentiation 
between inhalation and exhalation, this was not sufficiently robust or responsive for 
our needs. Furthermore, the system in question was rather cumbersome in terms of 
applying the sensors to the subject. Subsequently, some time was spent 
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investigating whether the individual sensors could be used in a homemade device, 
but this turned out to be rather difficult due to its construction. Modification of the 
software and electronics similarly proved to be too difficult. And, finally, although the 
ex-demonstration model was purchased quite inexpensively, a fully-calibrated virgin 
system would have been extremely expensive. For these reasons, the system was 
rejected.  
A measurement system based on M3 therefore seemed to be the most 
promising, and a simple proof of principle system (POPS) was built.  
 
4.5  PROOF OF PRINCIPLE (POPS) SYSTEM 
The POPS device consisted of a simple belt and a variable resistive element 
constructed from a rubber capillary tube and a liquid metal filling, and an operational 
amplifier (Figure 13). No software was used and the signal was not digitised. The 
POPS was built and the dynamic range of the output, its stability, and its usefulness 
were investigated using an oscilloscope. The POPS clearly demonstrated that it was 
practical to place a sensor on a belt and use simple electronics in order to monitor 
chest expansion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 13: PoPS 
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4.6  FIRST PROTOTYPE DESIGN 
Following the PoPS experiments, a simple system was designed without specifying 
the exact sensor type; it consisted of a belt with integrated sensor, as shown in 
Figure 14.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 14: The belt positioned on the subject’s chest  
 
A Wheatstone bridge arrangement (conditioning unit) was specified to enable 
temperature compensation for all sensor types and to correctly bias the strain gauge 
sensor. The output of the sensor was directly fed into a simple amplification circuit 
using an operational amplifier prior to Analogue-to-Digital Conversion (ADC); the 
output from all possible sensor types was analogue, and this needed to be converted 
to a digital signal for interpretation at the computer level.  
A Personal Computer (PC) was used to control the whole system with the use of 
a custom-built software package. The required specifications of the hardware were 
as follows: 
• Semi-elastic chest belt with buckle 
• Belt width approx 4 cm for comfort 
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• Length suitable for chest sizes up to 70 cm 
• Sensor placed in line or on the chest belt 
• Sensor power drawn from computer USB 
• Sensor to be small – no more than 10 cm x 3 cm including any integrated 
hardware such as pre-amplification stage 
• Sensor and hardware to be light – no more than 100 g 
• Sensor to be connected to external electronics via simple light coaxial cable 
(2 mm diameter max) 
• Facility to monitor and control two independent (and possibly different) 
sensors simultaneously 
• Main conditioning ADC control box to be a stand-alone adjustable gain 
system, offset for both sensors (independently) using linear potentiometers.  
• Sensor ID check signal buttons – simple button-operated signal that marks 
the signal graph to identify which signal belongs to which graph. 
• Output via USB to PC. 
• Output signal (displacement) should be reproducible to within 2 mm. 
 
4.6.1  Software Design 
The following specification was used as a first approach to the software design: 
• Written for PC using widows XP 
• Communication via USB port 
• Single screen system with all controls and output 
• Second screen for displaying sensor / simulated output or graphical data 
online or offline 
• Control of input, output, file generation and save features 
• Save features to include output formatted directly into MS excel and direct 
access ASCII formatted text file 
• Each file to be subject-specific with numerical identifier 
• Instant display function for online checking 
• No additional communication cards or graphics cards. 
 
The software should provide: 
• Input for record identification and data 
• Start / stop data record button 
 84
• Open / close file button 
• Indication of data from sensor (live) or simulated data 
• Input screen for data record identification 
• Simulated data facility (sine wave, square wave and triangular wave) 
• Amplitude and period adjustment (slider bars) for simulated wave form 
• Separate window for displaying the output graphs 
• Radio buttons to switch from bar graph to line graph output 
• Upper and lower marker line switches to produce guide lines on the active 
graph – these lines indicate a breathing depth that the subject is attempting to 
match. Switches allow indicator lines to be made visible / invisible. 
When in the active graph mode, i.e. displaying the sensor output in real time, the 
system should: 
• Display a displacement time graph (line graph) with the ability to present 
either the subject’s breathing pattern only, or that pattern overlaid with the 
control pattern, or the control pattern only, or neither. 
• Display a chart with two bars side-by-side, one showing the desired breathing 
pattern, the other the subject’s actual pattern. This should show either 
subject’s breathing, or both subject and control, or just control, or neither. 
• Be able to show output from either one or both of the sensors 
• Be able to allow the graph to continuously scroll in time or become stationary 
• Allow the upper and lower markers to be switched off or on independently. 
RM Cybernetics was approached to build the entire system — including software 
implementation — based on the abovementioned design criteria. As the project was 
experimental, a flexible contract was agreed to include small redesigns without 
additional cost, while major changes/additions would incur a cost. The first prototype 
system was delivered 6 weeks after the contract was agreed upon. 
Figure 15 shows the components of the system: an elastic belt was used to hold the 
sensor in place, and was designed to fit round the subject’s chest or abdomen. The 
output from the sensor was connected to the electronics (in the black box) via a thin 
flexible data cable. The box containing the conditioning circuit, together with the 
amplifier and ADC, had two outlets for two sensors to be used (A and B). 
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A USB lead was connected the electronics to the PC. A separate video monitor 
was used in order to display the breathing traces to the subject. Figure 15 shows the 
belt attached to a subject who is positioned for monitoring. 
 
Fig. 15: Components of the whole system.  
The belt (with its integral sensor) is seen across the subject’s chest with the USB 
connection to a laptop running the dedicated software. The monitor displays the feedback 
information to the subject. 
 
4.7  PRINCIPLES OF OPERATION 
This section provides a brief overview of the operation of the device. During the in-
breathing phase, the expansion of the chest caused a change in strain across the 
chest belt. In the cases of the liquid metal sensor, the chest expansion changed the 
cross-sectional area of the tube holding the liquid metal and then a change in the 
resistance of the liquid metal column. This change in resistance was measured with 
the Wheatstone bridge circuit, the output being a voltage change, which was 
approximately linear over a sensible range of strain (or chest expansion). The 
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change in voltage across the bridge amounted to a few millivolts for a full chest 
expansion. This voltage change was analogue, and had to be converted to a digital 
signal; it was conditioned, amplified and digitised electronically, and then passed to 
the PC.  
During exhalation, the strain in the belt — and hence the sensor — was reduced, 
and the voltage signal returned towards its base reading. The time progression of the 
voltage signal followed that of the chest wall expansion and contraction during 
breathing. The software displayed this in one of three ways: 
i) A continuous moving line graph (the amplitude indicating the depth of 
breathing, the period indicating the frequency of breathing and the phase 
indicating the phase of breathing; 
ii)  A continuous moving bar chart (the height of the bar indicating the depth of 
breathing) or a sound with increasing/decreasing pitch.  
 
4.8  SHAKEDOWN TESTS 
Initial tests on the prototype system were divided into three sections: 
I. Functionality and performance of the software subsystems; 
II. Functionality and performance of the hardware when used on a subject; 
III. Reproducibility and quality assurance studies. 
Tests were designed in order to evaluate several factors, such as the compliance 
of the system with the design criteria, the usability of the software, the ease of use of 
the system when monitoring a live subject, the reproducibility and accuracy with 
which the chest expansion and contraction was measurable and the robustness of 
the belt and sensor system. In all, the software and hardware went through three 
incarnations before being used to collect data from research subjects. 
 
4.8.1  Software 
Tests conducted on the software revealed several minor problems which limited the 
system’s functionality and ease of use. The initial and final versions of the opening 
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screen are shown in Figures 16 and 17. The problems identified in the shakedown 
tests are discussed below. 
 
 
 
 
 
 
 
 
 
 
Fig. 16: The first InRad breathing system starting screen 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 17: The modified InRad breathing system starting screen  
Note the addition of synthetic wave amplitude slider bar, data off-
set slider bars and a sample rate slider bar (see text). 
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4.8.1.1 Graph offset – data offset slider bars  
The vertical position of the subject’s breathing pattern depended on the measured 
output voltage from the sensors, which had two components: the time varying signal, 
seen as the breathing pattern, and a static offset, which was dependent upon the 
tightness of the belt around the subject, etc. The latter differed from subject to subject 
and measurement to measurement. In some cases, it was observed that this offset 
placed the graph on the extreme upper/lower portion of the screen. In order to 
compensate for this, a simple offset slider was added — in fact, there were three 
data offset sliders; one each for the two possible sensors and one for the synthetic or 
simulated waveform. These were designed purely to alter the way in which the graph 
was displayed and did not alter the recorded data in any way. 
 
4.8.1.2 Data sampling rate 
The data sampling rate was initially a fixed value, which resulted in an excessively 
large data file and incompatibility errors with the Excel spreadsheet (a Microsoft error 
which was outside the control of this project). A control variable was then added in 
order to allow the sample rate to be varied; in practice, this was always set at 10 ms. 
 
4.8.1.3 Waveform period control 
The waveform period control indicated seconds but did not function correctly. This 
was changed in later versions to ensure provision of true values in seconds, thus 
allowing the period of the simulated training waveform to be accurately set to the 
natural mean free-breathing period of the subject, as determined from short FB tests. 
 
4.8.1.4 Marker lines  
Upper and lower marker lines indicated the maximum extent to which the subject 
should breathe in and out; in other words, they provided the subject with a controlled 
breathing envelope. Clearly, different subjects would feel most comfortable with 
different depths of breathing, so the extremes of the envelope indicated by the upper 
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and lower guidelines had to be altered to suit each subject. In V1.0 of the software, 
the position of these lines was alterable only through the use of two slider bars which 
had no relationship to the actual amplitude of the breathing cycle. This was corrected 
by adding the ability to position the marker lines by setting absolute values for the 
amplitude and offset; this allowed the guide envelope to be easily set to the subject’s 
natural mean free-breathing amplitude as determined by a short FB experiment. The 
natural breathing amplitude determined could then be used in subsequent training 
episodes as the target amplitude to which the subject should match his/her breathing 
depth. 
 
4.8.1.5 Coordinate scaling  
During subject-based tests, it was observed that no coordinate scaling was provided 
for the graphs displayed. Effectively, the subject’s breathing pattern needed to be 
displayed in a way that would allow the patients to follow it visually; in other words, a 
function needed to be included in order to permit the time and amplitude scales to be 
altered. Furthermore, scaling changes needed to be consistently applied to both the 
subject’s measured breathing pattern and any simulated patterns; this was ultimately 
achieved by adding time and amplitude sliders, which permitted visual scaling.  
 
4.8.1.6 Time axis looping  
Initially, the time progression behaviour of the waveform was such that once the trace 
had reached the end of the data screen, the plot would reset and start again at a time 
of zero. This was both confusing and resulted in a discontinuity in the real-time plot, 
caused by a short time-latency in the reset phase. This was corrected by allowing the 
time axis to scroll continuously. The non-scrolling option was retained. 
 
4.8.2  Hardware 
Tests on the hardware revealed several problems associated with the belt and with 
system noise which made the initial system rather delicate and difficult to use; these 
are outlined below. There were also several minor problems in relation to plugs and 
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sockets, etc., which had no significant effect on performance but were nevertheless 
corrected; it is felt there is no need to discuss these here. 
4.8.2.1 Sensitivity 
The output of the system was found to be rather sensitive to the positioning of the 
belt on the subject’s chest, to chest motion during the breathing cycle and to the 
tension of the belt. This was an issue associated with the absolute sensitivity of the 
system which, in turn, was related to the system gain. In certain situations, it was 
found that the amplitude of the signal was too small for any meaningful work; 
increasing the amplitude scaling had a limited usefulness, as this would effectively 
stretch any inherent noise, making the graph difficult to follow. Initially, the degree of 
amplification was preset, although it could be altered through a logarithmic inline pot. 
The ADC system had sufficient accuracy to allow an amplification phase to be added 
to the circuit. The circuit was altered to provide a fixed degree of pre-amplification 
followed by a linearly variable post-amplification stage, permitting variable gain 
control.  
 
4.8.2.2 Noise 
Adding a second amplification phase had the undesirable effect of increasing the 
signal noise, both due to small motion slippage of the belt during breathing and also 
from AC environmental signals. Additional filtration — predominantly 250 Hz — was 
added to the circuit and effectively solved this problem. Figures 18 and 19 show 
respectively a sample trace with excessive noise after the inclusion of the second 
amplification phase and reduced noise after the inclusion of a noise filtration circuit. 
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Fig. 18: The real-time breathing of subject with excessive noise following the 
modification of the amplification circuit 
 
 
Fig. 19: Real-time breathing of subject with reduced noise following the addition of a 
noise filtration circuit 
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4.8.3  Reproducibility and quality assurance tests 
It was clearly important that sensitivity and time-based drift should be insignificant 
over the measurement period. To this end, a simple test was devised in order to 
attempt to evaluate the extent of such drift. The belt was attached to two spindles, 
ensuring it was kept under tension, and simulated by being placed around the 
subject’s chest. One spindle sat in a groove on a base-plate and could be driven in 
such a way as to alter the gap between the spindles periodically, simulating simple 
chest expansion/contraction. The test consisted of driving the spindle in a periodic 
(sinusoidal) motion for several minutes and then recording the output waveform from 
the sensors; this could then be compared with the driving signal which moved the 
spindle.  
The experiment was repeated several times, disconnecting the belt between 
experiments and reassembling. Repeatability across all measurements (amplitude 
and frequency) was within 5% and there was no observable drift in period or 
amplitude when measuring for prolonged periods (over 10 minutes). The system 
followed the driving signal with no significant time delay. This last point is quite 
important, as a time delay in the monitoring system would introduce a feedback delay 
for subjects, who would then see what they were doing some time after they did it, 
making the task of following a time-varying waveform rather difficult (Appendix A). 
 
4.9  TRAINING (SYNTHETIC) WAVEFORM GENERATION 
Figures 20, 21 and 22 show the results of setting up sine wave, triangular wave and 
square wave training patterns respectively. A series of such patterns were initiated 
and the data recorded using the ‘record data’ button. Following the record sequence, 
two functions were tested, which were concerned with the display of the data using 
the InRad breathing monitor software regarding retrieval and display of the data 
using MS excel. The InRad software provided a function to write the data to a 
formatted Excel spreadsheet.  
The period and amplitude of the saved data was then checked against the 
parameters set on the InRad setup screen. In all cases, the waveform, its period and 
its amplitude precisely matched the parameter settings, confirming that the waveform 
generator and save functions were operating correctly.  
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Fig. 20: InRad software displaying synthetic sine-wave data  
The figure is a post-generation plot using saved data. 
 
 
 
 
 
 
 
 
 
Fig. 21: InRad software displaying synthetic triangular-wave data  
The figure is a post-generation plot using saved data. 
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Fig. 22: InRad software displaying synthetic square-wave data  
The figure is a post-generation plot using saved data. 
The layout of the V 1.0 screen is shown in Figure 23, while Figure 24 shows the 
final version and the alternative bar-chart presentation: a moving column graph in 
which the height represents the y-axis displacement. 
 
 
 
 
 
 
 
Fig. 23: Layout and functionality of the V1.0 graph screen 
Note that the time axis has arbitrary units. 
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Fig. 24: Layout and functionality of final version of the graph screen (left-hand image)  
 
Notice the addition of the static marker tick-boxes, which allows the two marker 
lines to be switched on or off. Also, the time axis now has the units of seconds. The 
position of the upper and lower markers is controlled from the initial screen by graph 
marker buttons and sliders. The bar graph on the right shows the alternative 
presentation. The blue column moves up and down in time following the 
displacement and frequency of the sine-wave. Frequency is indicated by the rate of 
the rise and fall of the bar.  
 
The result of the system test is shown in Appendix A, which presents the actual 
data produced. 
 
4.10  BELT POSITIONING 
To evaluate the system in its entirety, a series of measurements were taken using 
two healthy volunteers. Various belt tightness settings and belt positions were 
investigated for both comfort and device functionality. The optimum position for the 
belt and sensor was found to be with the buckle placed on the subject’s back and the 
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sensor was with the belt positioned laterally; this provided good sensitivity with little 
tendency for the belt to slip over clothing. The positioning is shown in Figure 15 
above. 
 
4.11  SUMMARY 
The InRad breathing device used a belt with integral sensor to monitor the subject’s 
breathing patterns. It was fully computer controlled using USB power and data 
transfer. The system permitted the use of one or two individually-configured sensors. 
Only two screens were needed for the setup and operation of the hardware and 
software. 
The opening screen permitted the sensor type and number to be configured, as 
well as the data sample rate and record status. It provided controls for the generation 
of synthetic data (its type, period and amplitude) as well as data offset controls, 
which ultimately allowed the graph plotting to be controlled. These controls were 
placed on this page so that the graph screen could be presented as simply as 
possible in relation to the subject; any adjustments to be made during a monitoring 
session were not seen by subjects, and so would not disturb their attempts to 
following the training instructions, etc. The type of graph shown to the subjects during 
a measurement could also be chosen from this parameter setup screen (the opening 
screen). 
Finally, the parameter screen allowed the positioning of the upper and lower 
depths of breathing marks to be placed on the graph. These appeared as static lines 
and acted as upper and lower boundaries to the patient’s breathing envelope. 
Basic shakedown tests were performed on the software and hardware in both 
subject measurement and passive modes. These highlighted failures and 
weaknesses of both hardware and software, prompting successive redesigns prior to 
the taking of full data measurements from subjects. 
The second screen was the display screen, which had a minimum number of 
parameter controls and simply displayed the graphs in real time to the subject. 
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CHAPTER 5: EXPERIMENTAL DESIGN AND METHOD 
 
5.1 INTRODUCTION 
This chapter presents the methodological considerations and the decision-making 
choices used to conduct this study.  
 
The research categories used in this project were analytical and experimental. The 
goal of the project was to develop a non-invasive device which could monitor the 
breathing of subjects during radiation therapy treatment and to use this to investigate 
different methods by which subjects could be helped to perform regulated breathing. 
The experimental component of the research was thus divided into two distinct parts: 
phase 1 was the development and testing of the device and phase 2 was the 
investigation of the different methods of regulating breathing patterns. The 
development of the device and its testing are discussed in Chapter 4, while the 
current chapter relates only to phase 2, in which the device was then used with 
volunteer subjects to monitor their breathing patterns.  
 
5.2  EXPERIMENTAL DESIGN 
The research methodology used during phase 2 is now outlined. Table 6 summarizes 
the main aspects of experimental design. 
 
 
Ethics 
Application 
Consent for 
Design  
Information 
on Design 
Device 
Testing 
Subject 
Recruitment  
Experimental 
Design 
Measurements 
Al-
Mohammed 
/ Supervisor 
Al-
Mohammed 
Al-
Mohammed 
Al-
Mohammed 
Al-
Mohammed 
Al-
Mohammed 
Al-
Mohammed 
and 
Supervisor 
(3 subjects) 
 
Table 6: Experimental Design 
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5.2.1  Research Question 
 
The research question to be answered can be expressed as: Which breathing 
technique produces the most stable breathing pattern: free breathing (FB), audio 
prompting (AP) or video feedback (VF)? 
 
5.2.2  CONTROL 
In order to answer the research question and identify the best technique, FB, AP and 
VF were compared to a control breathing pattern. Under the assumption that we 
wished to regulate as much as possible the period, amplitude and phase of a 
subject’s breathing, a control pattern was defined as a clean (ideal) sinusoidal trace, 
having constant period and amplitude. This control was derived from the subject’s 
natural free breathing, the amplitude of the control being set as the mean amplitude 
of measured FB and the period of the control being set as the mean period of the 
same measured FB; thus, as required, the control had a constant period (TControl) and 
constant amplitude (AControl). In this way, the control was closely related to the 
subject’s natural breathing rhythm and avoided any form of unnatural forced 
breathing, i.e. at an uncomfortable frequency or amplitude. 
 
5.2.3  DECISION PARAMETERS 
The main parameters were: 
• the difference between the control amplitude and that of the breathing 
patterns created using FB, AP and VF; and  
• the difference between the control phase and that of the breathing patterns 
created using FB, AP and VF. 
 
A good breathing pattern is here defined as one that minimises the above 
differences. Clearly, a single measure of these differences is insufficient here, so the 
observable parameters are statistical estimates of the underlying mean difference 
and the standard deviation of the difference, the objective being to establish which, if 
any, of the FB, AP or VF methods has the smallest values of these statistical 
parameters. There are two cases to consider – averages over the number of cycles 
for a single subject and averages over all subjects. The analysis used is developed in 
chapter 6.  
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5.2.4  SAMPLE SIZE CONSIDERATIONS 
a. Averaging over subjects 
The number of subjects chosen was based on time constraints and the requirements 
of statistical significance. Estimates of the time needed to perform a complete 
measurement set on one subject obtained was limited to fifty. The counting error with 
fifty samples provides an uncertainty at one standard deviation (68% confidence) of 
approximately 14%. Clearly it would be better to have a lower standard uncertainty, 
but there was a limited timeframe for this project to be undertaken and based on the 
time needed to asses one subject, the limitations of subject availability and on the 
time available for use of the SAAD centre etc, it was decided that fifty subjects were 
as many as could be sensibly accommodated. 
b. Averaging over cycles 
The measurement protocol was set to approximate a typical timeframe as seen in a 
radiotherapy treatment but avoiding the risk of induced fatigue, which would 
otherwise bias the results. A measurement period of 4 minutes was chosen, typically 
providing 70 cycles. The uncertainty associated with this on a simple counting 
process is approximately 12%. It was felt that this was the best that could be 
achieved for this experiment.   
The total uncertainty, based on assuming that the above factors are uncorrelated, 
independent and can be combined in quadrate, is approximately 17% at 68% 
confidence. 
 
5.2.5  EXTERNAL BIAS 
The external bias for this project could include any fault in the device or the belt, any 
distraction during the measurements and finally any problem with the subject. To limit 
any external bias the device was fully tested before each measurement, access to 
the measurement room was limited to the subject and experimenters during the time 
of measuring and finally, the subject was fully informed about the procedure and the 
time that it was likely to take. 
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5.2.6  INTERNAL BIAS 
The internal bias includes the influence of any form of training, relaxation and fatigue 
of the subjects over the measurement period and specifically between measurement 
procedures (FB, AP, VF). Such learning or relaxation might potentially influence the 
results – presumably showing improvement as the session progressed (in the case of 
learning / relaxation) and presumably a worsening of results in the case of fatigue. 
However, the sequence of the measurements had to start with FB, to provide a trace 
on which to establish baseline control. Audio prompting was then placed before 
visual feedback so that the easier method came before the more complex procedure. 
In addition, visual feedback took time to set up; adjusting the monitor according to 
subject preference could cause changes in belt position, which would affect the AP 
reading later. It was felt that ordering the session in this way reduced the possibility 
of fatigue. Considering the learning effect, each method required a different physical 
response from the subject and so learning should not be an issue. Furthermore, prior 
to commencing measurements, the subjects were given some time to become 
familiar with the equipment and setup, and any questions were dealt with. In this 
respect the initial steep learning phase would apply to all three methods. This initial 
learning was supported by the initial one-minute session in which the subject was 
simply asked to breathe so that the system could be set up and tested. It is 
recognised that learning was not completely eliminated from this work, but its effects 
are seen as limited and the real possibility of fatigue if a different order had been 
chosen is seen to outweigh this potential bias. Due to time constraints, further 
random sequence tests could not be performed.  
 
5.2.7  EXPERIMENTAL ENDPOINTS/OUTCOMES 
The endpoints for this project were set as follows: 
1. to produce a simple, portable, basic device  
2. to produce software that could be used with the device 
3. to implement the device to be used in clinical facilities 
4. to establish if one of the training methods (FB, AP or VF) was best. 
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5.2.8  RECRUITMENT METHOD 
The recruitment methods for this project included: 
1. A flyer at the university hall inviting students and staff to join the study. It gave 
details of the time the measurements would take, the investigator's name, the 
contact person’s telephone number and email address (Appendix E); 
2. Asking people at work, family members and acquaintances if they would 
participate. 
 
5.2.9 INCLUSION CRITERIA 
The minimum inclusion criteria for volunteer enrolment in this project were the 
following: 
a) Healthy, male or female subjects aged 18-70 years; 
b) Unspecified pulmonary function; 
c) Subject has provided written consent; 
d) The ability to understand and discuss his/her participation; 
e) Does not require oxygen or any other form of breathing aid; and 
f) Is able to lie or sit in the supine position for approximately one hour. 
 
5.2.10 EXCLUSION CRITERIA 
Exclusion criteria for all subjects were: 
a) Any breathing problems which require breathing support, such as oxygen; 
b) Pain or discomfort when lying down or sitting up for the measurement time; 
c) Mental disorder; or 
d) Health problems, such as heart problem or back pain. 
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5.2.11  NON-CONFORMANCE TO PROTOCOL AND NON-SPECIFIC WAVEFORMS 
It seemed clear that better results in training would be obtained if a target were 
selected with a breathing pattern which was close to the natural pattern of the 
subject. This hypothesis was tested in a separate set of training exercises whereby 
we deliberately chose waveforms with parameters different from those of the natural 
breathing patterns of the subjects. The results (as discussed in Chapter 6) confirmed 
our hypothesis and so all our training sessions used data collected from the free-
breathing sessions.  
 
5.2.12 TRIAL MANAGEMENT  
The trial management of this project included all aspects of the processing of data 
recording, all subjects involved in the measurement, analysis of the measuring data, 
the quality plan of day-to-day measurement and the timeframe for the project. The 
supervisor was informed on all occasions of any changes to protocol and of any 
testing. The trial was seen as the initial basis for further study. 
 
5.3  ETHICAL CONSIDERATIONS AND CONSENT PROCEDURE 
The University’s full ethical consent procedure (under City University Guidelines) was 
followed (Approval of Experiment and Investigation Involving Human Subjects 
(Appendix D)) and ethical consent granted through the Ethics Committee. The signed 
ethical approval letter is shown in Appendix B and the completed ethical application 
form in appendix D. Some of the ethical considerations are detailed below. 
a. Confidentiality and Anonymity 
All data was anonymous and no personal information was stored under the subject’s 
name. Each subject was assigned a number in order to protect the privacy of the 
information. The data results were protected from unlawful detection or use under 
any circumstances by being stored in a laptop to which only the principal investigator 
had the right of access. All ethical considerations of protecting subjects’ privacy were 
taken to avoid any instance where data or information could be published or used by 
any unauthorised person. 
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b. Payment, recruitment and characteristics of subjects 
This investigation involved no payment or inducement for the volunteers to 
participate in the study; there was therefore no ethical consideration regarding 
payments to subjects. The study took into consideration that all the subjects had to 
be physically healthy volunteers without disorientation or poor mental health. 
Children and young people were excluded by the criterion that subjects had to be 
fully competent adults aged 18 or above.  
c. The Device, Duration of Measurement and Safety of Subjects  
The device was considered safe, consisting of a flexible belt carrying a strain gauge 
sensor (as described in Chapter 4). The device was not mains powered and had no 
direct contact to high voltage equipment. Participants were subjected to no risk of 
harm. Measurements took from 40 to 60 minutes to complete, including explanation 
and three sessions of different breathing patterns. The procedure was not invasive 
and was considered safe for all subjects, who were not restrained during the 
measurement. The safety of the subjects and their awareness of safety were fully 
considered.  
d. Written Informed Consent 
Prior to the measurement the subjects were informed about the procedure, its 
duration and the device. They were then asked to sign a written consent form 
(Appendix C). 
 
 
e. Withdraw from the study 
All subjects had the right to withdraw from the study at any time and not to complete 
a full session. 
 
5.4  EXPERIMENTAL METHODS AND PROCEDURE 
Fifty subjects were recruited for participation in this study; all were unpaid volunteers 
and presented a variety of profiles, from the young, healthy non-smoker with no 
medical conditions or pulmonary problems to the elderly smoker with an unspecified 
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pulmonary problem. No pre-selection was made except for the ethically approved 
inclusion criteria stated above. 
Prior to the taking of measurements, participants were shown the measuring 
system and were made to feel comfortable in the room and surroundings; heating 
and lighting were adjusted for their comfort. Each subject was assigned a randomly 
generated number that was used on all subsequent data files. It is important to note 
that only the principal investigators had access to any of the volunteers’ information, 
as required by the ethical approval obtained from City University Senate Research 
Ethics Committee for Approval of Experiment and Investigation Involving Human 
Subjects (Appendix E). 
During measurement, volunteers were placed in supine position with their arms in 
the sides. Although the literature suggests that breathing is predominantly controlled 
abdominally when the arms are placed above the head, our initial investigation during 
the testing phase showed that a more consistent measurement could be taken if the 
belt was placed above the xyphoid process, slightly towards the nipple. 
Consequently, all measurements were taken with the custom-made belt and strain 
gauge placed in this position, unless this was non-optimal for a specific subject.  
In order to ensure that the sensor was placed in the correct position, a short 
measurement (of less than one minute) was carried out prior to the actual data 
collection session. This allowed the sensor, belt position and tightness, monitor 
location and lighting to be optimally adjusted; all of these parameters were then fixed 
for each of the data collection/training sessions for that particular subject. Generally, 
only two such adjustment sessions were needed before the optimum settings were 
determined. The subject was not shown any breathing data, nor was the subject 
‘trained’ in any way during this initial setup phase.  
As previously mentioned, each data collection session lasted 4 minutes. There 
was an interval of 10 minutes between sessions for the subject to rest. 
Prior to the taking of each measurement, subjects were asked if they were 
comfortable and ready to start. If so, they were asked to relax as much as possible 
and not to move or fidget as, in a radiotherapy session, patient movement would 
cause a radiographer to terminate a treatment and reposition/settle the patient. 
Unless the subject specifically requested a halt, the researcher observed discomfort, 
or some other significant problem occurred, the data recording continued even if the 
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subject coughed or moved slightly, thereby simulating a real patient treatment 
session.  
The subjects of this study, who were divided into two groups, all had to be aged 
at least 18 years, be able to understand and discuss their participation, not require 
oxygen or any other form of breathing aid, have no pre-existing heart condition or 
other medical condition that could be exacerbated during the data collection episode, 
be able to lie or sit in the supine position for the duration of approximately one hour 
and provide full signed consent. Figure 14 in Chapter 4 shows a typical setup, where 
the subject is in a recumbent position for ease of photography (allowing the belt, 
waveform monitor and subject to be seen), while Figure 15 shows a demonstration of 
a typical attempt to follow a breathing trace, in this case a triangular wave (as with 
figure 14, the subject has not been placed in the treatment position).  
For each subject, a series of 4-minute breathing traces were collected under 
different training and feedback situations. The agreed protocol was to take the 
following measurements in the same order each time: free-breathing, audio 
prompting (therapist’s voice providing prompt commands to breathe in and out) and 
visual feedback. Originally, it was also planned to include audio-visual feedback, but 
initial investigations showed that this was problematic and caused confusion, so this 
suggestion was excluded.  
The data collection was organised in the above way in order to facilitate the most 
natural free-breathing response, i.e. one that was not influenced by any form of 
training or relaxation. Certainly, it was recognised that relaxation and/or fatigue could 
influence the later collections in the sequence, but analysis of the data showed no 
such effects. Audio prompting was placed before visual feedback so that the easier 
method came before the more complex procedure. In addition, visual feedback took 
time to set up; adjusting the monitor according to the subject’s preference could 
cause the belt position to vary, and thus would affect the AP reading later on. 
The data collected in all sessions were recorded and each recording contained 
the numerical data to enable the full 4-minute waveforms to be reconstructed in time 
correlation with any prompting or feedback waveform. Thus, the period, amplitude 
and phase patterns of the subject’s breathing could be analysed against the different 
prompt or feedback waveforms. The data was exported directly to Excel 
spreadsheets, as discussed in Chapter 4. 
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5.5 PROCEDURE DURING THE BREATHING SESSIONS 
5.5.1 FREE-BREATHING SESSION 
The first session of breath training was in free-breathing. The subject was asked to 
lie on a clinical bed for a total of four minutes, and the InRad respiratory belt was 
placed between the lower part of the chest and the upper part of the abdomen. 
The subject was asked to breathe normally, with no requirement to perform any 
particular kind of breathing. During this time, the breathing cycle was recorded via the 
sensor to the laptop computer. No images, sounds or any other feedback were 
presented to the subject. After the recording of the breathing cycles, which lasted for 
four minutes, the subject was told the session had concluded and was asked to rest 
prior to the next collection session. During this time, the time-averaged natural 
amplitude and frequency of the subject’s breathing was extracted from the data set 
collected.  
As will be seen in the results section, the amplitude and period of participants’ 
breathing varied with time over the 4-minute period, and so it was deemed necessary 
to establish an average for these parameters.  
There are two alternatives to setting up a training waveform: either the training 
waveform has approximately the same parameters as the natural breathing averages 
for the subject, or the period and amplitude of the training waveform are chosen 
simply for the convenience of the treatment, and so the training pattern is different 
from the subject’s normal breathing. In all of the training sessions, time-averaged 
data from the FB pattern were used in order to establish the parameters of a regular 
training pattern. 
 
5.5.2  AUDIO PROMPTING SESSION 
For the audio prompting session, the breathing belt was left on the patient from the 
FB session and the monitor software was set to produce a sine wave with a 
frequency and period determined as above. The sine wave was presented to the 
researcher (not the subject). During the session, the researcher would issue the 
simple verbal commands to ‘breathe in’ and ‘breathe out’ for the subject to follow. 
The aim here was to cause the subject to breathe regularly within a consistent period 
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and amplitude via simple commands, such as could be issued over an intercom 
system in a conventional treatment room. The researcher was prompted by the visual 
comparison of the subject’s breathing and the ‘ideal’ signal provided by the software. 
Again, four minutes of data were collected for each subject. 
After completing this session, the subject took a break for approximately ten 
minutes, then the video feedback session started. 
 
5.5.3  VISUAL FEEDBACK 
For visual feedback, the subject was presented with exactly the same training signal 
as had been presented to the researcher during the audio session, except that 
presented on the same rolling graph was the subject’s real-time breathing pattern. 
The subject was able to follow his/her real breathing and to try to match it with the 
ideal breathing. The real breathing was shown to the subject on a flat screen monitor 
which had been fitted to a medical stand and which the subject was able to adjust 
according to his/her position and vision, so that he or she could see the breathing 
trace very clearly; the idea behind this was that the subject should attempt to make 
his/her pattern follow as closely as possible the guiding (or synthetic) waveform, 
which took the form of a sine wave.  
 Upper and lower guidelines were also placed on the rolling graph (just above and 
below the maximum inhalation and minimum exhalation phases of the synthetic 
waveform) in such a way as to act as an envelope within which the subjects were 
asked to keep their breathing amplitude. They were asked to try to follow the 
synthetic sinusoid for four minutes.  
 
5.6 PILOT STUDY  
 
A pilot study was conduct on two subjects in order to determine whether all 
operational parameters of the device, belt and software were as expected, so that the 
full procedure could be applied to all fifty subjects. Problems were found relating to 
the positioning of the monitor (used by the subject in the VF experiment), room 
lighting / noise and methodology for transferring data in an efficient way. All of these 
issues were corrected prior to the full testing of subjects.  
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CHAPTER 6: RESULTS AND DISCUSSION 
6.1  INTRODUCTION 
As previously discussed, the success of advanced radiotherapy treatment modalities, 
— such as IMRT or very small field treatments — crucially depends on the ability to 
control (conform) the tumouricidal dose to the Planning Treatment Volume (PTV) 
while also sparing the healthy tissue and organs at risk. This is limited in turn by our 
ability to control how the treatment is delivered during the natural movement of the 
tumour, and currently depends on the stability and reproducibility of the patient’s 
breathing pattern.  
A portable monitoring system was designed, built and tested, as discussed 
previously. The device allows the patient’s breathing to be monitored, displayed and 
analysed in real time, and further permits various training techniques to be 
investigated via the presentation of a training or feedback waveform (visual or 
audible). The system does not rely on integration with the treatment machine, but is 
wholly independent of it, so it can, in principle, be used both inside the treatment 
room during treatment (following a training session), allowing patients to actively 
control their breathing in accordance with some agreed optimum feedback signal, 
and as a training aid prior to treatment so that patients can control their breathing in a 
passive way, without the use of the device.  
This chapter examines the relative appropriateness of the methods of providing 
the feedback signal to ensure that the subject’s breathing is repeatable. Such a 
signal would act as the guide-signal in the event that the device was used inside the 
treatment room during treatment, or simply as the training signal if the system was 
used purely outside the treatment room as an aid to passive breathing during 
treatment. 
 
6.2  SUBJECTS’ CHARACTERISTICS 
During this study, all fifty-one subjects were unpaid volunteers, divided into two 
groups. The first group consisted of healthy volunteers, each of whom was aged 
between 18 and 48 years old and had no health condition or smoking history; thirty-
eight were students or staff of City University or their family members. All of the 
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participants joined the project either after reading the flyer or because they worked in 
the same office or had otherwise received a personal invitation to join. All were 
considered to be physically active, practicing sport and exercising as a regular 
routine in their daily lives.  
This group was investigated in a simulated room within the SAAD Centre at City 
University, London. This was a fully equipped diagnostic room used in the training of 
therapy and diagnostic radiographers. It mimicked, as closely as possible, the 
treatment room within a radiotherapy department. The subject was placed on a 
medical couch in a position typically adopted for radiotherapy treatment. 
The second group of four subjects comprised elderly relatives and friends in a 
nursing home, whose ages ranged from 56 years to 70 years. Each of them was very 
well mentally oriented, able to discuss and sign the consent forms, and experienced 
no problems with vision or hearing. The subjects there had a full introduction session 
concerning the device and the purpose of the study, and had the right to ask any 
questions. Three of the volunteers within this group had been smokers for a long time 
before quitting, while the remaining member still smoked. There were no health 
conditions of which we should have been aware besides coughing and mild 
rheumatism; none of the participants had cancer or severe pulmonary dysfunction. 
These subjects were measured in the nursing home, since they could not visit the 
SAAD Centre. Analysis was undertaken with the subject recumbent in a quiet room. 
The subjects had no problem with measurement and could cope with the duration of 
the sessions; there was minimum distraction caused by coughing or having to ask 
questions.  
The study was conducted over a period of several months. The data from one 
subject was rejected as it was later discovered that the subject had only one lung – 
but this had not been revealed to the researcher before testing. Thus 50 subjects in 
total were included in the analysis. 
Access to the nursing home proved to be time-restrictive, which imposed a further 
significant restriction on the total number of subjects who could be investigated. 
Typically, a single investigation would take approximately one hour. 
The experimental procedure adopted for all measurements on all subjects is fully 
discussed in Chapter 5. 
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6.3  FREE-BREATHING, UBIQUITOUS SINE-WAVE FORMULATION AND AMPLITUDE 
GATING 
For several years it has been common practice, as advocated by several research 
groups, to treat a patient’s breathing pattern effectively as a single sine wave with a 
fixed period and amplitude. Hence, it is often assumed that treatment gating can be 
set using a single period with the patient breathing freely. Contrary to this 
assumption, our evidence suggests that such a technique is inadequate for deriving a 
gating procedure. Figures 25 and 26 are examples of free-breathing patterns from 
two subjects measured during this work. The individual traces correspond to isolated 
inhale-exhale cycles (of which only seven are shown in each plot for brevity). These 
figures have been created by chopping individual cycles out of the subject’s wave 
form and laying them on top of each other. What is evident from this is that the 
amplitude and position of maximal inhalation (corresponding to the phase) and the 
period vary from cycle to cycle. The effect is subject-dependent, as can be seen by 
comparing Figures 25 and 26. For example, in Figure 25 the variation in all 
parameters is quite pronounced, while subject B, as shown in Figure 26, had a more 
tightly controlled breathing pattern. He had the ability to produce a more stable 
breathing pattern, which has limiting effects on the period and amplitude in his 
breathing cycle. Looking at Figure 26 on the time axis, we can see that the subject 
was limiting his breathing period between 30.75 and 34 seconds, whereas Figure 25 
shows that for subject A, the period shifted in every cycle. The variation in period, 
amplitude and phase shown in Figures 25 and 26 were all replicated for all subjects 
studied in this work; clearly then, it is inappropriate to attempt to gate a treatment 
under the assumptions of consistency in amplitude, period or phase for free-
breathing. 
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Fig. 25: Variation in free-breathing pattern for subject A. 
Each curve represents a measured inhalation-exhalation cycle. Seven cycles are 
shown, superimposed in the time domain. Clearly, the shape, period and location of 
maximum change from cycle to cycle, as does the baseline level. 
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Fig. 26: Variation in free-breathing pattern for subject B. 
Each curve represents a measured inhalation-exhalation cycle. Seven cycles 
are shown. Here the location of the maxima, the baseline level and the period 
are more consistent from cycle to cycle than for subject A in Figure 25. 
 
6.3.1 BASELINE SHIFT PHENOMENON 
Figure 27 shows a trace from subject B; again, this is a free-breathing trace, so there 
was no feedback or breath training. The trace shows a characteristic changing 
baseline, which corresponds to the subject slowly changing the style of breathing by 
not completely emptying the lungs during the exhale portion of the cycle. It 
demonstrates quite graphically an interesting problem which can arise if we choose 
to gate the radiotherapy beam on amplitude criteria. If, as is usual practice, we set an 
amplitude window based on the exhale portion of the breathing pattern, then the 
shifting baseline will eventually force the treatment to a halt; although the phase may 
be correct, the patient is breathing outside the window. In such a case, the treatment 
would stop even though it is likely that the tumour is within the treatment beam. This 
effect is shown in Figure 27, where an exhale amplitude window has been 
superimposed on the breathing pattern of Figure 28. During the real-time treatment 
with gating, the verification for tumour position would be checked using EPI, portal 
film or by tracking, as explained earlier in Chapter three, where here we are 
estimating the shift from the subject’s real-time breathing trace and studying what 
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might happen if the gating window were set either at the exhale amplitude maximum 
or the inhale amplitude maximum. 
Fig 27: Free breathing trace for subject B. 
The subject had no training: note the irregularity in breathing pattern and the changing 
baseline (corresponding to a change in the subject’s mean chest position at exhale). 
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Fig 28: Exhale amplitude window. 
This shows difficulties which can arise in setting a treatment (beam-on) window 
based simply on the free-breathing pattern when, in this case, using the exhale portion of 
the cycle. The beam is switched on only when the exhale maximum (positions of 
minimum displacement on this graph) falls within the shaded trigger region. Beyond 
about 60 seconds, the machine will be turned off even if the phase (local position in time) 
of the breathing is correct. 
The opposite effect would occur in this case if gating were to be set on the inhale 
amplitude. This is shown in Figure 29, where the machine would switch on between 
20 seconds and 100 seconds, irrespective of the phase. 
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Fig 29: Inhale amplitude window. 
When the window is based on the inhale portion of the subject’s breathing, the 
opposite effect to that shown in Figure 27 occurs. From about 20 seconds to 100 
seconds, the beam will trigger irrespective of the phase (time position of the 
maximum). In other words, even if the tumour is in a position which is diametrically 
opposed to its required position, the beam will nevertheless be switched on 
because the amplitude is within the window. 
 
Figures 27 to 29 demonstrate the importance of controlling both the amplitude 
and the phase of the patient’s breathing pattern, and of gating on phase (and 
possibly amplitude), rather than amplitude alone. All of the 50 subjects who were 
examined and measured produced the baseline shift, as explained above, due to the 
fact that they would not take a full inhalation as they were supposed to, or they did 
not totally exhale and empty their lungs. This phenomenon of baseline shifting was 
even worse with elderly subjects and smokers.  
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6.3.2  BREATHING WITH FEEDBACK – SIMPLE COMPARISON 
Figures 30 to 32 demonstrate the effects of feedback on a subject’s breathing 
pattern. Again, subject B is presented, and so Figure 30 should be compared directly 
with Figure 28 for a simple comparison of Free-Breathing and breathing with 
feedback. Using video feedback where the subject’s real-time breathing trace is 
presented to the subject overlaying a ‘desired’ breathing waveform, the subject is 
able to remove the baseline drift in his or her breathing, and ensure that the 
amplitude remains reasonably constant, as seen in Figure 30, with the peaks and 
troughs staying mostly between approximately 150 and 110 units respectively. In 
Figure 30 the training signal has been removed for clarity; however, this can be seen 
in Figures 31 and 32, where it is clear that the phase of the subject’s breathing (the 
relative positions of the peaks and troughs with respect to the guiding signal) does 
not change significantly. 
 
Fig 30: Video-trained breathing trace for subject B 
The training signal has been removed for clarity. Notice how the breathing 
pattern does not show the baseline drift present in the free breathing trace 
(Figure 27). 
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Fig. 31: Video-trained breathing trace (blue) for subject B & the training pattern 
(black) 
For clarity we have limited the time axis to 80 seconds, but the pattern persists 
beyond this (see Figure 32). The subject is seen to match the peaks and troughs of the 
training signal (period and phase) very well, while the amplitude (depth of breathing) is 
relatively constant. 
Fig. 32: Video-trained breathing trace (blue) for subject B & training pattern (black) for 
the whole measurement period. 
Consistency is maintained throughout. 
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6.3.3  BREATHING WITH IN/OUT AUDIO PROMPTING – SIMPLE COMPARISON 
Figure 33 shows the same subject (B) breathing under audio prompting (the 
researcher addressing the subject with in/out commands, but without the subject 
seeing either his/her own breathing signal or a guide signal). Here we are able to see 
the effect of the delayed feedback, as the researcher is responding to the position of 
the subject’s trace relative to the guide signal and attempting to cause the subject to 
regulate his/her breathing by matching it to the ‘ideal’. In comparison to Figures 27 
and 30, it is evident that the average stability of the subject’s breathing (amplitude, 
period and phase) varies less in the case of the video feedback session than for the 
audio prompting session which, in turn, is considered to be far more stable than the 
Free-Breathing session. This pattern was generally repeated throughout the studies 
reported within this thesis, as will be demonstrated in the remainder of this chapter. 
Fig. 33: Audio prompted breathing trace (blue) for subject B & the ideal pattern (pink) 
The researcher used in/out prompts to attempt to regulate the subject’s breathing and 
to match it in amplitude and period to that of the ideal pattern. Shown here is a 
section from 100 to 260 seconds. Clearly, the match is less than good. 
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6.3.4  RANGE OF MOTION ANALYSIS 
In this section, we are able to compare the variation in the inhalation and exhalation 
depth across all subjects for free-breathing, audio prompting and video feedback. 
Despite the fact that the breathing analysis system used in this work could be directly 
calibrated to provide an absolute measure of breathing depth (cm), this was not 
practical, as it would have required recalibration several times during a 
measurement. For example, the calibration would change if the belt were moved 
between measurements; instead, only relative measurements were taken, but these 
were normalised to the same baseline in order to allow a comparison between 
subjects.  
Thus, if we denote the inhalation maxima by Imax and the exhalation maxima by 
Emax, then we define the mid-point of the tidal displacement for cycle i as: 
( )maxmax
2
1
iii EI +=∆         
 1 
We then define: 
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to be the normalised maximum inhalation and normalised maximum exhalation 
for the ith cycle. By doing this, we are effectively removing any necessity to calibrate 
the system, which ultimately allows all measurements to be simply compared. Notice 
that the normalised values are all dimensionless numbers. 
In an obvious way, we define the averages over all cycles to be: 
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Similarly, we define the second moment (variance) as: 
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The quantity ( )•S  is the estimated standard deviation of the population for the 
variable x  based on the values of ix  which were actually sampled. The estimated 
variance of x  is given by 
N
SS
x
2
2
= , where x  stands for either maxI  or maxE , 
depending on whether we are considering inhalation or exhalation respectively. 
Notice that these expressions do not solely depend on any restriction on the 
distributions of x  or x , such as normality, beyond requiring the first moment (mean) 
and the second moment (variance) exist and are finite. However, it would have been 
difficult to test whether these last two conditions were true for the samples 
considered, and so we opted to test for normality of the data using the Kolmogorov-
Smirnov test. As such, we therefore computed the means and standard variations, 
which are sufficient to fully characterising the underlying distributions, provided that 
trends have been removed (where appropriate) and the data passed the 
Kolmogorov-Smirnov test for normal distributions.  
The range of motion (RoM) provides information on the maximum displacement 
of the abdomen and, thereby, under the overall assumption of correlation, on the 
maximum displacement of a lung tumour. We computed the average RoM and the 
standard deviation for all subjects for each of the different techniques: free-breathing, 
audio prompting and video feedback. 
Figures 34 to 36 show the average RoM for all subjects as defined using 
Equation 3. Figures 37 to 39 show the corresponding standard deviation analysis 
using Equations 4. For all data, we used the null hypothesis of a normal distribution 
in the Kolmogorov-Smirnov test and accepted this for D values <0.08. All data — 
except for that corresponding to one subject — were accepted as approximately 
normal. Data for the apparently non-normal subject showed bi-modal behaviour; the 
subject had no defined respiratory illness specified at the time of testing, but later 
discussions revealed that the subject had only one lung; this data was therefore 
rejected from the current analysis. 
When comparing Figures 34-36, it is clear that the RoM was generally largest in 
the case of AP, with more extreme inhalation/exhalation swings than for any other 
technique, while the range of motion was least for the video feedback technique, the 
excursions in inhalation/exhalation were slightly less than for FB and considerably 
less than for AP. 
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Fig. 34: Free breathing range of motion analysis for every subject 
The RoM is defined by Equation 3 and represents the difference in the mean maximum 
inhalation and the mean maximum exhalation for a given subject. 
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Fig. 35: Audio prompted breathing range of motion analysis for every subject 
The RoM is defined by Equation 3 and represents the difference in the mean maximum 
inhalation and the mean maximum exhalation for a given subject. 
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Fig. 36: Video feedback range of motion analysis for all subjects 
The RoM is defined by Equation 3 and represents the difference in the mean maximum 
inhalation and the mean maximum exhalation for a given subject. 
Figures 37-39 show the mean standard deviation (averaged over all cycles for a 
given subject) for each subject. It is clear from the comparison of these figures that 
VF reduced considerably the variation in breathing depth in comparison to free 
breathing, whilst AP increased the swings in inhalation and exhalation in comparison 
to free breathing. 
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Fig. 37: Free-breathing standard deviation of range of motion analysis for every subject 
The standard deviation is expressed in Equation 4 and represents the variation in the 
difference between maximum inhalation and maximum exhalation over all cycles for each 
subject. 
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Fig. 38: Audio prompting standard deviation of range of motion analysis for all subjects 
The standard deviation is expressed in Equation 4 and represents the variation in the 
difference between maximum inhalation and maximum exhalation over all cycles for each 
subject. 
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Fig. 39: Video feedback standard deviation of range of motion analysis for all 
subjects.  The standard deviation is expressed in Equation 4 and represents the variation 
in the difference between maximum inhalation and maximum exhalation over all cycles 
for each subject. 
 
Table 7 provides a summary of the statistical parameters (mean value x ), 
standard deviation (σ ) and 68% confidence interval ( σ±x ) for the range of 
motion, as described in Figures 34-39. What is now clear is that video feedback 
offers an improvement in the ability of subjects to regulate their breathing patterns (at 
the 68% level), ultimately allowing them to reduce the overall swing in the 
inhalation/exhalation pattern, and to further reduce the variation in these swings over 
the measured breathing time of 4 minuets. Furthermore, it is apparent that audio 
prompting disturbs the subjects’ breathing (at the 68% level), causing more violent 
swings in inhalation and exhalation when compared to both Free-Breathing and 
video-feedback.  
 
 
 Mean ( x ) Standard 
deviation (σ ) σ±x  
Free breathing 1.13 0.2 [0.93, 1.33] 
Audio  prompting 1.82 0.3 [1.52, 2.12] 
Video-feedback 0.66 0.1 [0.56, 0.76] 
 
Table 7: Summary of distribution statistics for each technique, with 68% confidence 
interval (column 4) 
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6.3.5  PHASE DRIFT CONTROL ANALYSIS 
In this section we will investigate how well the subjects are able to control the phase 
of their breathing throughout the 4-minute measurement period: If the breathing 
phase changes in relation to the ideal waveform, the position of the maximum 
inhalation or maximum exhalation will then occur at a later or earlier time than 
expected; if this occurs during treatment, the tumour will be out of position and the 
dose distribution will be correspondingly wrong. Figure 40 is a graphical illustration of 
this; notice that, although the period and amplitude of the ideal waveform and the 
subject waveform are identical, the peaks and troughs occur at different times. If the 
treatment machine is being switched on at the time when the ideal signal is at a 
minimum (maximum exhalation), then due to the fact that there is a phase difference, 
the subject has gone beyond the maximum exhalation point and started to inhale, 
and so the tumour will not be in the expected position.  
 
Fig 40: The concept and implication of differing phases. 
The blue curve represents an ideal (expected) breathing pattern, whilst the pink curve 
shows a subject breathing slightly out of phase — i.e. peaks (and troughs) of the two 
curves occur at different times. Both curves have the same amplitude and period 
(distance between peaks). Clearly the trough (peak) of the ideal curve occurs after that 
of the subject, so that a beam switched on at this point will not have the subject at the 
maximum exhalation (inhalation) point. 
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For every subject, the position of every maximum inhalation and every maximum 
exhalation was determined for each 4-minute measurement period. This was done 
for all techniques: FB, AP and VF. For AP and VF, these positions (in time) were 
compared with the associated ideal curve which the subject was attempting to 
replicate; this was not applicable in the case of FB where the subject was simply 
Free-Breathing with no ideal curve. To the knowledge of the author, this is the first 
time such an analysis has been attempted. 
Figure 41 shows a typical phase analysis for a subject during audio prompting. Figure 
42 shows the corresponding plot for video feedback. 
Fig 41: Difference in peak arrival-time between ideal waveform and subject’s measured 
breathing pattern under audio prompting (Subject 2) 
The vertical axis represents this difference; clearly there is a significant degree of 
variation in arrival time compared with the corresponding VF plot shown in Fig 42. 
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Fig 42: Difference in peak arrival time between ideal waveform and subject’s measured 
breathing pattern under video feedback (Subject 2) 
The vertical axis represents this difference; clearly, the degree of variation in arrival 
time is reduced compared to the corresponding AP plot shown in Figure 41. 
 
Figure 43 shows a plot of the average time-of-arrival difference (averaged across 
all cycles) for each subject under the AP technique.  The range of arrival time 
differences was approximately -2.2 seconds to +1.5 seconds; comparing this to the 
average period over all subjects and all cycles of approximately 4 seconds, we are 
able to determine that this corresponds to a large phase shift. The mean value of the 
time difference was approximately +0.6 seconds, with no indication of significant drift 
over the measurement period. 
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Fig 43: Difference in arrival time (averaged over cycles) between ideal waveform and 
subject’s measured breathing pattern under audio prompting. 
The ideal waveform for each subject is derived from the FB analysis prior to the AP 
measurement. 
 
In comparison, Figure 44 shows the results for the VF technique. It can be 
immediately seen in this instance that the control of the breathing phase over all 
subjects was much improved when compared to AP breathing. The figures in this 
case ranged from approximately -0.25 seconds to +0.1 seconds, with the mean value 
being approximately -0.07 seconds, and there being no indication of drift over the 
measurement period. 
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Fig 44: Difference in arrival time (averaged over cycles) between ideal waveform and 
subject’s measured breathing pattern under video feedback 
The ideal waveform for each subject is derived from the FB analysis prior to the VF 
measurement. 
 
Table 8 summarises the statistical data. Again, as the data are approximately 
normal, the mean and standard deviation are sufficient to characterising the 
distributions. 
 
 Mean ( x ) Standard 
deviation (σ ) σ±x  
AP 0.647 0.474 [+0.173, +1.12] 
VF -0.066 0.085 [-0.092, +0.019] 
 
Table 8: Summary of means and standard deviations for mean difference in arrival times 
of peaks/troughs for each technique, with 68% confidence interval (column 4) 
 
Table 8 shows that the VF procedure provides a much tighter control over the 
breathing phase than the AP technique does, with an SD of 0.09 for VF compared to 
0.47 for AP. It can also be seen that, for VF, on average, the subjects’ breathing 
showed little phase difference from the ideal wave form, while there was 
nevertheless a large phase difference in the case of AP: The mean differences were 
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0.65 seconds and -0.1 seconds for AP and VF respectively; the means come from 
different distributions and is significant at the 68% level with p≤0.001 from a t-test (in 
fact, it was also highly significant at the 99.98% level). Thus, we conclude that the 
difference in means is highly significant and VF provides a far better approach to 
regulating the phase than does AP. 
 
6.3.6  PHASE-SHIFTING IN FREE BREATHING 
It is instructive to consider how a subject’s Free-Breathing changed over the course 
of a 4-minute measurement period; this was done by making an estimate of the initial 
breathing period for each subject by averaging the inter-peak and inter-trough times 
(periods) over 30 seconds, beginning at 15 seconds after the start of the 
measurement (subject-by-subject). In other words, the FB measurement was made 
over 4 minutes and recorded; post-analysis was performed in order to establish the 
inter-peak/-trough times from a point 15 seconds after the recording started. This 
‘shakedown’ time allowed the subject to establish regular breathing, and ultimately 
avoided any initial disturbances.   
For a single subject, from the derived average period (averaged over 30 
seconds), a simulated cycle was generated which assumed, as before, a simple sine 
wave of single period (equal to the derived average). This was then compared with 
the recorded breathing wave, assuming that both started at time t=15 seconds and 
were initially in phase. From this, an analysis identical to that above was performed, 
i.e. the average difference in arrival time (over all cycles starting from t=15 seconds) 
was computed, together with the standard deviation. This was then repeated for all 
subjects; this approach is similar to a rather crude auto-correlation analysis. 
Figure 45 shows the average time of arrival difference for each subject based on 
the assumptions previously discussed. A sensitivity analysis of the mean period 
showed that shifting, reducing or increasing the settling time resulted in less than 4% 
change in the calculated period. 
The sensitivity in respect of the assumption that the ideal cycle and the measured 
cycle started in phase was approximately 10%. These sensitivities have been 
included in the calculation of the standard deviation, assuming Gaussian statistics. 
Thus, the standard deviation in this case is calculated as: 
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( ) ( ) ( )222*
111
Vσσσ
+=                                                                                  5     
where σ  represents the purely statistical standard deviation from the random 
fluctuations in the data and ( )Vσ  represents the component of variation derived from 
perturbing the initial phase and assumed period. In fact, these were also combined 
assuming Gaussian statistics and no correlation, thus: 
( ) ( ) ( )222
111
TSPSV σσσ
+=                                                                          6 
where ( )2PSσ  is the variance associated with shifting the phase and ( )2TSσ  is the 
variance associated with shifting the period. 
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Fig 45: Difference in arrival time (averaged over cycles) between a waveform (based on the 
first 30-second average period derived from subject’s free breathing) and subject’s free 
breathing pattern 
The graph suggests that FB is slightly worse than VF in controlling the phase (cf Figure 44) 
but apparently better than AP (cf Figure 43). 
 
The mean difference in arrival time and associated standard deviation are shown 
in Table 9, together with the 68% confidence interval. Again, a simple t-test indicates 
that the means for FB and VF did not come from the same distribution (p≤0.001). 
Thus we conclude that VF provides a better phase control than FB. 
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 Mean ( x ) Standard 
deviation (σ *) σ±x * 
FB 0.277 0.278 [-0.001, 0.555] 
 
Table 9: Statistical parameters for phase control of free breathing 
 
In all of the above we have used the usual definition for the t-statistic: 
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where mms σ≈  for manoeuvre m and mN  is the population size for manoeuvre 
m. The test was performed as a two-tailed test with one degree of freedom in each 
case. 
 
6.3.7  FIGURE OF MERIT 
Just as it was pointed out above that basing a gating system on the amplitude of 
breathing alone is not wise, it can also be argued that while, theoretically, it is far 
better to gate on phase, it is probably better still to do so, if possible, on both 
amplitude and phase. In this vein, a simple Figure of Merit (FoM) is here proposed in 
order to attempt to establish whether one technique is better than another; this FoM 
takes into consideration the ability to control both phase and amplitude, and is given 
by: 
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where the A and P represent amplitude and phase respectively, x∆ is the mean 
difference between the desired amplitude and the subject’s measured amplitude over 
all measurement cycles and all subjects, and pt∆  is the mean difference between 
the times of arrival of the desired breathing and the measured breathing over all 
cycles and all subjects. Notice that a modulus has been included in the denominator, 
as the difference in amplitude can be negative or positive, as defined earlier, but in 
reality, this is of no consequence here. Furthermore, for the FoM to be a real number, 
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the denominator of the final expression must be positive, so it is always true that FoM 
≥ 0. Thus, as the standard deviation decreases, and so the FoM increases; similarly, 
as the amplitude increases further from the desired amplitude, so the FoM 
decreases. 
The technique with the greatest FoM is thus best at controlling the overall 
breathing cycle, considering both the phase and amplitude together. For the 
techniques considered in this work, the composite FoMs are derived from Tables 7 to 
9 and Equation 8, and summarised in Table 10. It should be noted that the FoM, as 
proposed here, is approximately linear with the combined variation in standard 
deviations and means, so that a doubling of the FoM implies, in some way, that the 
technique is twice as good. 
 
Technique FoM 
FB 2.8   (3) 
AP 1.6   (2) 
VF 7.3   (7) 
 
Table 10: Calculated values of the figure of merit  
(as defined by Equation 8 and using the data presented in Tables 7, 8 and 9. The higher 
the FoM the better is the technique. The table shows that VF is better at controlling the 
breathing cycle than either FB or AP and that AP performs the worst) 
 
Thus, we see that an advantage is gained in terms of using VF against either FB 
or AP, and that AP is the worst technique to use when attempting to control and 
regulate both the phase and amplitude of a subject’s breathing.  
 
6.4  SUMMARY 
This chapter has reported the use of the breathing monitor whose design was 
discussed in previous chapters. The effects of different techniques designed to 
regulate a patient’s breathing were also investigated in a population of some 50 
subjects, each of whom were randomly chosen and ranging in age from 18 to 72 
years. Three regulation techniques were investigated: Free-Breathing, visual 
feedback and audio prompting, with the latter being the method most commonly used 
in order to regulate a patient’s breathing. It has been demonstrated that the 
commonly-held assumption that FB can be described by a simple sine wave with a 
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single period and amplitude is false, and that gating a radiotherapy treatment on 
amplitude — the most common practice and founded on the above assumption — is 
not wise (see Figures 25-29). Figures 30-32 show how the FB for a given subject 
was modified by applying VF, while Figure 33 shows how using AP can have a 
worsening affect on the breathing pattern of a subject by producing exaggerated 
amplitude swings.  
A range-of-motion analysis was performed for each technique and for every 
subject. Figures 34-39 show graphically how the mean RoM and its associated 
standard variation were affected by the different techniques. Table 7 summarises the 
results and suggests that VF allowed subjects to better control their breathing in 
terms of both the mean RoM and of the standard deviation. Although this is clearly 
significant from the table (the 68% confidence interval), a t-test was performed which 
rejected the null hypothesis that the means came from the same distribution (VF v 
AP, VF v FB and AP v FB); thus it was concluded that, in terms or RoM, the order of 
preference is VF first, followed by FB and by AP last. 
The effects of the different techniques on the phase control of a subject’s 
breathing were also analysed for AP and VF. Figures 41-44 demonstrate this 
graphically and Table 7 summarises the results. The order of preference (VF first, 
followed by AP) was found to be statistically significant. 
An analysis of phase control, akin to a crude autocorrelation analysis, was 
conducted for the case of FB. A sine wave was derived from a 30-second average 
(period and amplitude) of the FB trace. The peak arrival times of the FB trace were 
then compared with the expected arrival times of the stationary simulation wave. A 
sensitivity study was conducted in order to investigate thoroughly how the arrival 
times varied as the assumed period and assumed epoch were varied, and this was 
built into the analysis of variance for the overall results. Figure 45 and Table 9 
summarise these results.  
In Figure 45, the time difference of each cycle arrived for each subject is shown; 
when we compared the real time of each FB cycle arriving with the ideal free-
breathing that had been established and built into the model, the model then took 
account of the average of the thirty-second period and estimated the rest for the total 
measuring time (4 minutes); the mean and standard variation were then compared 
with those for AP and VF, allowing the conclusion that in terms of phase control, the 
statistically significant preference was VF, followed by FB and finally AP. 
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Finally, a figure of merit was proposed (Equation 8) which took into account the 
effects of phase and amplitude to rank the different techniques. Table 10 summarises 
the FoM for each of these, and allows us to conclude that VF is by far the most 
effective technique for regulating a patient’s breathing in terms of both amplitude and 
phase, while the worst method is considered to be AP, which is, unfortunately, 
currently the most popular approach. If some form of breathing monitor and VF 
system is not available, then the best approach would be to leave the patient to 
breathe freely.  
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CHAPTER 7: CONCLUDING COMMENTS 
This work has analysed the effectiveness of different breath control methods in 
establishing a regular respiratory pattern appropriate for subjects undergoing 
radiotherapy on mobile lung tumours. The aim of such breath control techniques is to 
increase the fidelity of the treatment; this is achieved through two complimentary 
effects:  
• By reducing the frequency and extent to which the tumour moves out of the 
treatment beam; and  
• By reducing the frequency and extent to which healthy tissue and organs at 
risk move into the treatment beam.  
Although this work was based on a relatively small subject population size, it has 
nevertheless conclusively demonstrated that an approach based on visual feedback 
offers the greatest degree of control. It has also demonstrated that audio prompting 
(the method most commonly used today) is by far the least effective approach of the 
three considered. 
Whilst audio prompting appears to improve the phase-control of breathing over 
free-breathing, it also results in more abrupt and larger swings in amplitude, thus 
presumably driving the tumour out of the beam further than would occur in free-
breathing and thereby destroying the desired uniform dose distribution over the 
tumour, reducing both the tumour dose and the TCP. Concomitantly, more healthy 
tissue would be driven into the beam, distorting the desired isodose distribution, 
increasing the non-tumour dose and thus the NTCP. Together, these would 
presumably reduce the efficacy of the treatment and the patient’s survival probability.  
In the above paragraph, I have used the term ‘presumably’, as there is currently 
no firm evidence which conclusively demonstrates the effects that breathing-induced 
tumour motion has on the dose-volume histogram and three-dimensional dose 
distribution for a prescribed treatment. However, a recent study by Britton (2009) 
investigated the effects of respiratory motion during the course of treatment of 
NSCLC internal anatomy, normal tissues and dose distributions, using weekly four-
dimensional computed tomography scans. The study concluded that there was a 
small dosimetric variation (mean and SD differences between the prescribed dose to 
PTV and the internal target volume using 4-DCT were -11.9% ± 12.1% and -2.5% ± 
3.9%, correspondingly, and -2.3% ± 4.1 for the ITV). The study recommended the 
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use of image-guided treatment for any locally advanced lung cancer patients for the 
duration of treatment.  
Furthermore, the exact correlation between the tumour motion and externally-
measured breathing has not yet been established, although it is fair to say that all the 
evidence gathered from the fluoroscopic measurements suggests a strong direct 
correlation. What is clear, however, is that the more tightly the dose is conformed to 
the tumour (as in the now routine use of IMRT), the greater the risk of the tumour 
partially moving out of the field during treatment, ultimately leading to underdosing 
and an inhomogeneous dose distribution; the consequence will be an increase in the 
probability of incomplete tumour kill and hence of tumour cell repopulation. 
Video feedback showed a clear improvement in the phase control of the subject’s 
breathing (as did audio prompting) and in amplitude control (unlike audio prompting). 
Together, such control results in a much closer match of the subject’s breathing cycle 
to the desired periodic cycle. Using such a method allows for an accurate approach 
to administering gated radiotherapy, as it makes possible a more precise calculation 
of the correct times at which the beam can be switched on (when the tumour is in the 
correct place) and off (when the tumour has been forced out of position by the 
patient’s breathing). Closely tuning the patient’s breathing to the desired regular 
waveform will maximise the duty cycle, which is the ratio between the beam-on time 
(treating) and beam-off time (non-treating).  
In the case of audio prompting, the duty cycle would decrease as the machine 
would switch off during the frequent amplitude excursions, and so the overall 
treatment time would increase; as a result, the patient might then be less tolerant of 
the treatment, as a consequence of having to remain lying for longer in what may be 
a slightly uncomfortable position. Furthermore, it would potentially reduce the 
throughput of patients within the hospital, and thereby increase the cost of treatment. 
In this study, it was not possible to investigate the possibility of video training 
which involves using the video feedback system prior to treatment in order to train 
patients to breathe regularly. However, even if this method did work, it would 
significantly increase the resources needed for a given treatment, which goes rather 
against the spirit of quality control, as there would be no evidence of correct machine 
synchronisation during the treatment.  
 138
All subjects studied during this work tolerated the monitoring belt and feedback 
method well; the system was quick to position on the subject and is inexpensive. It 
therefore seems reasonable to draw the conclusion that there would be little or no 
advantage to using video training in most cases. 
The project was mostly carried out in order to establish a way of helping patients 
with NSCLC to produce stable breathing patterns, which would then eliminate the 
extra advanced machines and radiation dose that might otherwise be required. 
During the time of this project, other devices — such as Stardust, as was explained 
in Chapter Four — were investigated for use; however, it was found that such 
methods required extra hardware and accessories to be employed during the 
measurement. Furthermore, the project was time- and budget-limited in such a way 
that we were unable to include a higher number of subjects or otherwise to spend 
time interviewing and collecting surveys. After a series of searching and reviewing 
the literature in this field, a device was built to our specifications and then tested in 
order to determine whether we could help to produce a stable breathing pattern.  
Our results are similar to those obtained by Kini et al. (2003) and Keall et al. 
(2006), who found that patient coaching — using audio prompting or video feedback 
— would improve the breathing patterns and ultimately increase the reproducibility. 
However, these earlier studies were carried out with the objective of investigating the 
use of this coaching during respiratory gating radiotherapy, with the aim of improving 
the outcome of treatment, whereas the present study aimed to improve the breathing 
pattern first, so that it could then be incorporated in the radiation therapy treatment.  
 
7.1.  STUDY LIMITATIONS 
During the project some limitations were experienced, the main ones being: 
a) The timeframe — the project had to be completed within 3 years; 
b) Cost — the project was budget-limited; 
c) Device building and testing; 
d) No access to a real treatment unit; 
e) Subject recruitment and time spent with everyone. 
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Some more detailed limitations of the project were as follows: 
• It took a full hour to measure each subject, which included explaining the 
procedure, setting up and measuring. In the early part of the study, we began 
each session with FB, then randomly progressed onto either audio-prompting 
measurement or video prompting feedback. At this point, we established that 
when the video was done before the audio, the belt had always moved and 
was never in the initial position. This was due to the fact that during VF, the 
subject had to move the monitor according to his or her preference, which 
then gave us a reading which was different to the reading we expected from 
the ideal patterns. In addition, the time of measurement would be longer, 
since the belt had to be restored to the correct position and the measurement 
started again from free-breathing. After a while, we decided to follow the order 
which had been adopted by Kini et al., 2003, in which the free-breathing 
method is implemented first, followed by audio-prompting and finally video 
feedback. 
• It was noted that during our measurements, six subjects did better with audio 
prompting and felt more satisfied when following the voice commands of 
‘breathe in’ and ‘breathe out’, then following their own breathing patterns. 
However, investigating the difference between visual learners and audio 
learners is outside the scope of this thesis. 
• No data was collected on how this measurement needed to improve and what 
the subjects’ recommendations were. The aim at the beginning of the study 
was to interview each participant and ask them after the measurement to 
complete a questionnaire form concerning how the measurement could be 
improved. However, given the time restrictions and the subjects’ desire to 
leave the measurement room, this stage was omitted. 
 
7.2  FURTHER WORK AND RECOMMENDATIONS 
There is still much further work to be completed in order for the device to be proven 
for clinical use. First, there is a need for the device to be made as rugged and 
durable as possible so that it would not be affected if accidently dropped; second, the 
sensor needs to be changed in such a way that it could be placed in the middle of the 
chest instead of at the left side of the subject; third, the device and the sensor should 
be wireless so that the patient would be able to use it in the treatment room while the 
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laptop or PC would be in the console area; fourth, the belt needs to be made of a 
suitable cloth material which would not irritate the patient’s skin and the buckle needs 
to be positioned at the front; fifth, the belt needs to have a proper marker so that 
when the patient changes his position, it can be put back to a default position; finally, 
suitable software needs to be built in order to analyse the data thoroughly and 
effectively instead of having to use Microsoft Excel, which is time-consuming, as it 
can take up to a full day to complete each subject’s analysis.  
It is the researcher’s belief that if all of these recommendations were to be 
implemented, the device would then need to be examined on patients with NSCLC 
after having approval from the ethics Committee or Trust. 
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APPENDIX A 
 
APPENDIX ON TESTING THE DEVICE 
 
 
 
A1. Displacement-time tests. 
 
This test was performed in order to check that the monitor correctly followed a well 
calibrated sinusoidal motion – the period of which was similar to that expected for the 
breathing rate of a subject. The belt was tensioned over two pegs – one of which could 
be moved towards and away from the other (thereby reducing and increasing the 
tension in the belt). The movable peg was driven with a stepper motor controlled 
through a computer. The computer was programmed to activate the stepper motor so 
as to produce a in a series of sinusoidal displacements of the peg and the output of the 
belt monitored using its custom software. Figure 1 shows the recorded motion of the 
belt for a period of 5 seconds whilst figure 2 shows the recorded motion with an 
oscillatory period of 12 seconds. In each figure, the solid line represents the actual 
programmed motion of the peg whilst the solid dots are the recorded motion using the 
belt. For both figures, the recorded displacement is an average of 10 separate 
measurements. It is clear that the monitor is closely following the motion of the pegs 
with virtually no difference in the actual time displacement trace (amplitude and 
phase are consistent to better than 2 %). S mall discrepancy is seen where there is a 
rapid change – ie close to the maxima and minima of each cycle – but again this is 
less than 2%. 
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Figure 1: Displacement time trace for a cycle with 5 second period. The solid line is 
the actual mechanical oscillations whilst the solid symbols are the time displacement 
values measured using the monitor. 
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Figure 2: Displacement time trace for a cycle with 12 second period. The solid line is 
the actual mechanical oscillations whilst the solid symbols are the time displacement 
values measured using the monitor. 
 
 
 
 
A2. Stability measurements. 
 
A series of tests were performed to ensure that the monitor remained stable for a 
period of time – longer than the 1 hour expected for the subject tests. In this case, the 
belt was tensioned and the pegs remained stationary for approximately 2 hours. 
Output readings were taken every 1 min. Clearly these readings should be identical 
apart from system noise but there was a possibility that changes in environmental 
conditions eg temperature etc may affect the readings. For this reason, the belt and 
sensor were left close to an open window so that they saw any changes in local temp 
etc. Figure 3 shows the time trace of the output – in this case the average of five 
experiments. The variation is less than 1 % over the whole measurement time. Also 
shown on the graph is a trend line,. Ideally this should have zero slope – indicating no 
trend. The indicated slope is very small, amounting to a change in output of the device 
(over the 2 hours) far less than is statistically measurable – in other words there is no 
statistically significant output change over a 2 hour measurement period. 
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Figure 3. The stability of the output of the monitor is measured over a 2 hour period. 
The solid dots show the measured out put (for constant belt tension) every 1 min. The 
slightly sloping line is a curve fit to the data – this has zero as required. 
 
A3 Summary 
 
The above test clearly demonstrate that the sensor provides a signal that robustly 
follows the movement of the test bed – a sinusoidal oscillation with characteristics 
similar to that of normal human breathing (figures 1 and 2). Figure 3 demonstrates 
that the system is stable with respect to long term measurement (2 hours in this case) 
even when no attempt is made to isolate it from the changing environmental 
conditions. 
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APPENDIX C 
 
INFORMED CONSENT FORM FOR PROJECT PARTICIPANTS 
Project Title: 
DEVELOPMENT OF A BREATHING MONITOR AND TRAINING SYSTEM, AND THE 
ANALYSIS OF METHODS OF TRAINING PATIENTS TO REGULATE THEIR BREATHING WHEN 
UNDERGOING RADIOTHERAPY OF LUNG CANCER  
 
I agree to take part in the above City University research project. I have had the 
project explained to me and I have read the Explanatory Statement, which I may 
keep for my records. I understand that agreeing to take part means that I am willing 
to: 
• participate in a breathing study for the length of approximately 45-60 minutes 
• lie on a stretcher or on a clinical bed and have my breathing patterns 
recorded whilst following various instructions.  
 
DATA PROTECTION 
The data collected in this study will be held and processed to allow us to examine the 
best approach to creating a comfortable and stable breathing pattern in patients 
undergoing radiotherapy treatment of non small-cell lung cancer. 
I understand that any information I provide is confidential and that no information 
that could lead to my identification will be stored or disclosed in any reports on the 
project or to any other party.  
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WITHDRAWAL FROM THE STUDY 
I understand that my participation is voluntary, that I can choose not to participate in 
part or all of the project and that I can withdraw at any stage of the project without 
being penalised or disadvantaged in any way. 
 
COMPLAINTS PROCEDURE 
If at any time you have a complaint regarding the way in which the study has been 
conducted you may contact the secretary to the Ethics Committee, 
or by letter at the following address: 
Dr Roland Petchey 
Chairman of the Senate Ethics Committee 
City University, Northampton Square, London EC1V 0HB 
 
Name:      ........................................................................... (Please print) 
 
Signature:  .............................................................…  Date: ...................... 
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1. Please tick the following items which apply to you: 
 
 Sex: Male _____  Female _____ 
 
2. Do you have any health problems?  
 
 
  Yes_____                       No _____ 
 
If yes please state what they are: 
 
______________________________________________ 
 
 
3. Do you smoke? 
 
  
 Yes_____                       No _____ 
 
4. Do you practise any kind of sport or exercise? 
 
  
 Yes_____                       No _____ 
 
 
 
If yes, please state what: 
 
______________________________________________ 
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APPENDIX F 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Breathing 
Do you have 60 minutes of your spare time to help in a breathing study? All 
you need to do is relax and breathe normally whilst we measure your 
breathing profile. 
If you are  
 
 
 
